{
    "testId": 396303647,
    "parentTestId": null,
    "userId": 4331736,
    "sequenceId": 111,
    "qbankId": 2,
    "isSim": 0,
    "testModeId": 0,
    "testModeName": "Timed",
    "questionModeId": 0,
    "questionModeName": "ALL",
    "testName": "",
    "totalQuestionCorrect": 33,
    "correctToIncorrect": 1,
    "incorrectToCorrect": 1,
    "incorrectToIncorrect": 1,
    "timeInSeconds": 2903,
    "averageTimeSpentInSeconds": 107,
    "otherAverageTimeSpentInSeconds": 66,
    "isStarted": true,
    "isEnded": true,
    "formId": 0,
    "bLockId": 0,
    "subscriptionId": 13863865,
    "lastQuestionVisited": 40,
    "containsMediaQuestion": false,
    "sectionId": 1010,
    "sectionName": "Step 2 Review",
    "difficultyLevelId": null,
    "difficultyLevelName": null,
    "testTypeId": null,
    "testTypeName": null,
    "allottedTime": null,
    "allottedTimeTypeId": null,
    "canResume": null,
    "assignmentId": null,
    "canViewAssignmentResult": null,
    "questionModeIds": "1",
    "testSource": 1,
    "testTypes": "",
    "questionList": [
        {
            "exhibits": null,
            "sequenceId": 1,
            "questionId": 14212,
            "questionIndex": 15620,
            "questionText": "<p>A 62-year-old woman comes to the office due to a weeklong history of brief episodes of sharp chest pain that worsen with deep inspiration.&nbsp; She has had no cough or dyspnea but has had fatigue and stiffness and pain in the hands and knees.&nbsp; Medical history is significant for obesity, hypertension, and nonischemic cardiomyopathy with a left ventricular ejection fraction of 40%.&nbsp; She has a history of intolerance to angiotensin system inhibitor therapy.&nbsp; Medications include carvedilol, furosemide, hydralazine, and isosorbide mononitrate.&nbsp; Her medications were adjusted 6 months ago.&nbsp; She does not use tobacco, alcohol, or illicit drugs.&nbsp; Temperature is 37.8 C (100 F), blood pressure is 134/78 mm Hg, and pulse is 74/min and regular.&nbsp; Physical examination shows nondistended jugular veins and no heart murmurs.&nbsp; Lung auscultation reveals no crackles, but an inspiratory rub is present.&nbsp; There is moderate swelling and tenderness of the hand and knee joints bilaterally.&nbsp; No rash is present.&nbsp; Which of the following is the most likely cause of this patient&#39;s current symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T51239\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Features of drug-induced lupus erythematosus</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features*</strong></p></td><td><p>Acute onset of:</p><ul><li>Constitutional symptoms (eg, fever, malaise)</li><li>Arthralgias</li><li>Serositis (eg, pleuritis, pericarditis)</li><li>Rash (less common compared with SLE)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>High drug dose, prolonged use (&gt;3 months)</li><li>Slow acetylator status</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>Antihistone antibodies (&gt;90%)</li><li>Antinuclear antibodies (&gt;95%)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Implicated drugs</strong></p></td><td><ul><li>Most common: procainamide, hydralazine, penicillamine</li><li>Others: minocycline, TNF-&#945; inhibitors (eg, etanercept, infliximab), isoniazid</li></ul></td></tr><tr><td colspan=\"2\"><p>*No minimum number of SLE criteria is needed for diagnosis.</p><p><strong>SLE</strong> = systemic lupus erythematosus; <strong>TNF-&#945;</strong> = tumor necrosis factor-alpha.</p></td></tr></tbody></table></div><p>This patient likely has <strong>drug-induced lupus erythematosus</strong> from hydralazine use.&nbsp; Drug-induced lupus erythematosus can be diagnosed if at least one lupus erythematosus criterion occurs after initiation of certain medications; the presentation most commonly includes <strong>arthralgia</strong>, <strong>fever</strong>, or <strong>serositis</strong>, as seen in this patient with new pleuritic chest pain and pleural rub (indicating serositis).&nbsp; Compared with systemic lupus erythematosus, drug-induced lupus erythematosus produces more <strong>abrupt symptom onset</strong>, is less likely to involve the skin, and affects men and women of any age.</p><p><strong>Hydralazine</strong>, often combined with nitrates for the treatment of heart failure in angiotensin system inhibitor&ndash;intolerant patients, is strongly linked to drug-induced lupus erythematosus (frequency &#8804;20%).&nbsp; Other medications linked to drug-induced lupus erythematosus include procainamide, minocycline, tumor necrosis factor&ndash;alpha inhibitors, and isoniazid.&nbsp; Lupus-like symptoms may be related to autoantibodies induced by these drugs (eg, antinuclear antibodies, <strong>antihistone antibodies</strong>).&nbsp; Patient risk factors include prolonged use (&gt;3 months) and <strong>slow acetylator status</strong>.&nbsp; Treatment includes <strong>stopping the causative medication</strong> and treating symptoms (eg, nonsteroidal anti-inflammatory drugs).</p><p><strong>(Choice B)</strong>&nbsp; Granulomatosis with polyangiitis is a necrotizing, small-vessel vasculitis that can cause acute-onset fever and tracheopulmonary disease.&nbsp; However, isolated pleuritis (without cough or dyspnea) and synovitis are uncommon.&nbsp; Additionally, the typical findings of rhinosinusitis, hematuria, and rash (eg, palpable purpura) are not present in this patient.</p><p><strong>(Choice C)</strong>&nbsp; Hypertrophic osteoarthropathy is a syndrome associated with underlying lung disease (eg, adenocarcinoma, chronic pulmonary infection) and can cause arthralgia.&nbsp; However, it classically causes skin thickening and digital clubbing; a history of chronic, insidious symptoms (rather than this patient&#39;s acute pleuritis) would be expected.</p><p><strong>(Choice D)</strong>&nbsp; Polyarticular gout can occur as a late complication of untreated gout, or may manifest as a symptom of a myeloproliferative disorder.&nbsp; Although polyarticular gout can cause acute-onset arthralgia, pleuritic chest pain and an inspiratory rub would not be likely.</p><p><strong>(Choice E)</strong>&nbsp; Pulmonary embolism can cause acute-onset dyspnea and pleuritic chest pain, but an inspiratory rub or arthralgia is unlikely.</p><p><strong>Educational objective:</strong><br>Drug-induced lupus erythematosus should be suspected in patients developing acute onset of fever, arthralgia, and serositis after initiation of causative medications.&nbsp; Hydralazine is strongly associated with drug-induced lupus erythematosus.&nbsp; Treatment includes cessation of the causative medication and symptom management.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 19642,
            "topic": "SLE",
            "titleId": 19642,
            "title": "SLE",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Drug adverse effects",
                    "choiceNumber": 1,
                    "correctTaken": 7932,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Granulomatosis with polyangiitis",
                    "choiceNumber": 2,
                    "correctTaken": 1765,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypertrophic osteoarthropathy",
                    "choiceNumber": 3,
                    "correctTaken": 3422,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Polyarticular gout",
                    "choiceNumber": 4,
                    "correctTaken": 1635,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thromboembolism",
                    "choiceNumber": 5,
                    "correctTaken": 695,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28722919",
                    "mediaDataId": 0,
                    "title": "Hydralazine-induced lupus erythematosus.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28722919",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "2193156",
                    "mediaDataId": 0,
                    "title": "Hydralazine induced lupus and Sweet’s syndrome.  Report and review of the literature.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/2193156",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20656071",
                    "mediaDataId": 0,
                    "title": "Drug-induced lupus: an update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20656071",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "16466117",
                    "mediaDataId": 0,
                    "title": "Hydralazine-induced lupus: maintaining vigilance with increased use in patients with heart failure.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/16466117",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 226,
            "othersAvgTimeSpent": 96,
            "notes": null,
            "peopleTaken": 15449,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 51,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 2,
            "questionId": 10856,
            "questionIndex": 11988,
            "questionText": "<p>A 23-year-old previously healthy woman comes to the clinic due to a 3-month history of intermittent hand stiffness and pain.&nbsp; She has also felt excessively tired and has had occasional episodes of knee and sharp chest pain.&nbsp; The patient takes no medications and does not use tobacco, alcohol, or illicit drugs.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 130/70 mm Hg, and pulse is 80/min.&nbsp; Bilateral hand joints and wrists are mildly tender and swollen.&nbsp; Lungs are clear to auscultation and heart sounds are normal.&nbsp; The abdomen is soft and nontender with no organomegaly.&nbsp; There is mild bilateral lower extremity edema.&nbsp; The patient has no rash or lymphadenopathy.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Hemoglobin</td><td style=\"vertical-align:middle;\">12.2 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">Platelets</td><td style=\"vertical-align:middle;\">98,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Leukocytes</td><td style=\"vertical-align:middle;\">3,300/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Creatinine</td><td style=\"vertical-align:middle;\">0.8 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Urinalysis</td><td style=\"vertical-align:middle;\">2+ protein, 5-10 erythrocytes/hpf</td></tr></tbody></table><p>Which of the following is the best next step in establishing the diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t50395\"><table class=\"table-default-style table-header-footer-style\" style=\"width:552px\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Rheumatologic diseases &amp; commonly associated autoantibodies</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Sensitivity (%)</strong></p></td><td><p align=\"center\"><strong>Specificity (%)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Rheumatoid arthritis</strong></p></td><td><p align=\"center\">RF: 70-80</p></td><td><p align=\"center\">Anti-CCP: 95</p></td></tr><tr><td><p align=\"center\"><strong>Systemic lupus erythematosus</strong></p></td><td><p align=\"center\">ANA: 95</p></td><td><p align=\"center\">Anti-dsDNA/anti-Sm: 96</p></td></tr><tr><td><p align=\"center\"><strong>Drug-induced lupus</strong></p></td><td><p align=\"center\">ANA: 95</p></td><td><p align=\"center\">Antihistone: 95</p></td></tr><tr><td><p align=\"center\"><strong>Diffuse systemic sclerosis</strong></p></td><td><p align=\"center\">ANA: 95</p></td><td><p align=\"center\">Anti&ndash;Scl-70: 99</p></td></tr><tr><td><p align=\"center\"><strong>Limited systemic sclerosis</strong></p></td><td><p align=\"center\">ANA: 95</p></td><td><p align=\"center\">Anticentromere: 97</p></td></tr><tr><td><p align=\"center\"><strong>Polymyositis/dermatomyositis</strong></p></td><td><p align=\"center\">ANA: 75</p></td><td><p align=\"center\">Anti&ndash;Jo-1: 99</p></td></tr><tr><td colspan=\"3\"><p><strong>ANA </strong>= antinuclear antibodies; <strong>anti-CCP</strong>&nbsp;= anti&ndash;cyclic citrullinated peptide; <strong>anti-dsDNA</strong>&nbsp;= anti&ndash;double-stranded DNA; <strong>anti&ndash;Scl-70</strong>&nbsp;= anti&ndash;topoisomerase I; <strong>anti-Sm</strong>&nbsp;= anti-Smith; <strong>RF</strong>&nbsp;= rheumatoid factor.</p></td></tr></tbody></table></div><p>This patient has a symmetric polyarthritis (ie, pain, stiffness, tenderness) associated with possible serositis (ie, sharp chest pain).&nbsp; In the context of systemic features (eg, fatigue), mild cytopenias (leukopenia, thrombocytopenia), and protein-losing nephropathy (edema, proteinuria, microscopic hematuria), this presentation is suspicious for <strong>systemic lupus erythematosus (SLE)</strong>.&nbsp; Initial evaluation of SLE should include a complete blood count, renal function studies (ie, urinalysis, serum creatinine), and serum complement levels (eg, C3, C4).</p><p>In addition, autoantibody studies are recommended to support the diagnosis.&nbsp; An <strong>antinuclear antibody</strong> (ANA) titer is very sensitive (95%-100%) for SLE and should be obtained as the initial <strong>first-order test</strong>.&nbsp; However, ANA is not specific and can be elevated in other autoimmune disorders and in up to 20% of healthy women.&nbsp; If the ANA test is positive, more specific <strong>confirmatory tests</strong> such as <strong>anti&ndash;double-stranded DNA</strong> and anti-Sm (Smith) antibodies can be obtained.&nbsp; However, these second-order assays are much less sensitive than ANA and are not recommended as initial tests, although some laboratories offer them as reflex tests if the ANA test is positive.</p><p><strong>(Choice A)</strong>&nbsp; Cyclic citrullinated peptide antibodies are specific for rheumatoid arthritis, which causes a symmetric polyarthritis, but nephropathy (eg, hematuria, proteinuria) is uncommon.</p><p><strong>(Choice B)</strong>&nbsp; Antihistone antibodies are specific for drug-induced lupus.&nbsp; This patient is not taking medications associated with drug-induced lupus (eg, hydralazine, procainamide, minocycline), and drug-induced lupus is not usually associated with nephropathy.</p><p><strong>(Choice C)</strong>&nbsp; Anti&ndash;neutrophil cytoplasmic antibodies are associated with a number of vasculitic disorders, especially granulomatosis with polyangiitis.&nbsp; This condition can cause glomerulonephritis and arthralgias, but most patients also have upper (eg, epistaxis, nasal ulcers) or lower (eg, wheezing, hemoptysis) respiratory features.</p><p><strong>(Choice E)</strong>&nbsp; Anti-Ro/SSA antibodies are classically associated with Sj&ouml;gren syndrome (eg, dry eyes, xerostomia).&nbsp; They are seen in some patients with SLE and confer an increased risk of neonatal lupus syndrome due to transplacental passage of the antibodies.&nbsp; However, anti-Ro has low sensitivity for SLE and is not done as an initial test.</p><p><strong>(Choice F)</strong>&nbsp; Anti&ndash;Scl-70 (anti-topoisomerase) antibodies have moderate sensitivity and high specificity for systemic sclerosis (scleroderma) and are associated with extensive skin involvement and interstitial pulmonary fibrosis.</p><p><strong>Educational objective:</strong><br>Antinuclear antibody (ANA) is a very sensitive, but nonspecific, marker for systemic lupus erythematosus.&nbsp; If ANA titers are elevated, more specific autoantibodies (eg, anti&ndash;double-stranded DNA) can confirm the diagnosis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 19642,
            "topic": "SLE",
            "titleId": 19642,
            "title": "SLE",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Anti&ndash;cyclic citrullinated peptide antibody",
                    "choiceNumber": 1,
                    "correctTaken": 2693,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Antihistone antibody",
                    "choiceNumber": 2,
                    "correctTaken": 727,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Anti&ndash;neutrophil cytoplasmic antibody",
                    "choiceNumber": 3,
                    "correctTaken": 1060,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Antinuclear antibody",
                    "choiceNumber": 4,
                    "correctTaken": 9991,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Anti-Ro antibody",
                    "choiceNumber": 5,
                    "correctTaken": 381,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Anti-topoisomerase antibody",
                    "choiceNumber": 6,
                    "correctTaken": 631,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22428449",
                    "mediaDataId": 0,
                    "title": "Rational use of blood tests in the evaluation of rheumatic diseases.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22428449",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24383972",
                    "mediaDataId": 0,
                    "title": "Sensitivity and specificity of ANA and anti-dsDNA in the diagnosis of systemic lupus erythematosus: a comparison using control sera obtained from healthy individuals and patients with multiple medical problems.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24383972",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 124,
            "othersAvgTimeSpent": 71,
            "notes": null,
            "peopleTaken": 15483,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 3,
            "questionId": 3554,
            "questionIndex": 3554,
            "questionText": "<p>A 5-year-old boy is brought to the emergency department by his parents due to difficulty walking.&nbsp; The patient first developed pain in the legs this morning and has not wanted to walk today.&nbsp; He played 2 soccer games yesterday with no pain or trauma.&nbsp; A week ago, the patient had a low-grade fever and cough that have since resolved.&nbsp; He has had no nausea, emesis, diarrhea, weight loss, or night sweats.&nbsp; The patient has no significant medical history and takes no daily medications.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 90/40 mm Hg, pulse is 138/min, and respirations are 20/min.&nbsp; Examination shows an uncomfortable-appearing boy lying in bed; the patient cries with any attempt to move his legs.&nbsp; A purplish, nonblanching rash is noted over the buttocks and posterior thighs.&nbsp; The abdomen is soft with active bowel sounds.&nbsp; There is mild, diffuse tenderness to palpation with no rebound or guarding.&nbsp; Lower extremity joints demonstrate no deformity, erythema, swelling, or warmth.&nbsp; The patient refuses to walk due to pain in his legs.&nbsp; Laboratory results from urinalysis are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Specific gravity</td><td style=\"vertical-align:middle;\">1.016</td></tr><tr><td style=\"vertical-align:middle;\">pH</td><td style=\"vertical-align:middle;\">7.0</td></tr><tr><td style=\"vertical-align:middle;\">Protein</td><td style=\"vertical-align:middle;\">trace</td></tr><tr><td style=\"vertical-align:middle;\">Blood</td><td style=\"vertical-align:middle;\">large</td></tr><tr><td style=\"vertical-align:middle;\">Glucose</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">Ketones</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">Leukocyte esterase</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">Nitrites</td><td style=\"vertical-align:middle;\">negative</td></tr></tbody></table><p>This patient is at greatest risk for developing which of the following complications?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t38401\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p style=\"text-align: center;\"><strong>IgA vasculitis (Henoch-Sch&ouml;nlein purpura)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>Perivenular leukocytoclastic (neutrophils &amp; monocytes) vasculitis</li><li>Deposition of IgA, C3 &amp; fibrin in small vessels</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />manifestations</strong></p></td><td><ul><li>Classic findings*:<ul style=\"list-style-type:circle;\"><li>Palpable purpura/petechiae on lower extremities</li><li>Arthritis/arthralgia</li><li>Abdominal pain, intussusception</li><li>Renal disease (similar to IgA nephropathy)</li></ul></li><li>Other findings: scrotal pain &amp; swelling</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory<br />findings</strong></p></td><td><ul><li>Normal platelet count &amp; coagulation studies</li><li>Normal to &uarr;&nbsp;creatinine</li><li>Hematuria &plusmn; RBC casts &amp;/or proteinuria</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Supportive care (hydration &amp; NSAIDs) for most patients</li><li>Hospitalization &amp; systemic glucocorticoids for severe symptoms</li></ul></td></tr><tr><td colspan=\"2\"><p>*Clinical diagnosis requires purpuric rash plus &ge;2 additional classic findings.</p><p><strong>NSAIDs</strong> = nonsteroidal anti-inflammatory drugs; <strong>RBC</strong> = red blood cell.</p></td></tr></tbody></table></div><p>This patient likely has <strong>Henoch-Sch&ouml;nlein purpura</strong> (HSP), an IgA-mediated, small-vessel vasculitis that occurs most commonly in school-aged children.&nbsp; <a href=\"40407\">Classic manifestations</a> include nonblanching <strong>palpable purpura</strong> on the legs and buttocks, lower extremity <strong>arthralgia/arthritis</strong> (which can result in refusal to ambulate), <strong>abdominal pain</strong>, and renal disease (<strong>hematuria</strong> &plusmn; proteinuria).&nbsp; Symptoms are often preceded by a mild upper respiratory infection, as seen in this child.</p><p>Typical abdominal symptoms are caused by localized bowel wall inflammation and include colicky, diffuse pain often associated with nausea and vomiting.&nbsp; However, severe abdominal pain in HSP should prompt further workup for gastrointestinal complications, most commonly <strong>intussusception</strong>.&nbsp; <strong>Intestinal edema</strong> and <strong>bleeding</strong> associated with HSP can act as a lead point for the intestines to telescope into the adjacent bowel.&nbsp; In contrast to most pediatric cases of idiopathic intussusception, which is typically ileocolic, intussusception in HSP is usually confined to the small bowel <strong>(ileoileal)</strong>.</p><p>Intussusception typically presents with <strong>severe, episodic abdominal pain</strong> and currant jelly or <a href=\"857\">bloody stools</a>.&nbsp; Although ileocolic intussusceptions are treated with air or contrast enema, ileoileal intussusceptions that do not reduce spontaneously often require surgical management.</p><p><strong>(Choice A)</strong>&nbsp; Hemolytic uremic syndrome (HUS) is characterized by hemolytic anemia, thrombocytopenia that can lead to petechiae and ecchymosis, and acute kidney injury.&nbsp; In contrast to HSP, HUS is typically preceded by a diarrheal illness and does not cause leg pain.</p><p><strong>(Choice C)</strong>&nbsp; Septic arthritis, which can result in joint destruction if untreated, typically presents with fever and inflammation (eg, swelling, erythema) of a single joint, features not seen in this patient.&nbsp; Arthritis associated with HSP is self-limiting and does not cause long-term joint damage.</p><p><strong>(Choice D)</strong>&nbsp; Urethritis occurs with reactive arthritis, which presents with joint swelling and is typically preceded by an enteric infection (eg, <em>Campylobacter</em>, <em>Shigella</em>) causing diarrhea rather than an upper respiratory illness.&nbsp; In addition, purpura would not be seen with reactive arthritis.</p><p><strong>(Choice E)</strong>&nbsp; Uveitis is a complication of juvenile idiopathic arthritis (usually oligoarticular or polyarticular), which typically presents with chronic joint swelling.&nbsp; This patient with acute joint pain has no swelling and therefore has arthralgia, not arthritis.&nbsp; In addition, his hematuria and purpuric rash make HSP more likely.</p><p><strong>Educational objective:</strong><br>Henoch-Sch&ouml;nlein purpura is an IgA-mediated vasculitis that presents most commonly in children with palpable purpura, abdominal pain, arthralgia/arthritis, and hematuria.&nbsp; Patients are at increased risk for ileoileal intussusception due to intestinal edema and bleeding.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 23448,
            "topic": "IgA vasculitis",
            "titleId": 23448,
            "title": "IgA vasculitis",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Hemolytic anemia",
                    "choiceNumber": 1,
                    "correctTaken": 4436,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intussusception",
                    "choiceNumber": 2,
                    "correctTaken": 6401,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Joint destruction",
                    "choiceNumber": 3,
                    "correctTaken": 2473,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Urethritis",
                    "choiceNumber": 4,
                    "correctTaken": 734,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uveitis",
                    "choiceNumber": 5,
                    "correctTaken": 2251,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30725937",
                    "mediaDataId": 0,
                    "title": "Henoch Schonlein purpura.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30725937",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 175,
            "othersAvgTimeSpent": 78,
            "notes": null,
            "peopleTaken": 16296,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 39,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 4,
            "questionId": 14761,
            "questionIndex": 16184,
            "questionText": "<p>A 51-year-old woman comes to the office for a follow-up visit.&nbsp; The patient was initially evaluated 3 weeks ago for bilateral wrist and hand pain that had been occurring for 2 months.&nbsp; She was prescribed ibuprofen and now reports satisfactory improvement in the symptoms.&nbsp; Medical history includes obesity, hyperlipidemia, and major depressive disorder.&nbsp; She is postmenopausal.&nbsp; The patient occasionally drinks alcohol but does not use tobacco or illicit drugs.&nbsp; Vital signs are within normal limits.&nbsp; Physical examination shows decreased swelling and tenderness of bilateral wrists and metacarpophalangeal and proximal interphalangeal joints compared to 3 weeks ago.&nbsp; Laboratory studies show that the erythrocyte sedimentation rate is 52 mm/h, and anticitrullinated peptide antibodies are positive.&nbsp; Low-dose methotrexate therapy is planned.&nbsp; Obtaining which of the following is most appropriate prior to starting this therapy in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t38387\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Disease-modifying antirheumatic drugs</strong></p></td></tr><tr><td><p align=\"center\"><strong>Agent</strong></p></td><td><p align=\"center\"><strong>Mechanism</strong></p></td><td><p align=\"center\"><strong>Adverse effects</strong></p></td></tr><tr><td><p align=\"center\"><strong>Methotrexate</strong></p></td><td><ul><li>Folate antimetabolite</li></ul></td><td><ul><li>Hepatotoxicity</li><li>Stomatitis</li><li>Cytopenias</li></ul></td></tr><tr><td><p align=\"center\"><strong>Leflunomide</strong></p></td><td><ul><li>Pyrimidine synthesis inhibitor</li></ul></td><td><ul><li>Hepatotoxicity</li></ul><ul><li>Cytopenias</li></ul></td></tr><tr><td><p align=\"center\"><strong>Hydroxychloroquine</strong></p></td><td><ul><li>TNF &amp; IL-1 suppressor</li></ul></td><td><ul><li>Retinopathy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Sulfasalazine</strong></p></td><td><ul><li>TNF &amp; IL-1 suppressor</li></ul></td><td><ul><li>Hepatotoxicity</li><li>Stomatitis</li><li>Hemolytic anemia</li></ul></td></tr><tr><td><p align=\"center\"><strong>TNF inhibitors</strong><br />(eg, adalimumab, certolizumab,<br />etanercept, golimumab, infliximab)</p></td><td></td><td><ul><li>Infection</li><li>Demyelination</li><li>Congestive heart failure</li><li>Malignancy</li></ul></td></tr><tr><td colspan=\"3\"><p><strong>IL-1</strong> = interleukin&nbsp;1;<strong>TNF </strong>= tumor necrosis factor.</p></td></tr></tbody></table></div><p>This patient has <strong>rheumatoid arthritis</strong> (RA), presenting with <strong>symmetric polyarthritis</strong> affecting the metacarpophalangeal joints, proximal interphalangeal joints, and wrists, along with elevated inflammatory markers (eg, C-reactive protein, erythrocyte sedimentation rate).&nbsp; The diagnosis of RA is primarily based on clinical findings, but serologic markers (eg, rheumatoid factor, cyclic citrullinated peptide antibodies) can assist in diagnosis and are associated with higher risk of extraarticular manifestations (eg, rheumatoid nodules).</p><p>Patients with RA can be treated acutely with glucocorticoids (eg, prednisone) or nonsteroidal anti-inflammatory drugs (eg, ibuprofen), but these treatments provide only symptomatic relief and do not alter the long-term joint destruction of RA.&nbsp; For this reason, <strong>disease-modifying antirheumatic drugs</strong> (DMARDs), which do improve long-term joint function, are initiated as soon as practical after diagnosis.</p><p><strong>Methotrexate</strong> is the preferred first-line DMARD for most patients with RA.&nbsp; Its effects are mediated by inhibition of dihydrofolate reductase, which causes cellular folate depletion leading to impaired DNA synthesis.&nbsp; Methotrexate can cause significant <strong>hepatotoxicity</strong>, which can range from mild elevations in hepatic aminotransferases to chronic liver disease and cirrhosis.&nbsp; <strong>Serum liver studies</strong> should be checked prior to initiation of methotrexate and periodically during treatment.&nbsp; Patients should avoid alcohol intake.&nbsp; Much of the toxicity of methotrexate, including hepatotoxicity, can be mitigated by concurrent administration of folic (or folinic) acid, which does not reduce the effectiveness of the drug.</p><p><strong>(Choice A)</strong>&nbsp; Hydroxychloroquine is an antimalarial DMARD that is generally well tolerated.&nbsp; Long-term use is associated with potential retinal injury, and patients should have regular ophthalmologic evaluation while on treatment.&nbsp; Methotrexate is not associated with retinopathy.</p><p><strong>(Choice B)</strong>&nbsp; Sulfasalazine is an occasionally used DMARD that can cause hemolytic anemia in patients with glucose-6-phosphate dehydrogenase deficiency.&nbsp; This effect is not seen with methotrexate, which causes anemia via bone marrow suppression.</p><p><strong>(Choices C and E)</strong>&nbsp; Tumor necrosis factor inhibitors (eg, etanercept, infliximab) are biologic DMARDs (large-molecule agents produced primarily by recombinant DNA technology) that are used for patients who fail first-line therapy.&nbsp; They are associated with significant immune suppression, which can lead to reactivation of latent tuberculosis; therefore, pretesting with an interferon gamma release assay is recommended.&nbsp; They may also be associated with an increased risk of heart failure, and some experts advise pretreatment echocardiography for patients with ventricular dysfunction.</p><p><strong>Educational objective:</strong><br>Methotrexate therapy for rheumatoid arthritis is associated with hepatotoxicity.&nbsp; Serum liver studies should be checked prior to initiation and periodically thereafter.&nbsp; Much of the toxicity of methotrexate, including hepatotoxicity, can be mitigated by concurrent administration of folic acid, which does not reduce the effectiveness of the drug.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 3769,
            "topic": "Rheumatoid arthritis",
            "titleId": 3769,
            "title": "Rheumatoid arthritis",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Comprehensive ophthalmologic evaluation",
                    "choiceNumber": 1,
                    "correctTaken": 583,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Glucose-6-phosphate dehydrogenase level",
                    "choiceNumber": 2,
                    "correctTaken": 809,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Interferon gamma release assay",
                    "choiceNumber": 3,
                    "correctTaken": 2594,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Liver aminotransferase levels",
                    "choiceNumber": 4,
                    "correctTaken": 11373,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transthoracic echocardiography",
                    "choiceNumber": 5,
                    "correctTaken": 355,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 131,
            "othersAvgTimeSpent": 51,
            "notes": null,
            "peopleTaken": 15714,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 72,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 5,
            "questionId": 2315,
            "questionIndex": 2315,
            "questionText": "<p>A 27-year-old African American woman comes to the office due to 6 weeks of pain and swelling of her hands and wrists.&nbsp; The pain worsens in the morning and is associated with stiffness for 10-15 minutes.&nbsp; She also has had easy fatigability and muscle aches.&nbsp; The patient has no significant medical history and does not take any medications.&nbsp; She has been sexually active with a new partner.&nbsp; Temperature is 37.9 C (100.2 F), blood pressure is 140/90 mm Hg, and pulse is 76/min.&nbsp; Physical examination shows slightly swollen, tender metacarpophalangeal and proximal interphalangeal joints.&nbsp; There is a nontender ulcer on the buccal mucosa.&nbsp; Mild cervical and axillary lymphadenopathy are present.&nbsp; Cardiopulmonary auscultation is normal.&nbsp; The abdomen is soft and nontender.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Hemoglobin</td><td style=\"vertical-align:middle;\">11.0 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">Platelets</td><td style=\"vertical-align:middle;\">90,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Leukocytes</td><td style=\"vertical-align:middle;\">4,500/mm<font size=\"2\"><sup>3</sup></font></td></tr></tbody></table><p>X-ray of the hands and wrists reveals no bony erosions.&nbsp; Urinalysis shows 2+ protein and 20-30 red blood cells/hpf.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31457\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Manifestations of systemic lupus erythematosus</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />symptoms</strong></p></td><td><ul><li>Constitutional: fever, fatigue &amp; weight loss</li><li>Symmetric, migratory arthritis</li><li>Skin: butterfly rash &amp; photosensitivity</li><li>Serositis: pleurisy, pericarditis &amp; peritonitis</li><li>Thromboembolic events (due to vasculitis &amp; antiphospholipid antibodies)</li><li>Neurologic: cognitive dysfunction &amp; seizures</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory<br />findings</strong></p></td><td><ul><li>Hemolytic anemia, thrombocytopenia &amp; leukopenia</li><li>Hypocomplementemia (C3 &amp; C4)</li><li>Antibodies:<ul style=\"list-style-type:circle;\"><li>Antinuclear antibodies (sensitive)</li><li>Anti-dsDNA &amp; anti-Smith (specific)</li></ul></li><li>Renal involvement: proteinuria &amp; elevated creatinine</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>dsDNA</strong> = double-stranded DNA.</p></td></tr></tbody></table></div><p>This patient&#39;s fatigue, polyarticular arthritis, painless oral ulcer, thrombocytopenia, and likely glomerulonephritis (hematuria, proteinuria) raise strong suspicion for <strong>systemic lupus erythematosus</strong> (SLE), a multisystem, inflammatory disorder most common in <strong>young</strong>, <strong>African American women</strong>.</p><p><strong>Arthritis</strong> and arthralgias affect 95% of patients with SLE and tend to be <strong>migratory</strong>, <strong>symmetric</strong>, polyarticular, and accompanied by brief morning stiffness (much shorter in duration than rheumatoid arthritis [RA]).&nbsp; The knees, carpal joints, and joints of the fingers are most commonly affected.&nbsp; Joint pain often exceeds the objective findings on examination, and x-rays usually reveal <strong>no evidence of joint destruction</strong> or erosion (unlike other inflammatory arthritides such as RA).</p><p>Other common manifestations of SLE include malar <a href=\"6053\">rash</a>, serositis (eg, pericarditis), neuropsychiatric complications, and thromboembolic events.&nbsp; Lymphadenopathy often occurs as a primary manifestation (~50% of cases).</p><p><strong>(Choice A)</strong>&nbsp; Beh&ccedil;et disease typically presents with multiple oral and genital ulcers that are recurrent and painful.&nbsp; Uveitis is common.&nbsp; This patient has a nonpainful oral ulcer and hematologic and renal abnormalities, which are not typically seen with Beh&ccedil;et disease.</p><p><strong>(Choice B)</strong>&nbsp; Disseminated gonococcal infection can cause a purulent arthritis or the triad of tenosynovitis, dermatitis (eg, 2-10 painless pustules on the distal extremities), and polyarthralgia.&nbsp; Thrombocytopenia, oral ulcers, and proteinuria would be atypical.</p><p><strong>(Choice C)</strong>&nbsp; Felty syndrome is a potentially serious complication of RA characterized by neutropenia and splenomegaly.&nbsp; Recurrent bacterial infection is common (due to neutropenia) and may lead to lymphadenopathy.&nbsp; However, most cases occur in patients with long-standing erosive RA; this patient&#39;s short-duration morning stiffness, normal joint findings on x-ray, and lack of splenomegaly make Felty syndrome unlikely.</p><p><strong>(Choice D)</strong>&nbsp; Hodgkin disease can cause systemic symptoms and lymphadenopathy; it is also associated with minimal change disease and nephrotic syndrome.&nbsp; However, oral ulcers, synovitis, and glomerulonephritis (red blood cells on urinalysis) would be uncommon.</p><p><strong>(Choice E)</strong>&nbsp; Most adults with parvovirus infection are asymptomatic or have flulike symptoms.&nbsp; A minority may develop a self-limited, symmetric, nonerosive arthritis, but the prolonged duration of symptoms (&gt;3-4 weeks) and renal abnormalities (hematuria, proteinuria) make SLE more likely in this patient.</p><p><strong>(Choice F)</strong>&nbsp; Sarcoidosis typically presents with pulmonary and skin findings and can cause interstitial nephritis.&nbsp; However, glomerulonephritis and oral ulcers are unusual.</p><p><strong>Educational objective:</strong><br>Systemic lupus erythematosus is a multisystem, inflammatory disease that often presents with arthritis and arthralgias.&nbsp; Joint involvement tends to be symmetric, migratory, and nonerosive with brief morning stiffness.&nbsp; The knees, carpal joints, and joints of the fingers are most commonly affected.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 19642,
            "topic": "SLE",
            "titleId": 19642,
            "title": "SLE",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "7",
            "userAnswer": "7",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Beh&ccedil;et disease",
                    "choiceNumber": 1,
                    "correctTaken": 1452,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Disseminated gonococcal infection",
                    "choiceNumber": 2,
                    "correctTaken": 1148,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Felty syndrome",
                    "choiceNumber": 3,
                    "correctTaken": 1396,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hodgkin disease",
                    "choiceNumber": 4,
                    "correctTaken": 123,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Parvovirus B19 infection",
                    "choiceNumber": 5,
                    "correctTaken": 578,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sarcoidosis",
                    "choiceNumber": 6,
                    "correctTaken": 700,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Systemic lupus erythematosus",
                    "choiceNumber": 7,
                    "correctTaken": 10087,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 104,
            "othersAvgTimeSpent": 75,
            "notes": null,
            "peopleTaken": 15484,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 6,
            "questionId": 4295,
            "questionIndex": 4295,
            "questionText": "<p>A 40-year-old woman comes to the office for follow-up.&nbsp; The patient has a 4-year history of rheumatoid arthritis and has been taking a disease-modifying therapy.&nbsp; She reports significant improvement in joint pain and stiffness with treatment and can now perform daily activities without difficulty.&nbsp; The patient has no other medical conditions and does not use tobacco, alcohol, or illicit drugs.&nbsp; She consumes a balanced diet and exercises most days of the week.&nbsp; Vital signs are normal.&nbsp; Physical examination shows no significant joint swelling, erythema, or tenderness.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"width:254.15pt; vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"width:156pt; vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">11.2 g/dL</td></tr><tr><td style=\"width:156pt; vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Mean corpuscular volume</td><td style=\"vertical-align:middle;\">108 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"width:156pt; vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">226,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"width:156pt; vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">7,800/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\" style=\"width:254.15pt; vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"width:254.15pt; vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"width:156pt; vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Sodium</td><td style=\"vertical-align:middle;\">140 mEq/L</td></tr><tr><td style=\"width:156pt; vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Potassium</td><td style=\"vertical-align:middle;\">4.0 mEq/L</td></tr><tr><td style=\"width:156pt; vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Bicarbonate</td><td style=\"vertical-align:middle;\">24 mEq/L</td></tr><tr><td style=\"width:156pt; vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td style=\"vertical-align:middle;\">0.8 mg/dL</td></tr><tr><td style=\"width:156pt; vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Calcium</td><td style=\"vertical-align:middle;\">9.6 mg/dL</td></tr><tr><td style=\"width:156pt; vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td style=\"vertical-align:middle;\">98 mg/dL</td></tr></tbody></table><p>Laboratory studies were within normal limits 6 months ago.&nbsp; Which of the following is the most likely additional adverse effect of this patient&#39;s pharmacotherapy?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t38387\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Disease-modifying antirheumatic drugs</strong></p></td></tr><tr><td><p align=\"center\"><strong>Agent</strong></p></td><td><p align=\"center\"><strong>Mechanism</strong></p></td><td><p align=\"center\"><strong>Adverse effects</strong></p></td></tr><tr><td><p align=\"center\"><strong>Methotrexate</strong></p></td><td><ul><li>Folate antimetabolite</li></ul></td><td><ul><li>Hepatotoxicity</li><li>Stomatitis</li><li>Cytopenias</li></ul></td></tr><tr><td><p align=\"center\"><strong>Leflunomide</strong></p></td><td><ul><li>Pyrimidine synthesis inhibitor</li></ul></td><td><ul><li>Hepatotoxicity</li></ul><ul><li>Cytopenias</li></ul></td></tr><tr><td><p align=\"center\"><strong>Hydroxychloroquine</strong></p></td><td><ul><li>TNF &amp; IL-1 suppressor</li></ul></td><td><ul><li>Retinopathy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Sulfasalazine</strong></p></td><td><ul><li>TNF &amp; IL-1 suppressor</li></ul></td><td><ul><li>Hepatotoxicity</li><li>Stomatitis</li><li>Hemolytic anemia</li></ul></td></tr><tr><td><p align=\"center\"><strong>TNF inhibitors</strong><br />(eg, adalimumab, certolizumab,<br />etanercept, golimumab, infliximab)</p></td><td></td><td><ul><li>Infection</li><li>Demyelination</li><li>Congestive heart failure</li><li>Malignancy</li></ul></td></tr><tr><td colspan=\"3\"><p><strong>IL-1</strong> = interleukin&nbsp;1;<strong>TNF </strong>= tumor necrosis factor.</p></td></tr></tbody></table></div><p>This patient with <strong>rheumatoid arthritis</strong> (RA) is on disease-modifying antirheumatic drug (DMARD) therapy, which improves long-term joint function and is initiated as soon as practical after diagnosis.&nbsp; <strong>Methotrexate</strong> is the preferred <strong>first-line DMARD</strong> for most patients with RA.</p><p>However, this patient now has&nbsp;<strong>macrocytic anemia</strong> (mean corpuscular volume &gt;100 &micro;m<font size=\"2\"><sup>3</sup></font>), a potential adverse effect of methotrexate.&nbsp; Methotrexate inhibits dihydrofolate reductase, which can lead to cellular folate depletion.&nbsp; Hematologic effects can range from mild macrocytosis to severe pancytopenia.&nbsp; Methotrexate is also associated with <strong>hepatotoxicity</strong>, especially in patients with comorbid liver disease.&nbsp; Mild elevations in hepatic transaminases are common, and chronic liver disease and cirrhosis may occur over time.&nbsp; Other adverse effects of methotrexate include nausea, stomatitis, rash, interstitial lung disease, alopecia, and fever.</p><p>Therefore, patients on methotrexate should have regular monitoring with complete blood counts and hepatic function markers (eg, serum albumin, transaminases).&nbsp; Much of the toxicity of methotrexate, including hepatotoxicity, can be mitigated by concurrent administration of <strong>folic (or folinic) acid</strong>, which does not reduce the effectiveness of the drug.&nbsp; Due to the risk of hepatotoxicity, patients should avoid alcohol intake while on treatment.</p><p><strong>(Choice B)</strong>&nbsp; Calcineurin inhibitors (eg, cyclosporine, tacrolimus) are associated with neurotoxicity; manifestations include headache, seizures, tremor, encephalopathy, and peripheral pain.&nbsp; However, these medications do not commonly cause macrocytic anemia and are rarely used for RA.</p><p><strong>(Choice C)</strong>&nbsp; Glucocorticoids (eg, prednisone) are used in acute management of RA.&nbsp; Major adverse effects include Cushing syndrome, osteoporosis, adrenocortical atrophy, and poor wound healing; however, they do not commonly cause macrocytosis.&nbsp; Unlike DMARDs, glucocorticoids do not alter the course of joint destruction and are not continued chronically in most patients.</p><p><strong>(Choice D)</strong>&nbsp; Hydroxychloroquine is an antimalarial DMARD that is well tolerated in management of RA and other autoimmune disorders.&nbsp; It can cause irreversible retinal toxicity and warrants regular ophthalmologic examination.&nbsp; Hematologic effects are uncommon.</p><p><strong>(Choice E)</strong>&nbsp; Tumor necrosis factor (TNF) inhibitors (eg, etanercept, adalimumab) are large-molecule biologic DMARDs that are very effective in the treatment of RA.&nbsp; They have potent immunosuppressive qualities and are associated with increased risk for reactivation of latent tuberculosis.&nbsp; TNF inhibitors commonly cause neutropenia, but macrocytic anemia is not a common effect.</p><p><strong>Educational objective:</strong><br>Methotrexate is a disease-modifying antirheumatic drug used for rheumatoid arthritis.&nbsp; Macrocytic anemia and hepatotoxicity are common adverse effects.&nbsp; The toxicity of methotrexate (including hepatotoxicity) can be mitigated by the administration of folic acid, which does not reduce the effectiveness of the drug.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 3769,
            "topic": "Rheumatoid arthritis",
            "titleId": 3769,
            "title": "Rheumatoid arthritis",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Hepatotoxicity",
                    "choiceNumber": 1,
                    "correctTaken": 9319,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Neurotoxicity",
                    "choiceNumber": 2,
                    "correctTaken": 1344,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Osteoporosis",
                    "choiceNumber": 3,
                    "correctTaken": 770,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Retinal toxicity",
                    "choiceNumber": 4,
                    "correctTaken": 446,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Tuberculosis reactivation",
                    "choiceNumber": 5,
                    "correctTaken": 1541,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27721549",
                    "mediaDataId": 0,
                    "title": "Hepatic and hematological adverse effects of long-term low-dose methotrexate therapy in rheumatoid arthritis: an observational study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27721549",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 75,
            "othersAvgTimeSpent": 63,
            "notes": null,
            "peopleTaken": 13420,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 69,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 7,
            "questionId": 19015,
            "questionIndex": 20498,
            "questionText": "<p>A 7-year-old girl is brought to the emergency department by her father due to right hip pain.&nbsp; The patient first developed the pain yesterday after playing in the backyard.&nbsp; Her father placed ice on her hip, which initially helped, but after waking this morning, she refused to walk and now has pain in the left hip and left lower abdomen.&nbsp; The patient has no chronic medical conditions and takes no medications.&nbsp; Immunizations are up to date, and weight is at the 60th percentile.&nbsp; Temperature is 37.3 C (99.1 F), blood pressure is 94/66 mm Hg, pulse is 90/min, and respirations are 20/min.&nbsp; The patient is awake and alert.&nbsp; The oropharynx is clear.&nbsp; Cardiopulmonary examination is unremarkable.&nbsp; There is pain during passive range of motion of the right and left hips but no focal tenderness to palpation.&nbsp; Mild abdominal tenderness is present at the left lower quadrant.&nbsp; Several palpable petechiae are noted over the lower extremities.&nbsp; Complete blood count, coagulation studies, erythrocyte sedimentation rate, and urinalysis are normal.&nbsp; Which of the following is the best next diagnostic step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t38401\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p style=\"text-align: center;\"><strong>IgA vasculitis (Henoch-Sch&ouml;nlein purpura)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>Perivenular leukocytoclastic (neutrophils &amp; monocytes) vasculitis</li><li>Deposition of IgA, C3 &amp; fibrin in small vessels</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />manifestations</strong></p></td><td><ul><li>Classic findings*:<ul style=\"list-style-type:circle;\"><li>Palpable purpura/petechiae on lower extremities</li><li>Arthritis/arthralgia</li><li>Abdominal pain, intussusception</li><li>Renal disease (similar to IgA nephropathy)</li></ul></li><li>Other findings: scrotal pain &amp; swelling</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory<br />findings</strong></p></td><td><ul><li>Normal platelet count &amp; coagulation studies</li><li>Normal to &uarr;&nbsp;creatinine</li><li>Hematuria &plusmn; RBC casts &amp;/or proteinuria</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Supportive care (hydration &amp; NSAIDs) for most patients</li><li>Hospitalization &amp; systemic glucocorticoids for severe symptoms</li></ul></td></tr><tr><td colspan=\"2\"><p>*Clinical diagnosis requires purpuric rash plus &ge;2 additional classic findings.</p><p><strong>NSAIDs</strong> = nonsteroidal anti-inflammatory drugs; <strong>RBC</strong> = red blood cell.</p></td></tr></tbody></table></div><p>This patient&#39;s hip arthralgia, abdominal pain, and lower-extremity petechial rash are consistent with <strong>Henoch-Sch&ouml;nlein purpura</strong> (HSP), or <strong>IgA vasculitis</strong>, the most common vasculitis in <strong>children</strong>.</p><p><a href=\"40407\">Diagnosis of HSP</a> is <strong>clinical</strong>.&nbsp; Palpable <strong>petechiae/purpura</strong> without thrombocytopenia or coagulopathy, as seen in this patient, is <strong>required for diagnosis plus &#8805;2</strong> of the following:</p><ul><li><p>Arthritis/<strong>arthralgia</strong>, which most commonly affects the lower extremities and may cause refusal to walk in young children</p></li><li><p>Colicky <strong>abdominal pain</strong> due to intestinal edema, which can also lead to nausea, vomiting, gastrointestinal bleeding, and intussusception</p></li><li><p><strong>Renal disease</strong> (hematuria &plusmn; proteinuria)</p></li></ul><p>In pediatric patients with <strong>classic</strong> findings, as seen in this girl, <strong>no additional diagnostic testing</strong> is required.&nbsp; In adults (in whom IgA vasculitis is rare) and in children with an <strong>atypical</strong> or incomplete presentation, <strong>skin biopsy</strong> is the next diagnostic step, revealing neutrophilic infiltration with IgA, C3, and fibrin deposition within postcapillary venules.&nbsp; Elevated serum IgA and low C3 may be seen in some patients, but these tests are nonspecific and of little diagnostic use.</p><p><strong>(Choice A)</strong>&nbsp; Anti-DNA antibodies are specific for systemic lupus erythematosus, which can cause arthralgias and petechiae.&nbsp; However, laboratory evaluation typically shows elevated erythrocyte sedimentation rate and complete blood count abnormalities (eg, anemia, leukopenia, thrombocytopenia), neither of which is seen in this patient.</p><p><strong>(Choice B)</strong>&nbsp; Echocardiography is part of the evaluation for acute rheumatic fever, a complication of group A <em>Streptococcus</em> pharyngitis characterized by migratory arthritis, carditis, erythema marginatum (annular, pink rash), subcutaneous nodules, and Sydenham chorea.&nbsp; This patient&#39;s rash is not consistent with rheumatic fever.</p><p><strong>(Choice D)</strong>&nbsp; Pelvic radiography is used to assess for hip pain caused by slipped capital femoral epiphysis, which typically presents in overweight adolescents, or Legg-Calv&eacute;-Perthes disease (idiopathic avascular necrosis of the femoral head).&nbsp; With both conditions, symptoms (eg, hip pain, limp) are typically chronic and not associated with abdominal pain or petechiae.</p><p><strong>(Choice E)</strong>&nbsp; Renal disease in HSP may not be initially evident, as in this patient with a normal urinalysis, but it can develop months after symptom onset.&nbsp; Serial screening urinalyses should be performed, but renal ultrasonography is not typically indicated in HSP management.</p><p><strong>Educational objective:</strong><br>Henoch-Sch&ouml;nlein purpura is an IgA-mediated vasculitis most commonly seen in children.&nbsp; Diagnosis is clinical, and no further testing is required in patients with palpable petechiae/purpura plus &#8805;2 of the following: arthralgia, abdominal pain, and renal disease.&nbsp; Skin biopsy is performed for atypical or incomplete presentations.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 23448,
            "topic": "IgA vasculitis",
            "titleId": 23448,
            "title": "IgA vasculitis",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Anti-DNA antibodies",
                    "choiceNumber": 1,
                    "correctTaken": 1933,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Echocardiography",
                    "choiceNumber": 2,
                    "correctTaken": 578,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No additional diagnostic testing",
                    "choiceNumber": 3,
                    "correctTaken": 5008,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pelvic radiography",
                    "choiceNumber": 4,
                    "correctTaken": 6249,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Renal ultrasonography",
                    "choiceNumber": 5,
                    "correctTaken": 2504,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28654132",
                    "mediaDataId": 0,
                    "title": "Henoch-Sch&amp;#246;nlein purpura: a literature review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28654132",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 206,
            "othersAvgTimeSpent": 86,
            "notes": null,
            "peopleTaken": 16279,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 31,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 8,
            "questionId": 3173,
            "questionIndex": 3173,
            "questionText": "<p>A 34-year-old woman comes to the clinic with a facial rash, joint pains, and oral ulcers.&nbsp; She has no associated fever or other systemic symptoms and otherwise feels well.&nbsp; Medical history is unremarkable, and the patient&#39;s only concurrent medication is an oral contraceptive.&nbsp; She does not smoke and consumes alcohol only on social occasions.&nbsp; Antinuclear and anti-double-stranded DNA antibody titers are elevated.&nbsp; Creatinine and complement levels are normal.&nbsp; The patient is diagnosed with systemic lupus erythematosus, and therapy with hydroxychloroquine is initiated.&nbsp; Which of the following evaluations should be done periodically while the patient is taking this medication?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t38387\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Disease-modifying antirheumatic drugs</strong></p></td></tr><tr><td><p align=\"center\"><strong>Agent</strong></p></td><td><p align=\"center\"><strong>Mechanism</strong></p></td><td><p align=\"center\"><strong>Adverse effects</strong></p></td></tr><tr><td><p align=\"center\"><strong>Methotrexate</strong></p></td><td><ul><li>Folate antimetabolite</li></ul></td><td><ul><li>Hepatotoxicity</li><li>Stomatitis</li><li>Cytopenias</li></ul></td></tr><tr><td><p align=\"center\"><strong>Leflunomide</strong></p></td><td><ul><li>Pyrimidine synthesis inhibitor</li></ul></td><td><ul><li>Hepatotoxicity</li></ul><ul><li>Cytopenias</li></ul></td></tr><tr><td><p align=\"center\"><strong>Hydroxychloroquine</strong></p></td><td><ul><li>TNF &amp; IL-1 suppressor</li></ul></td><td><ul><li>Retinopathy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Sulfasalazine</strong></p></td><td><ul><li>TNF &amp; IL-1 suppressor</li></ul></td><td><ul><li>Hepatotoxicity</li><li>Stomatitis</li><li>Hemolytic anemia</li></ul></td></tr><tr><td><p align=\"center\"><strong>TNF inhibitors</strong><br />(eg, adalimumab, certolizumab,<br />etanercept, golimumab, infliximab)</p></td><td></td><td><ul><li>Infection</li><li>Demyelination</li><li>Congestive heart failure</li><li>Malignancy</li></ul></td></tr><tr><td colspan=\"3\"><p><strong>IL-1</strong> = interleukin&nbsp;1;<strong>TNF </strong>= tumor necrosis factor.</p></td></tr></tbody></table></div></p><p>This patient, with a new diagnosis of <strong>systemic lupus erythematosus</strong> (SLE), has limited disease, with skin, joint, and mucosal manifestations.&nbsp; Disease activity in SLE should be monitored with periodic blood counts, inflammatory markers (eg, erythrocyte sedimentation rate), complement levels, and anti-double-stranded DNA antibody titers.&nbsp; Patients should also be screened regularly for lupus nephritis with urinalysis, serum creatinine, and urine protein assay.</p><p>The choice of drug therapy in SLE depends on the degree of organ involvement.&nbsp; Most patients with active SLE benefit from <strong>hydroxychloroquine</strong>, a safe and well-tolerated medication.&nbsp; However, it can cause <strong>retinal toxicity</strong> on rare occasions, with a potential for irreversible vision loss.&nbsp; This is most common after 5-7 years of therapy.&nbsp; For this reason, patients treated with hydroxychloroquine should have a baseline <strong>ophthalmologic evaluation</strong>, with annual reassessment beginning after 5 years.</p><p><strong>(Choice A)</strong>&nbsp; Ototoxicity is a common adverse effect of aminoglycoside antibiotics and platinum-based chemotherapeutic agents.&nbsp; Hearing impairment has been reported with hydroxychloroquine, but routine audiometry is not currently recommended.</p><p><strong>(Choice B)</strong>&nbsp; Echocardiography is used to assess lupus myocarditis and can identify cardiotoxicity in patients with rheumatoid arthritis taking tumor necrosis factor inhibitors (eg, etanercept).&nbsp; Cardiotoxicity is not a significant concern with hydroxychloroquine.</p><p><strong>(Choices D and E)</strong>&nbsp; Methotrexate is used as a steroid-sparing agent in patients with moderate to severe SLE.&nbsp; Methotrexate is associated with multisystem toxicity affecting liver, lungs, mucosa, and bone marrow.&nbsp; Hepatic markers are frequently monitored in patients with SLE who take methotrexate, but hydroxychloroquine does not require routine liver testing.</p><p><strong>(Choice F)</strong>&nbsp; Amiodarone can cause a variety of endocrinopathies, including both hypo- and hyperthyroidism (for which periodic thyroid function monitoring is recommended).</p><p><strong>Educational objective</strong>:<br>Hydroxychloroquine is used for patients with active systemic lupus erythematosus.&nbsp; However, it can cause retinal toxicity with prolonged use.&nbsp; Patients treated with hydroxychloroquine should have a baseline ophthalmologic evaluation and periodic reassessment.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 19642,
            "topic": "SLE",
            "titleId": 19642,
            "title": "SLE",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Audiometry",
                    "choiceNumber": 1,
                    "correctTaken": 2345,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Echocardiogram",
                    "choiceNumber": 2,
                    "correctTaken": 1563,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Eye examination",
                    "choiceNumber": 3,
                    "correctTaken": 20209,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Liver function panel",
                    "choiceNumber": 4,
                    "correctTaken": 15323,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pulmonary function tests",
                    "choiceNumber": 5,
                    "correctTaken": 1332,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thyroid-stimulating hormone",
                    "choiceNumber": 6,
                    "correctTaken": 1271,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21292109",
                    "mediaDataId": 0,
                    "title": "Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21292109",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 23,
            "othersAvgTimeSpent": 40,
            "notes": null,
            "peopleTaken": 42043,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 9,
            "questionId": 2312,
            "questionIndex": 2312,
            "questionText": "<p>A 2-year-old girl is brought to the emergency department for fever.&nbsp; Eight days ago, the patient developed fever, abdominal pain, vomiting, and watery diarrhea.&nbsp; Her gastrointestinal symptoms subsided in 3 days, but her fever has persisted and has not responded to ibuprofen and acetaminophen.&nbsp; The patient has also been irritable with decreased oral intake.&nbsp; Temperature is 39.4 C (102.9 F), blood pressure is 110/60 mm Hg, pulse is 120/min, and respirations are 24/min.&nbsp; Examination shows injected sclera and dry, red, cracked lips.&nbsp; Heart and lungs are clear to auscultation.&nbsp; The abdomen is soft and nontender without organomegaly.&nbsp; A macular rash is present over the trunk, and the perineal region, palms, and soles are erythematous.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hematocrit</td><td style=\"vertical-align:middle;\">46%</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">12,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">540,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Urinalysis</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Protein</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;White blood cells</td><td style=\"vertical-align:middle;\">40/hpf</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Red blood cells</td><td style=\"vertical-align:middle;\">0/hpf</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Bacteria</td><td style=\"vertical-align:middle;\">none</td></tr></tbody></table><p>Which of the following is the most appropriate next step in management?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33230\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Kawasaki disease</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology &amp; epidemiology</strong></p></td><td><ul><li>Medium-vessel vasculitis</li><li>Usually affects children age &lt;5</li><li>&uarr; Incidence in East Asian ethnicity</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnostic criteria</strong></p></td><td><ul><li>Fever &ge;5 days plus &ge;4 of the following:<ul style=\"list-style-type:circle;\"><li>Conjunctivitis: bilateral, nonexudative</li><li>Mucositis: injected/fissured lips or pharynx, strawberry tongue</li><li>Cervical lymphadenopathy: &ge;1 nodes &gt;1.5 cm</li><li>Rash: perineal erythema &amp; desquamation; polymorphous, generalized</li><li>Erythema &amp; edema of the hands/feet, periungual desquamation</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>&uarr; Platelets &amp; white blood cells; &darr; hemoglobin</li><li>&uarr; Acute-phase reactants (eg, C-reactive protein)</li><li>&uarr; AST &amp; ALT</li><li>Sterile pyuria</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Intravenous immunoglobulin &amp; aspirin</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>Coronary artery aneurysm</li><li>Ventricular dysfunction</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>ALT</strong> = alanine aminotransferase; <strong>AST</strong> = aspartate aminotransferase.</p></td></tr></tbody></table></div><p>This patient has had fever &#8805;5 days, plus conjunctivitis, mucositis (ie, red, cracked lips), rash, and extremity changes, findings consistent with <a href=\"723\">Kawasaki disease</a> (KD).&nbsp; Nonspecific gastrointestinal (eg, vomiting, diarrhea) or respiratory (eg, cough, congestion) symptoms may precede the development of mucocutaneous findings, as seen here.</p><p>Laboratory evidence supportive of <strong>systemic inflammation</strong> in KD includes <strong>leukocytosis</strong> and <strong>thrombocytosis</strong>, as seen in this case.&nbsp; <strong>Sterile pyuria</strong>, which represents urethral inflammation, is also classic and characterized by urinary white blood cells with no bacteriuria.&nbsp; Although mild anemia is common, this patient&#39;s elevated hematocrit may represent hemoconcentration from poor fluid intake.</p><p><strong>Treatment</strong> of KD is with <strong>intravenous immunoglobulin</strong> (IVIG).&nbsp; Presumably due to its anti-inflammatory effect, IVIG <strong>decreases</strong> the risk of <strong>coronary artery aneurysms</strong>, which is highest in patients with delayed treatment.&nbsp; Therefore, IVIG therapy should be initiated <strong>within 10 days</strong> of symptom onset in all patients with KD.&nbsp; Aspirin is also administered for its anti-inflammatory and antiplatelet effects but does not affect aneurysm development.</p><p><strong>(Choice A)</strong>&nbsp; Colonoscopy evaluates for suspected inflammatory bowel disease, a rare condition in children age &lt;5.&nbsp; Initial findings may include fever, gastrointestinal symptoms (eg, abdominal pain, diarrhea [often bloody]), and laboratory evidence of systemic inflammation; however, presentation is typically chronic and insidious.&nbsp; In addition, perineal examination is more likely to reveal fissures, skin tags, or fistulas rather than erythema alone, and other extraintestinal findings can include aphthous ulcers (not red lips) and erythema nodosum (not a truncal, macular rash).</p><p><strong>(Choices B and E)</strong>&nbsp; Urinary tract infection can present with fever and pyuria, and dysuria may not be prominent in young children; intravenous antibiotic therapy (eg, ceftriaxone) and renal ultrasound may be indicated for some patients (eg, those unresponsive to oral therapy).&nbsp; However, bacteria on urinalysis/urine culture is required for diagnosis and not present here.&nbsp; Moreover, mucocutaneous findings are inconsistent with this diagnosis.</p><p><strong>(Choice D)</strong>&nbsp; Peripheral flow cytometry can aid in the diagnosis of leukemia, which often presents with prolonged or recurrent fever.&nbsp; However, supportive findings include hepatosplenomegaly, diffuse lymphadenopathy, pallor, or bleeding/bruising along with laboratory abnormalities of leukocytosis/leukopenia, anemia, and thrombocytopenia.&nbsp; None of these clinical features are seen, and this patient has thrombocytosis.</p><p><strong>Educational objective</strong>:<br>Classic manifestations of Kawasaki disease are typically accompanied by laboratory findings of systemic inflammation, such as thrombocytosis, leukocytosis, and sterile pyuria.&nbsp; Treatment includes intravenous immunoglobulin to decrease the risk of coronary artery aneurysms.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 15668,
            "topic": "Kawasaki disease",
            "titleId": 15668,
            "title": "Kawasaki disease",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Colonoscopy and mucosal biopsy",
                    "choiceNumber": 1,
                    "correctTaken": 311,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intravenous ceftriaxone",
                    "choiceNumber": 2,
                    "correctTaken": 4547,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intravenous immunoglobulin",
                    "choiceNumber": 3,
                    "correctTaken": 8547,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Peripheral flow cytometry",
                    "choiceNumber": 4,
                    "correctTaken": 1014,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Renal ultrasound",
                    "choiceNumber": 5,
                    "correctTaken": 1530,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28079915",
                    "mediaDataId": 0,
                    "title": "Intravenous immunoglobulin for the treatment of Kawasaki disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28079915",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 116,
            "othersAvgTimeSpent": 89,
            "notes": null,
            "peopleTaken": 15954,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 54,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 10,
            "questionId": 11122,
            "questionIndex": 12268,
            "questionText": "<p>An 83-year-old woman comes to the office due to dry eyes.&nbsp; For the last 3 years, the patient has had mild burning discomfort associated with a sensation of dust or sand in the eyes.&nbsp; She uses over-the-counter artificial tears to relieve the discomfort.&nbsp; Medical history is notable for hypertension treated with amlodipine.&nbsp; The patient drinks a glass of wine nightly and does not smoke.&nbsp; Vital signs are normal.&nbsp; On examination, the pupils are symmetrically round and reactive to light.&nbsp; The conjunctivae are normal bilaterally, and funduscopic examination is normal.&nbsp; Oropharyngeal examination shows dry mucosa.&nbsp; Neurologic examination is unremarkable.&nbsp; Serum chemistry panel, complete blood count, erythrocyte sedimentation rate, and TSH are normal.&nbsp; Serum antinuclear antibody assay is negative.&nbsp; Which of the following is the most likely cause of this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T93943\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Age-related dry eye syndrome vs Sj&ouml;gren syndrome</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Age-related dry eye syndrome</strong></p></td><td><p align=\"center\"><strong>Sj&ouml;gren syndrome</strong></p></td></tr><tr><td><p align=\"center\"><strong>Prevalence</strong></p></td><td><ul><li>Common</li></ul></td><td><ul><li>Uncommon to rare</li></ul></td></tr><tr><td><p align=\"center\"><strong>Age of onset</strong></p></td><td><ul><li>50s-80s</li></ul></td><td><ul><li>30s-60s</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br>features</strong></p></td><td><ul><li>Mild to moderate mucosal dryness</li></ul></td><td><ul><li>Mucosal dryness often severe</li><li>Parotid enlargement</li><li>Comorbid autoimmune disease (eg, scleroderma, rheumatoid arthritis)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnostic<br>features</strong></p></td><td><ul><li>Normal ESR and autoimmune markers*</li><li>Secretory function objectively normal/near-normal (eg, normal Schirmer test)</li></ul></td><td><ul><li>Abnormal ESR and autoimmune markers*</li><li>Secretory function objectively decreased (eg, abnormal Schirmer test)</li></ul></td></tr><tr><td colspan=\"3\"><p>*Examples: antinuclear antibody, anti-SSA (Ro), anti-SSB (La).</p><p><strong>ESR</strong> = erythrocyte sedimentation rate.</p></td></tr></tbody></table></div><p>This patient, an older woman with dry eyes and a foreign body sensation in the eyes but no evidence of autoimmune inflammation (eg, negative antinuclear antibody, normal erythrocyte sedimentation rate [ESR]), has features typical of <strong>age-related dry eye syndrome</strong> (ARDES).&nbsp; Exocrine output from lacrimal and salivary glands declines with age; this is associated with atrophy, fibrosis, and ductal dilation of the glands.&nbsp; Decreased blink rates, oxidative damage, excessive evaporation of tears (eg, due to meibomian dysfunction), and use of anticholinergic medications can also contribute to eye dryness.</p><p>ARDES is more common in women, with increased risk in patients with diabetes mellitus or thyroid disorders.&nbsp; Concurrent dry mouth symptoms are also common.&nbsp; Complications include corneal epithelial erosions, leading to <strong>impaired vision</strong>.&nbsp; Management is primarily with <strong>artificial tears</strong> or other ocular lubricants applied frequently, especially in dry or windy conditions.&nbsp; Cyclosporine drops can also be used to increase tear secretion.</p><p>Dry eye syndrome can also be a manifestation of Sj&ouml;gren syndrome, which is characterized by lymphocytic autoimmune destruction of the exocrine glands leading to pronounced xerostomia (dry mouth) and keratoconjunctivitis sicca (dry eyes).&nbsp; However, unlike ARDES, patients are typically age &lt;65 and have other evidence of autoimmune disease (eg, scleroderma, rheumatoid arthritis) and associated laboratory markers (eg, positive antinuclear antibodies, elevated ESR, elevated anti-Ro or anti-La antibodies).&nbsp; In this patient, ARDES is more likely than Sj&ouml;gren syndrome based on the absence of autoimmune markers and onset at an older age (&gt;65) <strong>(Choices B and C)</strong>.</p><p><strong>(Choice D)</strong>&nbsp; The nasolacrimal duct can become obstructed by involutional stenosis, dacryolith formation, orbital fracture, or blockade by granulomatous disease (eg, sarcoidosis) or neoplasm.&nbsp; Symptoms include excessive tearing with drainage to the face (epiphora).</p><p><strong>(Choice E)</strong>&nbsp; Systemic sclerosis is an autoimmune condition characterized by thickening and hardening of the skin and other tissues.&nbsp; It can occur in an overlap syndrome with Sj&ouml;gren syndrome, but almost all patients (~95%) have a positive antinuclear antibody assay.</p><p><strong>Educational objective:</strong><br>Age-related dry eye syndrome is due to a decrease in exocrine output from the lacrimal glands.&nbsp; Decreased blink rates, oxidative damage, and use of anticholinergic medications can also contribute.&nbsp; Sj&ouml;gren syndrome is an autoimmune disorder of the exocrine glands that can also present with dry eyes and dry mouth; it usually occurs at age &lt;65 and is commonly associated with a positive antinuclear antibody assay.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 8551,
            "topic": "Sjogren syndrome",
            "titleId": 8551,
            "title": "Sjogren syndrome",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "1",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Age-related exocrine gland atrophy",
                    "choiceNumber": 1,
                    "correctTaken": 10984,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Autoimmune destruction of exocrine glands",
                    "choiceNumber": 2,
                    "correctTaken": 3239,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inflammatory infiltration of exocrine glands",
                    "choiceNumber": 3,
                    "correctTaken": 728,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obstruction of nasolacrimal duct",
                    "choiceNumber": 4,
                    "correctTaken": 142,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Systemic sclerosis with mucosal involvement",
                    "choiceNumber": 5,
                    "correctTaken": 340,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25535823",
                    "mediaDataId": 0,
                    "title": "Age-related defects in ocular and nasal mucosal immune system and the immunopathology of dry eye disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25535823",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25197560",
                    "mediaDataId": 0,
                    "title": "Aging: a predisposition to dry eyes.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25197560",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 121,
            "othersAvgTimeSpent": 40,
            "notes": null,
            "peopleTaken": 15433,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 71,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 11,
            "questionId": 4014,
            "questionIndex": 4014,
            "questionText": "<p>A 45-year-old woman comes to the office due to a 3-month history of progressive exertional dyspnea and nonproductive cough.&nbsp; She has had no chest pain or pedal edema but reports intermittent episodes of difficulty swallowing.&nbsp; The patient has a history of hypertension and severe gastroesophageal reflux and has had Raynaud phenomenon for 2 years.&nbsp; She does not use tobacco or alcohol.&nbsp; Blood pressure is 142/86 mm Hg and pulse is 80/min.&nbsp; Physical examination shows the skin over her face, hands, arms, and trunk to be thick and firm.&nbsp; Scattered crackles are heard on lung auscultation.&nbsp; Which of the following is the most likely cause of this patient&#39;s current symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31126\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Systemic sclerosis subtype characteristics</strong></p></td></tr><tr><td><p align=\"center\"><strong>Limited cutaneous</strong></p></td><td><ul><li>Scleroderma on head &amp; distal upper extremities</li><li>Prominent vascular manifestations<ul style=\"list-style-type:circle;\"><li>Raynaud phenomenon</li><li>Cutaneous telangiectasia</li><li>Pulmonary arterial hypertension</li></ul></li><li>CREST syndrome</li><li>Anticentromere antibodies</li><li>Better prognosis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diffuse cutaneous</strong></p></td><td><ul><li>Scleroderma on trunk &amp; upper extremities</li><li>Prominent internal organ involvement<ul style=\"list-style-type:circle;\"><li>Scleroderma renal crisis</li><li>Myocardial ischemia &amp; fibrosis</li><li>Interstitial lung disease</li></ul></li><li>Anti&ndash;Scl-70 (topoisomerase type I) antibodies</li><li>Anti&ndash;RNA polymerase III antibodies</li><li>Worse prognosis</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>CREST</strong> = <strong>C</strong>alcinosis, <strong>R</strong>aynaud phenomenon, <strong>E</strong>sophageal dysmotility, <strong>S</strong>clerodactyly &amp; <strong>T</strong>elangiectasia.</p></td></tr></tbody></table></div><p>This patient with progressive dyspnea and nonproductive cough has most likely developed <strong>interstitial lung disease (ILD)</strong> due to underlying <strong>systemic sclerosis (SS)</strong>.&nbsp; Of the 2 subtypes of SS, <strong>diffuse cutaneous SS (dcSS)</strong> carries the stronger association with internal organ involvement, and ILD occurs in approximately 40% of cases.&nbsp; Considerable overlap exists in the clinical manifestations of dcSS and limited cutaneous SS (lcSS).&nbsp; Although vascular manifestations are more prominent in lcSS, <strong>Raynaud phenomenon</strong> is common in both subtypes.&nbsp; In addition, <strong>esophageal dysmotility</strong> with gastroesophageal reflux is commonly seen in both subtypes.&nbsp; In contrast, <strong>skin thickening</strong> involving the <strong>trunk</strong> is characteristic of dcSS.</p><p>ILD also occurs in patients with lcSS, but less frequently and typically less extensively than in those with dcSS.&nbsp; The stronger association of dcSS with internal organ involvement leads to an overall worse prognosis compared to lcSS.</p><p><strong>(Choice A)</strong>&nbsp; Chemical pneumonitis refers to damage to the lower airways due to aspiration of gastric contents (eg, gastric acid).&nbsp; Patients often present acutely in respiratory distress and have a history of dysphagia (eg, stroke) or reduced consciousness (eg, alcoholism).&nbsp; This patient&#39;s dysphagia puts her at risk for chemical pneumonitis, but her progressive dyspnea and features of SS (eg, Raynaud phenomenon) make ILD more likely.</p><p><strong>(Choice C)</strong>&nbsp; Cardiac involvement in SS can occur in the form of myocardial fibrosis, typically leading to ventricular diastolic dysfunction.&nbsp; Patients have symptoms of heart failure (eg, dyspnea, peripheral edema); absence of peripheral edema makes the diagnosis less likely.</p><p><strong>(Choice D)</strong>&nbsp; Bronchiolitis obliterans is an obstructive lung disease caused by proliferative narrowing of medium and small bronchioles.&nbsp; It can occur following viral infection or inhalation injury and is also associated with rheumatologic disease.&nbsp; However, it is rare in patients with SS and is more likely to present with wheezing (rather than crackles) on lung auscultation.</p><p><strong>(Choice E)</strong>&nbsp; Restriction of chest movement affecting respiration is most commonly seen in patients with obesity hypoventilation syndrome.&nbsp; It may occur in dcSS due to extensive thoracic skin fibrosis but is quite rare.</p><p><strong>Educational objective:</strong><br>Systemic sclerosis (SS) is divided into diffuse cutaneous and limited cutaneous subtypes.&nbsp; Although there is considerable overlap in disease manifestations between the 2 subtypes, internal organ involvement (eg, interstitial lung disease) is more common and more extensive in diffuse cutaneous SS, leading to a worse prognosis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 3789,
            "topic": "Systemic sclerosis",
            "titleId": 3789,
            "title": "Systemic sclerosis",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Chemical irritant pneumonitis",
                    "choiceNumber": 1,
                    "correctTaken": 214,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Interstitial lung disease",
                    "choiceNumber": 2,
                    "correctTaken": 10839,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Left ventricular diastolic dysfunction",
                    "choiceNumber": 3,
                    "correctTaken": 557,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obstruction of medium and small bronchioles",
                    "choiceNumber": 4,
                    "correctTaken": 559,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Restricted chest wall movement",
                    "choiceNumber": 5,
                    "correctTaken": 3296,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22506881",
                    "mediaDataId": 0,
                    "title": "Interstitial lung disease in systemic sclerosis: pathophysiology, current and new advances in therapy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22506881",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 81,
            "othersAvgTimeSpent": 50,
            "notes": null,
            "peopleTaken": 15465,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 70,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 12,
            "questionId": 3208,
            "questionIndex": 3208,
            "questionText": "<p>A 52-year-old woman comes to the office due to a diffuse rash that began a few weeks ago.&nbsp; Lately, the patient has also been having difficulty rising from a seated position and climbing stairs.&nbsp; Vital signs are within normal limits.&nbsp; The patient has an erythematous rash on the upper chest and violaceous periorbital edema.&nbsp; Examination shows symmetric proximal muscle weakness in the legs.&nbsp; This patient&#39;s condition is most often associated with which of the following?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t65136\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Clinical features of dermatomyositis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Muscle weakness</strong></p></td><td><ul><li>Proximal, symmetric</li><li>Weakness in UE = LE</li></ul></td></tr><tr><td><p align=\"center\"><strong>Skin findings</strong></p></td><td><ul><li>Gottron sign/papules</li><li>Heliotrope rash</li></ul></td></tr><tr><td><p align=\"center\"><strong>Extramuscular findings</strong></p></td><td><ul><li>Interstitial lung disease</li><li>Dysphagia</li><li>Myocarditis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>&uarr; CPK, aldolase, LDH</li><li>Anti-Mi2, anti-Jo-1</li><li>Diagnostic uncertainty: EMG/MRI, biopsy (skin/muscle)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>High-dose glucocorticoids <strong>plus</strong> glucocorticoid-sparing agent</li><li>Screening for malignancy</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>CPK</strong> = creatine phosphokinase; <strong>EMG</strong> = electromyography; <strong>LDH</strong> = lactate dehydrogenase; <strong>LE</strong> = lower extremity; <strong>UE</strong> = upper extremity.</p></td></tr></tbody></table></div><p><strong>Dermatomyositis</strong> is an autoimmune condition that is twice as common in <strong>women</strong>.&nbsp; In its most classic form, it causes a <strong>proximal</strong> muscle inflammatory myositis and characteristic <strong>cutaneous</strong> findings (eg, <strong>violaceous poikiloderma</strong> over various regions of the body).</p><ul><li>On the face, the eruption is often accompanied by periorbital erythema (often with edema) and is known as the <a href=\"673\">heliotrope sign</a>.</li></ul><ul><li>The erythematous rash follows a photodistributed pattern on the chest (v sign) and back (shawl sign).</li></ul><ul><li>Violaceous, occasionally scaly, lesions that can be flat (Gottron sign) or raised (<a href=\"2745\">Gottron papules</a>) can be present on the metacarpophalangeal joints, proximal interphalangeal joints, elbows, and knees and are <strong>pathognomonic</strong> for dermatomyositis.</li></ul><p>Due to the inflammatory nature of dermatomyositis, patients have elevated <strong>creatine phosphokinase</strong> (CPK) that is generally 10 times the upper limit of normal but can vary.&nbsp; The classic autoantibodies associated with dermatomyositis are <strong>anti-Mi-2</strong> (against helicase) and anti-Jo-1 (antisynthetase antibody, found more commonly in polymyositis).</p><p><strong>Malignancies</strong> are more common in patients with dermatomyositis (&gt;15% of adult patients).&nbsp; The most common malignancies are adenocarcinomas (eg, ovarian, lung, pancreatic, stomach, colorectal cancers).&nbsp; The pathophysiology for this association is unclear but may be related to cross-reactive autoantigens (eg, in the muscles and on tumor cells).&nbsp; Regular, age-appropriate cancer screening is essential, and other studies (eg, chest x-ray, gynecologic evaluation) are often considered at initial diagnosis for further investigation of underlying malignancy.</p><p><strong>(Choice A)</strong>&nbsp; Alveolar hemorrhage can be caused by autoimmune diseases (eg, ANCA-associated vasculitides and lupus) and toxins (eg, cocaine, amphetamine).&nbsp; Dermatomyositis is associated with interstitial lung disease (10% of patients).</p><p><strong>(Choice B)</strong>&nbsp; Aortic aneurysms can be caused by autoimmune diseases (eg, Takayasu arteritis, giant cell arteritis), infections (eg, syphilis, salmonella), and connective tissue disorders (eg, Marfan, Ehlers-Danlos).</p><p><strong>(Choice C)</strong>&nbsp; Carpal tunnel syndrome is associated with autoimmune conditions (eg, rheumatoid arthritis), infiltrative diseases (amyloidosis), and endocrinopathies (eg, diabetes, hypothyroidism).</p><p><strong>(Choice D)</strong>&nbsp; Glomerulonephritis can be caused by infections (eg, hepatitis B, hepatitis C, HIV), protein deposition diseases (eg, amyloidosis), and autoimmune diseases (eg, lupus, ANCA-associated vasculitides).&nbsp; Rarely, the elevated CPK in dermatomyositis can cause a myoglobin-induced acute kidney injury from tubular injury (rather than glomerulonephritis).</p><p><strong>(Choice F)</strong>&nbsp; Autoimmune diseases associated with sudden visual loss include giant cell arteritis and multiple sclerosis.</p><p><strong>Educational objective:</strong><br>Dermatomyositis is typically characterized by cutaneous findings accompanied by proximal muscle weakness.&nbsp; Over 15% of adult patients will have or develop a malignancy, most commonly adenocarcinomas.&nbsp; Regular, age-appropriate cancer screening is essential.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 15037,
            "topic": "Inflammatory myopathies",
            "titleId": 15037,
            "title": "Inflammatory myopathies",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alveolar hemorrhage",
                    "choiceNumber": 1,
                    "correctTaken": 327,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Aortic aneurysms",
                    "choiceNumber": 2,
                    "correctTaken": 542,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Carpal tunnel syndrome",
                    "choiceNumber": 3,
                    "correctTaken": 1124,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Glomerulonephritis",
                    "choiceNumber": 4,
                    "correctTaken": 3084,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Malignancy",
                    "choiceNumber": 5,
                    "correctTaken": 9382,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sudden visual loss",
                    "choiceNumber": 6,
                    "correctTaken": 1038,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 28,
            "othersAvgTimeSpent": 41,
            "notes": null,
            "peopleTaken": 15497,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 61,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 13,
            "questionId": 10904,
            "questionIndex": 12040,
            "questionText": "<p>A 44-year-old woman comes to the office due to worsening exertional dyspnea over the last 6 months.&nbsp; The patient struggles to walk more than 2 blocks on level ground due to shortness of breath.&nbsp; She has had no chest pain, orthopnea, light-headedness, or syncope but reports recent lower extremity swelling and abdominal &#x22;bloating.&#x22;&nbsp; Medical history is significant for severe gastroesophageal reflux disease and cold-induced painful digital pallor and cyanosis.&nbsp; The patient has a 20-pack-year history but quit 8 years ago.&nbsp; Blood pressure is 133/82 mm Hg, pulse is 75/min, and respirations are 20/min.&nbsp; Pulse oximetry on room air is 90% at rest and 86% with exertion.&nbsp; Breath sounds are clear bilaterally with excellent air movement and no crackles.&nbsp; Cardiac examination demonstrates a loud S2 over the left upper sternal border.&nbsp; Jugulovenous pressure is elevated.&nbsp; There is 2+ lower extremity edema.&nbsp; Skin examination shows ulceration and skin tightening on the fingertips.&nbsp; The results of pulmonary function testing are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Spirometry</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">FVC</td><td style=\"vertical-align:middle;\">normal</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">FEV<font size=\"2\"><sub>1</sub></font></td><td style=\"vertical-align:middle;\">normal</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">FEV<font size=\"2\"><sub>1</sub></font>/FVC ratio</td><td style=\"vertical-align:middle;\">0.82</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Lung volumes</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Total lung capacity</td><td style=\"vertical-align:middle;\">normal</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Residual volume</td><td style=\"vertical-align:middle;\">normal</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Diffusion capacity</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Diffusion capacity of the lungs for carbon monoxide</td><td style=\"vertical-align:middle;\">very low</td></tr></tbody></table><p>Anticentromere antibody is positive.&nbsp; Chest x-ray is normal.&nbsp; ECG shows right axis deviation.&nbsp; Which of the following is the most likely cause of this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T31117\"><table class=\"table-default-style table-header-footer-style\" style=\"width:603px\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Pulmonary involvement in systemic sclerosis</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>PAH alone</strong></p></td><td><p align=\"center\"><strong>ILD</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical<br>presentation</strong></p></td><td><ul><li>Dyspnea</li><li>Exertional syncope</li><li>Clear lungs</li></ul></td><td><ul><li>Dyspnea</li><li>Cough</li><li>Velcro-like crackles</li></ul></td></tr><tr><td><p align=\"center\"><strong>Pulmonary<br>function<br>testing</strong></p></td><td><ul><li>Normal FEV<sub>1</sub> &amp; FVC</li><li>Normal FEV<sub>1</sub>/FVC ratio</li><li>&#8595; DLCO</li></ul></td><td><ul><li>&#8595; FEV<sub>1</sub> &amp; FVC</li><li>Normal or &#8593; FEV<sub>1</sub>/FVC ratio</li><li>&#8595; DLCO</li></ul></td></tr><tr><td colspan=\"3\"><p><strong>DLCO</strong> = diffusion capacity of the lungs for carbon monoxide; <strong>ILD</strong> = interstitial lung disease; <strong>PAH</strong> = pulmonary arterial hypertension.</p></td></tr></tbody></table></div><p>This patient has progressive dyspnea and signs of <strong>right-sided heart failure</strong> (clear lungs, elevated jugulovenous pressure, loud P2, peripheral edema, right axis deviation).&nbsp; She also has limited <a href=\"32640\">systemic sclerosis (SS)</a>, as evidenced by sclerodactyly (fingertip skin tightening), Raynaud phenomenon, severe gastroesophageal reflux disease (dysmotility), and a positive anticentromere antibody.</p><p>Pulmonary involvement in SS has 2 major manifestations:</p><ul><li><p><strong>Pulmonary arterial hypertension (PAH)</strong> is the pulmonary expression of a widespread <strong>vasculopathy</strong>.&nbsp; It is more common with limited SS (aka CREST syndrome), sharing similar pathophysiology with digital ischemia and renal crisis.</p></li><li><p>Interstitial lung disease (ILD) results from alveolar basement membrane inflammation and fibrosis.&nbsp; It is more common with diffuse SS, which causes more extensive visceral organ scarring.</p></li></ul><p>Pulmonary function tests (PFTs) can distinguish between them.&nbsp; Both cause <strong>reduced DLCO</strong> (diffusion impairment), reflecting thickening of the vessel wall (SS-PAH) or the alveolar basement membrane (SS-ILD).&nbsp; Reduced DLCO <strong>despite normal lung mechanics</strong> (no obstruction [ie, normal FEV<font size=\"2\"><sub>1</sub></font>/FVC &gt;0.70] or restriction [ie, normal lung volumes &gt;80%]) indicates an isolated <strong>pulmonary vascular</strong> problem.&nbsp; Therefore, this patient likely has <strong>SS-PAH</strong>, in which vessel wall thickening can lead to <strong>luminal narrowing</strong>, elevated pulmonary vascular resistance, and eventual right ventricular failure.</p><p>In contrast, SS-ILD would produce a restrictive PFT pattern due to alveolar basement membrane fibrosis, causing loss of lung compliance.&nbsp; ILD would also present with inspiratory crackles and reticular infiltrates on chest imaging (vs clear breath sounds and normal parenchyma on chest x-ray in PAH) <strong>(Choice D)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Restrictive cardiomyopathy due to amyloidosis typically presents with biventricular heart failure due to indiscriminate cardiac wall involvement.&nbsp; In addition to right-sided congestion (peripheral edema, early satiety), left ventricular dysfunction (eg, pulmonary edema, pleural effusions) would also be present.&nbsp; Restrictive cardiomyopathy can accompany SS but is due to myocardial fibrosis rather than amyloid (eg, misfolded transthyretin) deposition.</p><p><strong>(Choice B)</strong>&nbsp; Smoking and SS both lead to accelerated coronary artery disease, which can present with exertional dyspnea (angina equivalent).&nbsp; However, cardiac ischemia would not explain this patient&#39;s hypoxemia, reduced DLCO, or isolated right ventricular dysfunction with loud P2.</p><p><strong>(Choice C)</strong>&nbsp; Smoking-induced emphysema can lead to reduced DLCO due to alveolar surface area destruction.&nbsp; However, an obstructive pattern and hyperinflated lung volumes are expected.</p><p><strong>Educational objective:</strong><br>Pulmonary arterial hypertension is a major complication of systemic sclerosis and should be suspected with signs of right-sided heart failure and a vascular pattern on pulmonary function testing (isolated, reduced DLCO despite normal mechanics).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 9805,
            "topic": "Pulmonary Arterial Hypertension",
            "titleId": 9805,
            "title": "Pulmonary Arterial Hypertension",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amyloid infiltration of the ventricular myocardium",
                    "choiceNumber": 1,
                    "correctTaken": 804,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Atherosclerotic stenosis of a coronary artery",
                    "choiceNumber": 2,
                    "correctTaken": 80,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Emphysematous enlargement of the alveoli",
                    "choiceNumber": 3,
                    "correctTaken": 172,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fibrosis of the lung basement membrane",
                    "choiceNumber": 4,
                    "correctTaken": 8762,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lumen narrowing of the pulmonary arteries",
                    "choiceNumber": 5,
                    "correctTaken": 5975,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27075793",
                    "mediaDataId": 0,
                    "title": "The heart and pulmonary arterial hypertension in systemic sclerosis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27075793",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23339456",
                    "mediaDataId": 0,
                    "title": "Loss of alveolar membrane diffusing capacity and pulmonary capillary blood volume in pulmonary arterial hypertension.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23339456",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 114,
            "othersAvgTimeSpent": 75,
            "notes": null,
            "peopleTaken": 15793,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 38,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 14,
            "questionId": 3169,
            "questionIndex": 3169,
            "questionText": "<p>A 46-year-old woman suffering from systemic lupus erythematosus (SLE) develops hematuria and proteinuria.&nbsp; She was diagnosed with SLE four years ago and has been treated with hydroxychloroquine and prednisone.&nbsp; A renal biopsy is performed and shows diffuse proliferative glomerulonephritis.&nbsp; She is started on cyclophosphamide, and hydroxychloroquine is stopped.&nbsp; This new therapeutic regimen puts her at an increased risk for which of the following conditions?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Cyclophosphamide</strong> is an alkylating agent frequently used as an immunosuppressant in systemic lupus erythematosus (SLE), vasculitis and certain cancers.&nbsp; Regarding SLE, cyclophosphamide is reserved for patients with significant renal or central nervous system problems.&nbsp; Unfortunately, cyclophosphamide has many side effects.&nbsp; Serious side effects include acute <strong>hemorrhagic cystitis</strong>, bladder carcinoma, sterility, and myelosuppression.&nbsp; Hemorrhagic cystitis and <strong>bladder cancer</strong> are caused by acrolein, a bladder-toxic metabolite of cyclophosphamide.&nbsp; Drinking plenty of fluids, voiding frequently, and taking mesna are all helpful in preventing these complications.</p><p><b>(Choice A)</b>&nbsp; Cochlear dysfunction is a side effect of cisplatin and carboplatin, both of which may be used to treat testicular, ovarian and bladder cancer. Aminoglycosides also may cause cochlear dysfunction.</p><p><b>(Choice B)</b>&nbsp; Ethambutol and hydroxychloroquine have been implicated in causing optic neuritis.</p><p><b>(Choice D)</b> Toxic causes of peripheral neuropathy include phenytoin, isoniazid, vincristine, heavy metals, and heavy alcohol use.</p><p><b>(Choice E)</b>&nbsp; Digital vasospasm (Raynaud phenomenon) may be caused by beta-blockers and ergotamine.</p><p><b>(Choice F)</b>&nbsp; Amiodarone and lithium are associated with thyroid dysfunction.</p><p><b>(Choice G)</b>&nbsp; Gout is a side effect of cyclosporine.</p><p><b>(Choice H)</b>&nbsp; Although alcohol use and gallstones account for the majority of cases of acute pancreatitis, certain drugs have also been implicated.&nbsp; Cyclophosphamide is not commonly associated with pancreatitis.</p><p><b>Educational objective</b><strong>:</strong><br>Long-term cyclophosphamide use is associated with the increased incidence of acute hemorrhagic cystitis and bladder carcinoma.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 16679,
            "topic": "Bladder cancer",
            "titleId": 16679,
            "title": "Bladder cancer",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cochlear dysfunction",
                    "choiceNumber": 1,
                    "correctTaken": 27105,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Optic neuritis",
                    "choiceNumber": 2,
                    "correctTaken": 17550,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bladder carcinoma",
                    "choiceNumber": 3,
                    "correctTaken": 186779,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Peripheral neuropathy",
                    "choiceNumber": 4,
                    "correctTaken": 26951,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Digital vasospasm",
                    "choiceNumber": 5,
                    "correctTaken": 2566,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thyroid dysfunction",
                    "choiceNumber": 6,
                    "correctTaken": 8182,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Crystal arthritis",
                    "choiceNumber": 7,
                    "correctTaken": 13977,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Acute pancreatitis",
                    "choiceNumber": 8,
                    "correctTaken": 12537,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 52,
            "othersAvgTimeSpent": 47,
            "notes": null,
            "peopleTaken": 295647,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 15,
            "questionId": 14816,
            "questionIndex": 16239,
            "questionText": "<p>A 52-year-old woman comes to the emergency department due to worsening chest pain and shortness of breath for the past week.&nbsp; The patient has right-sided, &#x22;stabbing&#x22; pain whenever she takes a deep breath associated with shortness of breath on moderate exertion.&nbsp; She has no fever, chills, or leg swelling but has had frequent pain in her hands and feet.&nbsp; The patient has pain while walking in the morning and is unable to bend her fingers to hold a coffee cup.&nbsp; She takes no medications.&nbsp; For several years in her twenties, the patient used tobacco (half-pack of cigarettes daily).&nbsp; She does not drink alcohol.&nbsp; Temperature is 37.2 (99 F), blood pressure is 142/80 mm Hg, pulse is 84/min, and respirations are 18/min.&nbsp; BMI is 30 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Lung auscultation reveals bilateral fine inspiratory crackles and decreased breath sounds over the right base.&nbsp; Heart sounds are normal with no murmurs.&nbsp; The patient has no rashes.&nbsp; The wrists and small joints of the hands are mildly swollen and tender bilaterally; there is no clubbing.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Hematocrit</td><td style=\"vertical-align:middle;\">32%</td></tr><tr><td style=\"vertical-align:middle;\">Leukocytes</td><td style=\"vertical-align:middle;\">8,200/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Serum creatinine</td><td style=\"vertical-align:middle;\">0.8 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Serum protein</td><td style=\"vertical-align:middle;\">6 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">Lactate dehydrogenase</td><td style=\"vertical-align:middle;\">70 U/L</td></tr><tr><td style=\"vertical-align:middle;\">TSH</td><td style=\"vertical-align:middle;\">4.0 &micro;U/mL</td></tr><tr><td style=\"vertical-align:middle;\">Antinuclear antibody (ANA)</td><td style=\"vertical-align:middle;\">negative</td></tr></tbody></table><p>Chest x-ray shows increased interstitial markings and a moderate-sized right pleural effusion.&nbsp; Diagnostic thoracentesis reveals pleural fluid protein of 4 g/dL, lactate dehydrogenase of 950 U/L, and glucose of 10 mg/dL.&nbsp; Which of the following is the most likely underlying cause of this patient&#39;s pleural effusion?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T33396\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\" style=\"width:33.0%\"><p align=\"center\"><strong>Exudative &amp; transudative pleural effusions</strong></p></td></tr><tr><td style=\"width:27.0%\"></td><td style=\"width:40.0%\"><p align=\"center\"><strong>Exudate</strong></p></td><td style=\"width:33.0%\"><p align=\"center\"><strong>Transudate</strong></p></td></tr><tr><td style=\"width:27.0%\"><p align=\"center\"><strong>Light criteria</strong></p></td><td style=\"width:40.0%\"><p align=\"center\">Pleural protein/serum protein &gt;0.5</p><p align=\"center\"><strong>OR</strong></p><p align=\"center\">Pleural LDH/serum LDH &gt;0.6</p><p align=\"center\"><strong>OR</strong></p><p align=\"center\">Pleural LDH &gt;2/3 upper limit of normal of serum LDH</p></td><td style=\"width:33.0%\"><p align=\"center\">Exudate criteria not met</p></td></tr><tr><td style=\"width:27.0%\"><p align=\"center\"><strong>Pathophysiology</strong></p></td><td style=\"width:40.0%\"><p align=\"center\">Inflammatory disruption of vascular permeability</p></td><td style=\"width:33.0%\"><p align=\"center\">Change in hydrostatic or oncotic pressure</p></td></tr><tr><td style=\"width:27.0%\"><p align=\"center\"><strong>Common causes</strong></p></td><td style=\"width:40.0%\"><ul><li>Infection (eg, TB, pneumonia)</li><li>Malignancy</li><li>Rheumatologic disease (eg, RA, SLE)</li><li>Pulmonary embolism</li><li>Pancreatitis</li><li>Post-CABG</li></ul></td><td style=\"width:33.0%\"><ul><li>Heart failure</li><li>Cirrhosis (hepatic hydrothorax)</li><li>Nephrotic syndrome</li><li>Constrictive pericarditis</li></ul></td></tr><tr><td colspan=\"3\" style=\"width:33.0%;\"><p><strong>CABG</strong> = coronary artery bypass grafting; <strong>LDH</strong> = lactate dehydrogenase; <strong>RA</strong> = rheumatoid arthritis; <strong>SLE</strong> = systemic lupus erythematosus; <strong>TB</strong> = tuberculosis.</p></td></tr></tbody></table></div><p>This patient with pleuritic chest pain has a pleural effusion with a high pleural fluid/serum protein ratio of 0.67 (4 g/dL / 6 g/dL) and a high lactate dehydrogenase (LDH) ratio of 13.6 (950 U/L / 70 U/L).&nbsp; Based on the Light criteria these findings are consistent with an <strong>exudative effusion</strong>, which usually results from an <a href=\"22505\">inflammatory disruption</a> of vascular permeability.&nbsp; Several features of this patient&#39;s presentation suggest <strong>rheumatoid arthritis</strong> (RA) as the underlying diagnosis:</p><ul><li><p>Rheumatoid effusions are often marked by very <strong>low</strong> (eg, &lt;50 mg/dL) <strong>glucose</strong> and very <strong>high LDH</strong> (&gt;700 U/L); they may also have a low pH resembling bacterial empyema.&nbsp; In general, effusions with <a href=\"9852\">very low glucose levels</a> are most often due to RA, empyema, malignancy, or tuberculosis.</p></li><li><p>The patient has evidence of an inflammatory arthritis with joint swelling, tenderness, and morning stiffness.</p></li><li><p>Her fine crackles on examination and increased interstitial markings on x-ray are consistent with <strong>interstitial lung disease</strong> (ILD), which, along with pulmonary nodules, is a pulmonary manifestation of RA.</p></li></ul><p>Exudative pleural effusions are a relatively common extraarticular manifestation of RA, although they may be asymptomatic and usually resolve spontaneously.</p><p><strong>(Choice A)</strong>&nbsp; Pleural effusions in decompensated heart failure are typically transudative (ie, due to increased pulmonary capillary hydrostatic pressure), with lower protein and LDH levels than in this patient.</p><p><strong>(Choices B and D)</strong>&nbsp; Diffuse cutaneous systemic sclerosis (scleroderma) can cause finger contractures (eg, difficulty bending the fingers) and is associated with ILD; however, pleural effusion is uncommon, patients often have Raynaud syndrome, and inflammatory arthritis is rare.&nbsp; Sarcoidosis also causes ILD and arthritis; however, pleural effusions are uncommon, and arthritis typically involves the ankles and is often seen in association with hilar adenopathy and erythema nodosum (ie, Lofgren syndrome).</p><p><strong>(Choice E)</strong>&nbsp; Systemic lupus erythematosus (SLE) can cause ILD and pleural effusions and can also cause inflammatory arthritis resembling RA.&nbsp; However, antinuclear antibodies (ANA) are extremely (&gt;95%) sensitive for SLE, with a positive result seen in 98%-100% of patients with active SLE; therefore, this patient&#39;s negative ANA result makes SLE much less likely.&nbsp; In contrast, RA is associated with a positive ANA result in &lt;50% of cases; therefore, the negative ANA result in this patient does not rule out the diagnosis, especially given the other findings (eg, exudative effusion with low glucose, inflammatory arthritis with morning stiffness).</p><p><strong>Educational objective:</strong><br>Rheumatoid arthritis can cause exudative pleural effusions characterized by low glucose, very high lactate dehydrogenase, and (often) low pH and is associated with interstitial lung disease.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 3769,
            "topic": "Rheumatoid arthritis",
            "titleId": 3769,
            "title": "Rheumatoid arthritis",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Decompensated heart failure",
                    "choiceNumber": 1,
                    "correctTaken": 429,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Diffuse systemic sclerosis",
                    "choiceNumber": 2,
                    "correctTaken": 4917,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rheumatoid arthritis",
                    "choiceNumber": 3,
                    "correctTaken": 7106,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sarcoidosis",
                    "choiceNumber": 4,
                    "correctTaken": 2105,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Systemic lupus erythematosus",
                    "choiceNumber": 5,
                    "correctTaken": 1460,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 95,
            "othersAvgTimeSpent": 108,
            "notes": null,
            "peopleTaken": 16017,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 44,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 16,
            "questionId": 17224,
            "questionIndex": 18676,
            "questionText": "<p>A 78-year-old woman comes to the office due to a 2-week history of achy pain and prolonged morning stiffness in the shoulders and hips.&nbsp; Associated symptoms include fatigue and low-grade fever, but the patient has had no headache, swelling in the joints, or other new symptoms.&nbsp; Medical history is unremarkable.&nbsp; Physical examination shows pain with active abduction at the shoulders and inability to abduct the humerus above the horizontal.&nbsp; Motor strength and deep tendon reflexes are normal and symmetric.&nbsp; Laboratory results show a markedly elevated erythrocyte sedimentation rate and mild normocytic anemia; a serum chemistry panel and TSH are normal.&nbsp; Low-dose prednisone therapy is prescribed.&nbsp; A week later, the patient returns and reports substantial improvement in symptoms.&nbsp; Which of the following additional studies is needed to confirm the diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T57380\" style=\"overflow-x:auto;\" tid=\"31534\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Polymyalgia rheumatica</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical<br>features</strong></p></td><td><ul><li>Rapid-onset pain &amp; stiffness in shoulders &amp; hips &plusmn; neck involvement</li><li>Fatigue, weight loss, low-grade fever</li><li>~10% associated with GCA (eg, headache, jaw claudication, visual symptoms)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnostic<br>testing</strong></p></td><td><ul><li>Elevated acute phase markers (eg, ESR, CRP)</li><li>Temporal artery biopsy if symptoms of GCA</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Very rapid response to oral glucocorticoids</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>CRP</strong> = C-reactive protein; <strong>ESR</strong> = erythrocyte sedimentation rate; <strong>GCA</strong> = giant cell (temporal) arteritis.</p></td></tr></tbody></table></div><p>This patient has <strong>polymyalgia rheumatica (PMR)</strong>, an inflammatory disorder characterized by the following features:</p><ul><li><strong>Acute</strong> onset of symptoms (eg, 2 weeks) at <strong>age &#8805;50</strong></li><li>Prolonged <strong>morning stiffness</strong> and gelling (stiffness with inactivity) in <strong>proximal joints</strong> (eg, hips, shoulders)</li><li><strong>Systemic symptoms</strong> (eg, fever, weight loss)</li><li>Markedly elevated inflammatory markers (eg, erythrocyte sedimentation rate, C-reactive protein)</li></ul><p>PMR involves periarticular structures (eg, bursae, tendons), but the muscle tissue itself is unaffected and remains histologically normal.&nbsp; Therefore, objective muscle strength is preserved, as in this patient, although range of motion can be limited due to pain and stiffness.</p><p>There are no specific diagnostic tests for PMR.&nbsp; Treatment with <strong>low-dose glucocorticoid therapy</strong> (eg, prednisone 20 mg daily) is usually initiated in patients with a characteristic presentation; a <strong>rapid response</strong> supports the diagnosis, whereas lack of improvement should prompt consideration of other diagnoses.&nbsp; This patient&#39;s presentation and rapid symptom improvement with prednisone are sufficient to establish the diagnosis of PMR, and <strong>no additional testing</strong> is required.</p><p><strong>(Choice A)</strong>&nbsp; Cyclic citrullinated peptide antibodies are specific for rheumatoid arthritis (RA).&nbsp; Although RA presents with joint pain and stiffness, symptoms are typically insidious rather than acute, the small joints of the hands are affected more often than the shoulders and hips, and joint swelling is typically seen.</p><p><strong>(Choice B)</strong>&nbsp; Infective endocarditis can cause myalgia, fever, and elevated inflammatory markers.&nbsp; However, this patient has no risk factors (eg, valvular heart disease) or embolic manifestations (eg, splinter hemorrhages) to warrant work-up for endocarditis with echocardiography.</p><p><strong>(Choice C)</strong>&nbsp; Muscle biopsy is used in the diagnosis of polymyositis.&nbsp; Polymyositis directly affects muscle tissue, resulting in prominent, symmetric proximal muscle weakness, but pain is usually mild or absent.&nbsp; This patient&#39;s preserved muscle strength and marked stiffness and pain are unexpected in polymyositis and make PMR more likely.</p><p><strong>(Choice E)</strong>&nbsp; A minority of PMR cases are associated with giant cell (temporal) arteritis (GCA), which is characterized by headache, jaw claudication, and visual disturbances.&nbsp; When GCA is suspected, patients require high-dose glucocorticoid therapy and expedited temporal artery biopsy.&nbsp; However, this patient has no features of GCA, so temporal artery biopsy is not indicated.</p><p><strong>Educational objective:</strong><br>Polymyalgia rheumatica is an inflammatory disorder that occurs in patients age &#8805;50; it is characterized by aching pain and stiffness in the hips and shoulders.&nbsp; The diagnosis is suggested by elevated inflammatory markers (eg, erythrocyte sedimentation rate, C-reactive protein), and the condition responds rapidly to low-dose glucocorticoid therapy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 8281,
            "topic": "Polymyalgia rheumatica",
            "titleId": 8281,
            "title": "Polymyalgia rheumatica",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "4",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cyclic citrullinated peptide antibody assay",
                    "choiceNumber": 1,
                    "correctTaken": 642,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Echocardiography",
                    "choiceNumber": 2,
                    "correctTaken": 25,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Muscle biopsy",
                    "choiceNumber": 3,
                    "correctTaken": 823,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No additional studies",
                    "choiceNumber": 4,
                    "correctTaken": 2913,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Temporal artery biopsy",
                    "choiceNumber": 5,
                    "correctTaken": 577,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31493201",
                    "mediaDataId": 0,
                    "title": "Pathogenesis, diagnosis and management of polymyalgia rheumatica.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31493201",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 57,
            "othersAvgTimeSpent": 70,
            "notes": null,
            "peopleTaken": 5064,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 58,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 17,
            "questionId": 10848,
            "questionIndex": 11980,
            "questionText": "<p>A 76-year-old woman comes to the office for evaluation of leukopenia.&nbsp; The patient came to the United States to visit her son a month ago and was seen at an urgent care clinic 2 weeks ago for acute sinusitis, where she was found to have leukopenia.&nbsp; She was prescribed an oral antibiotic, and a repeat blood test was advised.&nbsp; The patient has had 2 episodes of skin infections over the past 3 months.&nbsp; She also has had pain and swelling in the joints of her hands and knees for the past several years.&nbsp; The patient does not use tobacco, alcohol, or illicit drugs.&nbsp; Temperature is 37.2 C (98.9 F), blood pressure is 130/80 mm Hg, and pulse is 74/min.&nbsp; Physical examination shows normal heart and lung sounds, moderate splenomegaly, generalized lymphadenopathy, no sinus tenderness, and well-healing lower extremity ulcerations.&nbsp; The small joints of the hands are swollen and deformed.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"width:166.5pt; vertical-align:middle;\">Hemoglobin</td><td style=\"vertical-align:middle;\">11.8 g/dL</td></tr><tr><td style=\"width:166.5pt; vertical-align:middle;\">Mean corpuscular volume</td><td style=\"vertical-align:middle;\">92 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"width:166.5pt; vertical-align:middle;\">Platelets</td><td style=\"vertical-align:middle;\">280,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"width:166.5pt; vertical-align:middle;\">Leukocytes</td><td style=\"vertical-align:middle;\">1,800/mm<font size=\"2\"><sup>3</sup></font> (20% neutrophils)</td></tr><tr><td style=\"width:166.5pt; vertical-align:middle;\">Creatinine</td><td style=\"vertical-align:middle;\">0.8 mg/dL</td></tr><tr><td style=\"width:166.5pt; vertical-align:middle;\">Calcium</td><td style=\"vertical-align:middle;\">9.2 mg/dL</td></tr><tr><td style=\"width:166.5pt; vertical-align:middle;\">Erythrocyte sedimentation rate</td><td style=\"vertical-align:middle;\">68 mm/h</td></tr><tr><td style=\"width:166.5pt; vertical-align:middle;\">HIV serology</td><td style=\"vertical-align:middle;\">negative</td></tr></tbody></table><p>Additional evaluation of this patient is most likely to reveal which of the following?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t50312\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Felty syndrome</strong></p></td></tr><tr><td style=\"width: 20%;\"><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td><ul><li>Rheumatoid arthritis<ul style=\"list-style-type:circle;\"><li>Severe erosive joint disease &amp; deformity</li><li>Rheumatoid nodules</li><li>Vasculitis (mononeuritis multiplex, necrotizing skin lesions)</li></ul></li><li>Neutropenia (ANC &lt;2000/&micro;L)</li><li>Splenomegaly</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Anti-CCP &amp; RF are positive in &gt;90% of patients</li><li>Markedly elevated ESR, often &gt;85 mm/hr</li><li>Peripheral smear &amp; bone marrow biopsy to rule out other causes of neutropenia</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>ANC</strong> =&nbsp;absolute neutrophil count; <strong>anti-CCP</strong>&nbsp;=&nbsp;anticyclic citrullinated peptide; <strong>ESR</strong>&nbsp;=&nbsp;erythrocyte sedimentation rate;&nbsp;<strong>RF</strong>&nbsp;=&nbsp;rheumatoid factor.</p></td></tr></tbody></table></div><p>This patient with swollen, deformed hand joints and an elevated erythrocyte sedimentation rate likely has untreated inflammatory polyarthritis.&nbsp; The presence of concurrent neutropenia and splenomegaly raise strong suspicion for <strong>Felty syndrome</strong>, an uncommon but serious complication of long-standing, erosive <strong>rheumatoid arthritis</strong> (RA).</p><p>Felty syndrome is marked by the formation of autoantibodies against neutrophil components and granulocyte colony-stimulating factor, leading to <strong>neutropenia</strong> (ie, absolute neutrophil count &lt;2,000/mm<font size=\"2\"><sup>3</sup></font>) and an increased risk of <strong>recurrent bacterial infection</strong> (particularly of the skin and sinuses).&nbsp; Neutrophils coated with antibodies are also trapped in the spleen, which usually results in <strong>splenomegaly</strong>.&nbsp; Most patients also have extraarticular manifestations of RA such as lymphadenopathy, rheumatoid nodules, and/or necrotizing skin lesions.</p><p>The diagnosis is made based on clinical features but is supported by the presence of high-titer <strong>rheumatoid factor</strong> and <strong>anticitrullinated peptide antibodies</strong> (both of which are usually elevated in RA).&nbsp; Most patients are also HLA-DR4 positive (indicating a genetic susceptibility).&nbsp; Other causes of neutropenia should be ruled out with bone marrow biopsy and peripheral smear prior to establishing the diagnosis.&nbsp; Symptoms generally improve with treatment of the underlying RA.</p><p><strong>(Choice B)</strong>&nbsp; Vitamin B<font size=\"2\"><sub>12</sub></font> deficiency can cause pancytopenia due to increased hematopoietic cell apoptosis and impaired DNA maturation.&nbsp; However, patients usually have macrocytic (not normocytic) anemia, and significant neutropenia/recurrent infection would be atypical.&nbsp; This patient&#39;s normocytic anemia is likely due to anemia of chronic disease from her joint inflammation.</p><p><strong>(Choice C)</strong>&nbsp; Aplastic anemia is marked by diffusely hypocellular bone marrow due to injury to hematopoietic stem cells.&nbsp; Patients typically have significant reductions in all 3 cell lines (not normal platelet count), and splenomegaly is atypical.</p><p><strong>(Choice D)</strong>&nbsp; Chronic myeloid leukemia is associated with the <em>BCR</em>-<em>ABL1</em> fusion gene, commonly due to a chromosome 9/22 translocation (Philadelphia [Ph<font size=\"2\"><sup>1</sup></font>] chromosome).&nbsp; Patients often develop splenomegaly and lymphadenopathy but usually have dramatic leukocytosis (often &gt;100,000/mm<font size=\"2\"><sup>3</sup></font>), not leukopenia.</p><p><strong>(Choice E)</strong>&nbsp; Multiple myeloma is a plasma cell neoplasm characterized by production of a monoclonal immunoglobulin.&nbsp; It can present with systemic symptoms, recurrent infection, and normocytic anemia but is also commonly associated with bone pain, renal insufficiency, and hypercalcemia.&nbsp; In addition, splenomegaly is atypical.</p><p><strong>Educational objective:</strong><br>Felty syndrome is a complication of seropositive rheumatoid arthritis (RA) characterized by neutropenia and splenomegaly.&nbsp; Most patients have high-titer rheumatoid factor and anticitrullinated peptide antibodies (both of which are usually elevated in RA).&nbsp; Risk of recurrent bacterial infection is significantly increased due to neutropenia.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 3769,
            "topic": "Rheumatoid arthritis",
            "titleId": 3769,
            "title": "Rheumatoid arthritis",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Anticitrullinated peptide antibodies",
                    "choiceNumber": 1,
                    "correctTaken": 8843,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased vitamin B<font size=\"2\"><sub>12</sub></font> level",
                    "choiceNumber": 2,
                    "correctTaken": 105,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypocellular bone marrow",
                    "choiceNumber": 3,
                    "correctTaken": 1999,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Philadelphia (Ph<font size=\"2\"><sup>1</sup></font>) chromosome",
                    "choiceNumber": 4,
                    "correctTaken": 2848,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum monoclonal proteins",
                    "choiceNumber": 5,
                    "correctTaken": 1707,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25614773",
                    "mediaDataId": 0,
                    "title": "Felty&#39;s syndrome, insights and updates.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25614773",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23292482",
                    "mediaDataId": 0,
                    "title": "Felty&#39;s syndrome without rheumatoid arthritis?",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23292482",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 99,
            "othersAvgTimeSpent": 95,
            "notes": null,
            "peopleTaken": 15505,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 57,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 18,
            "questionId": 9415,
            "questionIndex": 9939,
            "questionText": "<p>A 51-year-old woman comes to the office due to 2 months of pain and numbness of her right index and middle fingers.&nbsp; Her fingers turn white when subjected to cold, and they hurt until she thoroughly warms them.&nbsp; The patient has no problems with her left fingers or toes.&nbsp; Medical history is significant for chronic cough, lower back pain, and acid reflux disease.&nbsp; She has a 28-pack-year smoking history.&nbsp; On examination, there are 2 small ulcers on the tip of her right index finger.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t52673\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Raynaud phenomenon</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Primary</strong></p></td><td><p align=\"center\"><strong>Secondary</strong></p></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Etiology</strong></p></td><td><ul><li>Idiopathic response to cold or stress</li><li>Risk factors include CVD, smoking</li></ul></td><td><ul><li>Vasoconstriction due to vascular pathology</li><li>Causes: autoimmune disease (eg,&nbsp;systemic sclerosis), drugs (eg,&nbsp;amphetamines), trauma (eg,&nbsp;frostbite)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />presentation</strong></p></td><td><ul><li>Young; predominantly female</li><li>Symmetric attacks</li><li>Normal examination &amp; laboratory results</li></ul></td><td><ul><li>Older (&gt;40); male &amp; female</li><li>Asymmetric attacks</li><li>Examination/laboratory results: tissue injury (eg,&nbsp;digital ulcers), abnormal nail fold capillaries, autoimmune antibodies (eg,&nbsp;ANA)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Nonpharmacologic: warming techniques, smoking cessation, stress reduction</li><li>Medication: CCB (first-line), PDE-5 inhibitor (second-line)</li></ul></td><td><ul><li>Evaluate &amp; treat underlying disorder</li><li>Same medications as for primary RP</li><li>Consider aspirin if increased risk for digital ulceration</li></ul></td></tr><tr><td colspan=\"3\"><p><strong>ANA</strong>&nbsp;=&nbsp;antinuclear antibody; <strong>CCB</strong>&nbsp;=&nbsp;calcium channel blocker; <strong>CVD</strong>&nbsp;=&nbsp;cardiovascular disease;<strong> ESR</strong>&nbsp;=&nbsp;erythrocyte sedimentation rate; <strong>PDE-5</strong>&nbsp;=&nbsp;phosphodiesterase type 5; <strong>RP</strong>&nbsp;=&nbsp;Raynaud phenomenon.</p></td></tr></tbody></table></div></p><p>This patient&#39;s clinical features suggest <strong>Raynaud phenomenon (RP)</strong>, which is caused by abnormal vasoconstriction of digital arteries in response to cold or emotional distress.&nbsp; Primary RP is not associated with a systemic disorder, but secondary RP (eg, systemic lupus erythematosus, scleroderma, thromboangiitis obliterans) is.</p><p>Patients typically experience sudden onset of cold at the extremities (fingers or toes) and sharply demarcated color changes (white or blue) of the digits.&nbsp; <strong>Primary RP</strong> typically affects young patients (ages 15-30, often female), who have <strong>symmetric</strong> episodic attacks without tissue injury.&nbsp; Patients with <strong>secondary RP</strong> are generally older (age &gt;40, often male) and have <strong>asymmetric</strong> attacks with clinical features of tissue ischemia (eg, numbness, ulcers) and systemic disease (autoimmune or vascular).</p><p>Based on history and physical examination, workup for patients with suspected secondary RP may include:</p><ul><li>Complete blood count and metabolic panel</li><li>Urinalysis</li><li><strong>Antinuclear antibody (ANA)</strong> and rheumatoid factor</li><li>Erythrocyte sedimentation rate and complement levels (C3 and C4)</li></ul><p>If the ANA screen is positive, specific antibodies (eg, antitopoisomerase-1 for systemic sclerosis) may be obtained.</p><p><strong>(Choice B)</strong>&nbsp; An arteriogram may be used to diagnose thromboangiitis obliterans (Buerger&nbsp;disease), a vasculitis that affects small and medium-sized arteries of young patients who smoke.&nbsp; It presents with distal-extremity ischemia, ulcers, or gangrene.&nbsp; Thromboangiitis obliterans is more common in men, typically presents age 40-45, and is usually diagnosed after the exclusion of other systemic diseases (eg, diabetes mellitus, autoimmune and hypercoagulable disorders); therefore, ANA and other blood tests should be obtained prior to an arteriogram (a more invasive study) in this patient.</p><p><strong>(Choice C)</strong>&nbsp; Treatment of RP includes smoking cessation and avoidance of cold temperatures and emotional stress.&nbsp; Pharmacologic therapy includes dihydropyridine <strong>calcium channel blockers</strong> (CCB) such as nifedipine or amlodipine.&nbsp; Some studies have shown limited benefit of losartan in decreasing RP attacks in patients unable to tolerate CCB (or other recommended agents).</p><p><strong>(Choice D)</strong>&nbsp; Although hypothyroidism can cause cold vasospasm, it generally does not cause tissue ischemia or well-demarcated digit color changes.</p><p><strong>(Choice E)</strong>&nbsp; Transthoracic echocardiogram is useful for initial evaluation of infective endocarditis (IE).&nbsp; This patient&#39;s skin manifestations are not suggestive of Janeway lesions (ie, painless, erythematous lesions on palms or soles) or Osler&nbsp;nodes (ie, painful, papular pustules on pulp of fingers or toes) typically found in patients with bacteremia and IE.</p><p><strong>Educational objective:</strong><br>Raynaud phenomenon (RP) is abnormal vasoconstriction of digital arteries in response to cold or emotional stress.&nbsp; It may be primary, or may occur in association with systemic disease, especially autoimmune disorders.&nbsp; Patients with suspected secondary RP should be tested for autoantibodies and inflammatory markers.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 15233,
            "topic": "Raynaud phenomenon",
            "titleId": 15233,
            "title": "Raynaud phenomenon",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antinuclear antibodies",
                    "choiceNumber": 1,
                    "correctTaken": 2395,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Arteriogram",
                    "choiceNumber": 2,
                    "correctTaken": 1735,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Losartan therapy",
                    "choiceNumber": 3,
                    "correctTaken": 188,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thyroid function studies",
                    "choiceNumber": 4,
                    "correctTaken": 88,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transthoracic echocardiogram",
                    "choiceNumber": 5,
                    "correctTaken": 530,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21117349",
                    "mediaDataId": 0,
                    "title": "Raynaud's phenomenon.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21117349",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 53,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 5027,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 19,
            "questionId": 9387,
            "questionIndex": 9906,
            "questionText": "<p>A 28-year-old woman comes to the clinician with pain and numbness of both hands over the last 6 months.&nbsp; Cold temperatures seem to precipitate these episodes.&nbsp; Medical history includes exercise-induced asthma, lower back pain, and hypothyroidism.&nbsp; The patient takes levothyroxine daily.&nbsp; She does not use alcohol or illicit drugs but has a 10-pack-year smoking history.&nbsp; Laboratory studies show normal complete blood count and chemistry panel.&nbsp; TSH is 4.7 &micro;U/mL.&nbsp; Antinuclear antibody screen is negative.&nbsp; Physical examination findings are shown in the image below.</p><P><img id=\"2449\"  src=\"https://www.uworld.com/media/U9626.jpg\" draggable=\"false\" ></P><p>In addition to smoking cessation, which of the following is the best initial therapy for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t52673\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Raynaud phenomenon</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Primary</strong></p></td><td><p align=\"center\"><strong>Secondary</strong></p></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Etiology</strong></p></td><td><ul><li>Idiopathic response to cold or stress</li><li>Risk factors include CVD, smoking</li></ul></td><td><ul><li>Vasoconstriction due to vascular pathology</li><li>Causes: autoimmune disease (eg,&nbsp;systemic sclerosis), drugs (eg,&nbsp;amphetamines), trauma (eg,&nbsp;frostbite)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />presentation</strong></p></td><td><ul><li>Young; predominantly female</li><li>Symmetric attacks</li><li>Normal examination &amp; laboratory results</li></ul></td><td><ul><li>Older (&gt;40); male &amp; female</li><li>Asymmetric attacks</li><li>Examination/laboratory results: tissue injury (eg,&nbsp;digital ulcers), abnormal nail fold capillaries, autoimmune antibodies (eg,&nbsp;ANA)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Nonpharmacologic: warming techniques, smoking cessation, stress reduction</li><li>Medication: CCB (first-line), PDE-5 inhibitor (second-line)</li></ul></td><td><ul><li>Evaluate &amp; treat underlying disorder</li><li>Same medications as for primary RP</li><li>Consider aspirin if increased risk for digital ulceration</li></ul></td></tr><tr><td colspan=\"3\"><p><strong>ANA</strong>&nbsp;=&nbsp;antinuclear antibody; <strong>CCB</strong>&nbsp;=&nbsp;calcium channel blocker; <strong>CVD</strong>&nbsp;=&nbsp;cardiovascular disease;<strong> ESR</strong>&nbsp;=&nbsp;erythrocyte sedimentation rate; <strong>PDE-5</strong>&nbsp;=&nbsp;phosphodiesterase type 5; <strong>RP</strong>&nbsp;=&nbsp;Raynaud phenomenon.</p></td></tr></tbody></table></div></p><p>Clinical features suggest that this patient has primary Raynaud phenomenon (RP), an increased vascular response to cold temperature or emotional stress without an underlying cause.&nbsp; Primary RP occurs usually in women age &lt;30 with symptoms of symmetrical episodic attacks and without evidence of peripheral vascular disease, connective tissue disease, tissue injury, or abnormal nailfold capillary examination.&nbsp; Abnormalities such as dilated or dropout vessels in the nailfold capillaries are predictive for future development or the presence of a connective tissue disease.&nbsp; Episodes can also involve tingling, numbness, and pain with skin color changes of pallor (white attack) or cyanosis (blue attack).&nbsp; Laboratory studies (eg, antinuclear antibodies, erythrocyte sedimentation rate) are usually negative.</p><p>Primary RP does not require further evaluation.&nbsp; Treatment mainly involves <strong>avoiding aggravating factors</strong> (ie, cold stimuli, emotional stress).&nbsp; Dihydropyridine <strong>calcium channel blockers</strong> (eg, nifedipine, amlodipine) are the drugs of choice for continuing symptoms.</p><p><strong>(Choices B, D, and E)</strong>&nbsp; Clonidine, angiotensin II converting enzyme inhibitors, and beta blockers are not helpful for treatment of RP.&nbsp; In fact, some studies have shown that nonselective beta blockers may worsen the condition.</p><p><strong>(Choice C)</strong>&nbsp; Although hypothyroidism can lead to generalized cold intolerance, sharply demarcated digit color changes are not typical of cold-induced vasospasm caused by hypothyroidism.</p><p><strong>Educational objective:</strong><br>Primary Raynaud phenomenon is an increased vascular response to cold temperature or emotional stress.&nbsp; It is usually found in women age &lt;30 with symptoms of symmetrical episodic attacks without evidence of peripheral vascular disease, tissue injury, or abnormal nailfold capillary examination.&nbsp; Treatment involves mainly calcium channel blockers (eg, nifedipine, amlodipine) and avoiding aggravating factors.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 15233,
            "topic": "Raynaud phenomenon",
            "titleId": 15233,
            "title": "Raynaud phenomenon",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amlodipine",
                    "choiceNumber": 1,
                    "correctTaken": 94752,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Clonidine",
                    "choiceNumber": 2,
                    "correctTaken": 10438,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increase in levothyroxine dose",
                    "choiceNumber": 3,
                    "correctTaken": 6365,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lisinopril",
                    "choiceNumber": 4,
                    "correctTaken": 1986,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Metoprolol",
                    "choiceNumber": 5,
                    "correctTaken": 7222,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23618525",
                    "mediaDataId": 0,
                    "title": "Current medical and surgical management of Raynaud's syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23618525",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22261435",
                    "mediaDataId": 0,
                    "title": "The association of Raynaud syndrome with ß-blockers: a meta-analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22261435",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 85,
            "othersAvgTimeSpent": 33,
            "notes": null,
            "peopleTaken": 120763,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 78,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 20,
            "questionId": 15709,
            "questionIndex": 17145,
            "questionText": "<p>A 56-year-old woman is brought to the hospital due to altered mental status after being found at home in a state of confusion by her husband.&nbsp; He reports that the patient has had headaches and intermittent vision changes for the past week.&nbsp; She has no other medical history.&nbsp; Temperature is 36.6 C (98 F), blood pressure is 220/115 mm Hg (previously 100/66 mm Hg), and pulse is 90/min.&nbsp; Oxygen saturation is 99% on room air.&nbsp; On examination, the patient is lethargic.&nbsp; Flexion of the neck does not elicit pain.&nbsp; The skin on the hands is shiny and thickened with multiple telangiectasias.&nbsp; The lungs are clear, and there is 1+ lower extremity edema to the shins.&nbsp; A noncontrast head CT scan is unremarkable.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Leukocytes</td><td style=\"vertical-align:middle;\">8,000/mm<font size=\"2\"><sup>3</sup></font></td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">Potassium</td><td style=\"vertical-align:middle;\">4.8 mEq/L</td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">Bicarbonate</td><td style=\"vertical-align:middle;\">18 mEq/L</td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">Blood urea nitrogen</td><td style=\"vertical-align:middle;\">20 mg/dL</td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">Creatinine</td><td style=\"vertical-align:middle;\">3.4 mg/dL</td><td style=\"vertical-align:middle;\">(previously 0.8 mg/dL)</td></tr></tbody></table><p>Urinalysis demonstrates 1+ proteinuria without bacteria or casts.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31109\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Systemic sclerosis</strong></p></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Pathogenesis</strong></p></td><td><ul><li>Progressive tissue fibrosis</li></ul><ul><li>Vascular dysfunction</li></ul></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Clinical features</strong></p></td><td><ul><li>Skin: telangiectasia, sclerodactyly, digital ulcer, calcinosis cutis</li><li>Extremities: arthralgia, myalgia, contracture</li><li>Gastrointestinal tract: esophageal dysmotility, dysphagia, acid reflux</li><li>Lungs: dyspnea, dry cough</li><li>Vascular system: Raynaud phenomenon</li></ul></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Autoantibodies</strong></p></td><td><ul><li>Antinuclear</li><li>Anti&ndash;topoisomerase type I (anti&ndash;Scl-70) (diffuse SSc)</li><li>Anticentromere (limited SSc)</li></ul></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Complications</strong></p></td><td><ul><li>Lungs: interstitial lung disease, pulmonary arterial HTN</li><li>Kidneys: HTN, scleroderma renal crisis (severe HTN, AKI, MAHA)</li><li>Heart: myocardial fibrosis, pericarditis, pericardial effusion</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>AKI</strong> = acute kidney injury; <strong>HTN</strong> = hypertension; <strong>MAHA</strong> = microangiopathic hemolytic anemia; <strong>SSc</strong> = systemic sclerosis.</p></td></tr></tbody></table></div><p>This woman with shiny, thickened skin and multiple telangiectasias likely has <strong>systemic sclerosis (SS)</strong> (ie, <strong>scleroderma</strong>), which is characterized by widespread fibrosis of multiple organ systems.&nbsp; Other common manifestations include swollen digits, ulcerations at the digital tips, and Raynaud syndrome.&nbsp; In association with <strong>severe hypertension</strong> and <strong>acute renal failure</strong>, this presentation suggests <strong>scleroderma renal crisis (SRC)</strong>.</p><p>SRC is a life-threatening complication of systemic sclerosis that may be the initial manifestation of the disease.&nbsp; Renal vascular injury (due in part to collagen deposition) leads to renal ischemia, which results in activation of the <strong>renin-angiotensin-aldosterone system</strong> (RAAS).&nbsp; This raises blood pressure and further damages the renal vasculature, causing a vicious cycle of worsening hypertension and renal dysfunction (eg, elevated creatinine, edema).&nbsp; Hypertensive emergency with end-organ dysfunction (eg, encephalopathy, retinal hemorrhage) is common.&nbsp; Thrombocytopenia and microangiopathic hemolytic anemia can be seen.&nbsp; Urinalysis is usually normal but may show mild proteinuria, as in this patient; casts are unexpected.</p><p>The mainstay of therapy for SRC includes <strong>ACE inhibitors</strong>, which reduce RAAS activity and improve renal function and blood pressure.&nbsp; Short-acting ACE inhibitors (typically <strong>captopril</strong>) are used because they can be rapidly uptitrated.&nbsp; An elevated serum creatinine level is <strong>not a contraindication</strong> for ACE inhibitors in this population, and slight elevations in creatinine are common during drug initiation.</p><p><strong>(Choice B)</strong>&nbsp; Beta blockers (eg, esmolol) are usually avoided in patients with SS due to the increased risk of vasospasm (eg, worsening Raynaud phenomenon).</p><p><strong>(Choice C)</strong>&nbsp; Hemodialysis may be required in some patients with SRC; however, this patient has no urgent indications (eg, hyperkalemia, volume overload with respiratory impairment).&nbsp; ACE inhibitors improve renal function and would likely prevent the need for dialysis.</p><p><strong>(Choice D)</strong>&nbsp; Glucocorticoids (ie, methylprednisolone) can cause salt and water retention and lead to hypertension; they are a major risk factor for the development of SRC and should be avoided in patients with SS.</p><p><strong>(Choice E)</strong>&nbsp; Transdermal clonidine can serve as an antihypertensive but is typically slower acting and cannot be rapidly uptitrated.&nbsp; In addition, it would not treat the underlying RAAS hyperactivity.</p><p><strong>Educational objective:</strong><br>Scleroderma renal crisis is characterized by the acute onset of hypertension and acute kidney injury in patients with systemic sclerosis.&nbsp; The mainstay of therapy is ACE inhibitors (typically captopril), which reduce renin-angiotensin-aldosterone system hyperactivity, improve renal function, and normalize blood pressure.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 3789,
            "topic": "Systemic sclerosis",
            "titleId": 3789,
            "title": "Systemic sclerosis",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "1",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "ACE inhibitor",
                    "choiceNumber": 1,
                    "correctTaken": 4627,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Beta blocker",
                    "choiceNumber": 2,
                    "correctTaken": 3124,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hemodialysis",
                    "choiceNumber": 3,
                    "correctTaken": 3201,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Methylprednisolone",
                    "choiceNumber": 4,
                    "correctTaken": 3789,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transdermal clonidine",
                    "choiceNumber": 5,
                    "correctTaken": 1433,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25613774",
                    "mediaDataId": 0,
                    "title": "Scleroderma renal crisis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25613774",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 165,
            "othersAvgTimeSpent": 79,
            "notes": null,
            "peopleTaken": 16174,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 29,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 21,
            "questionId": 4581,
            "questionIndex": 4581,
            "questionText": "<p>A 62-year-old man comes to the office due to worsening joint pain for the past several months.&nbsp; The patient reports pain and stiffness in the small joints of the hands.&nbsp; The symptoms are worse in the morning and can last for several hours.&nbsp; He has also had intermittent swelling and pain involving the entire fingers.&nbsp; Nonsteroidal anti-inflammatory agents improved the symptoms initially, but, lately, they have provided inadequate relief.&nbsp; Hand examination findings are shown in the <a href=\"67890\">exhibit</a>.&nbsp; Several asymmetric distal and proximal interphalangeal joints are mildly tender to palpation.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32112\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\" style=\"margin-left:.1in;\"><strong>Clinical features of psoriatic arthritis</strong></p></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Arthritis </strong></p></td><td><ul><li>Affects peripheral and axial skeleton</li><li>Causes prolonged (&ge;30 min) morning stiffness</li><li>Varied patterns: oligoarthritis, symmetric polyarthritis, spondylarthritis (eg,&nbsp;sacroiliitis), distal arthritis (eg,&nbsp;DIP joint)</li><li>Severe and deforming disease possible (eg, arthritis mutilans)</li></ul></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Soft tissue &amp; nail involvement </strong></p></td><td><ul><li>Enthesitis (inflammation at tendon insertion site)</li><li>Dactylitis (sausage digits) of toe or finger</li><li>Nail pitting &amp; onycholysis</li><li>Pitting edema of hands or feet</li></ul></td></tr><tr><td><p align=\"center\" style=\"margin-left:8.35pt;\"><strong>Skin lesions </strong></p></td><td><ul><li>Typically precedes onset of arthritis</li><li>May also occur with or after onset of arthritis</li></ul></td></tr></tbody></table></div><p>This patient has <strong>joint pain</strong> accompanied by prolonged (eg, &#8805;30 min) <strong>morning stiffness</strong> and visible <strong>dactylitis</strong> (swelling involving entire fingers) on examination, findings suggestive of <strong>inflammatory arthritis</strong> (eg, psoriatic arthritis [PA], rheumatoid arthritis, gout, lupus).&nbsp; The presence of <a href=\"67891\">nail pitting</a> is a highly <strong>specific</strong> finding for <strong>psoriatic arthritis</strong>.</p><p>In most cases, psoriatic skin disease typically precedes the onset of arthritis by several years.&nbsp; However, a minority of patients (eg, up to 15%) initially have arthritis.&nbsp; Such patients should undergo a <strong>comprehensive skin examination</strong> (including scalp, umbilicus, axilla, and groin) to assess for occult skin lesions, which can assist in establishing the diagnosis.</p><p><strong>(Choice A)</strong>&nbsp; Disseminated gonococcal infection (DGI) can present with acute polyarthralgia, polyarthritis, tenosynovitis, and/or systemic symptoms (eg, fever, chills).&nbsp; Nail pitting is inconsistent with DGI and more specific for PA.</p><p><strong>(Choice B)</strong>&nbsp; Acute gouty arthritis, caused by elevated serum uric acid levels, typically presents with painful monoarthritis in the first metatarsophalangeal joint or knee.&nbsp; Nail pitting and joint involvement in the fingers suggest a different diagnosis.</p><p><strong>(Choice C)</strong>&nbsp; The transferrin saturation level is elevated in hereditary hemochromatosis, which can cause arthralgia and arthritis in the hands.&nbsp; However, nail pitting and dactylitis are not characteristic.</p><p><strong>(Choice D)</strong>&nbsp; Hypertrophic osteoarthropathy is a paraneoplastic manifestation of lung cancer, which is screened with low-dose CT of the lung in high-risk individuals (eg, significant smoking history).&nbsp; Patients have <a href=\"57469\">clubbing</a>, arthralgias, and long bone pain.&nbsp; Nail pitting and dactylitis are not characteristic.</p><p><strong>(Choice F)</strong>&nbsp; <a href=\"61221\">Hand osteoarthritis</a>, which often affects the distal interphalangeal joints, is treated with physical therapy.&nbsp; However, prolonged morning stiffness, nail pitting, and dactylitis are not consistent with this diagnosis.</p><p><strong>Educational objective:</strong><br>Joint pain and prolonged (eg, &#8805;30 min) morning stiffness accompanied by dactylitis (swelling of the digit) and nail changes (eg, nail pitting, oil spots) are highly suggestive of psoriatic arthritis.&nbsp; Arthritis can be the initial presenting symptom of psoriasis in some patients; therefore, a thorough skin examination should be performed to assess for occult skin lesions.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 16058,
            "topic": "Psoriasis",
            "titleId": 16058,
            "title": "Psoriasis",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Inquire about sexually transmitted infections",
                    "choiceNumber": 1,
                    "correctTaken": 693,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Measure the serum uric acid level",
                    "choiceNumber": 2,
                    "correctTaken": 1543,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain a transferrin saturation level",
                    "choiceNumber": 3,
                    "correctTaken": 925,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Order low-dose screening CT scan of the lung",
                    "choiceNumber": 4,
                    "correctTaken": 909,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform a comprehensive skin examination",
                    "choiceNumber": 5,
                    "correctTaken": 9035,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassure and recommend hand exercises",
                    "choiceNumber": 6,
                    "correctTaken": 2130,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "33812489",
                    "mediaDataId": 0,
                    "title": "Psoriasis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/33812489",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 95,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 15235,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 59,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 22,
            "questionId": 3317,
            "questionIndex": 3317,
            "questionText": "<p><u><strong>Patient Information</strong></u><br><strong>Age:</strong> 70 years<br><strong>Gender:</strong> M, self-identified<br><strong>Race/Ethnicity:</strong> unspecified<br><strong>Site of Care:</strong> office</p><p><u><strong>History</strong></u><br><strong>Reason for Visit/Chief Concern:</strong> &#x22;I&#39;ve had joint pains, and I&#39;ve felt tired.&#x22;<br><strong>History of Present Illness:</strong><br>&#8226; pain and stiffness in his neck, shoulders, and hips for the past 2 months<br>&#8226; 1-2 hours daily of stiffness that is worse in the morning<br>&#8226; general malaise and recent weight loss of 3.18 kg (7 lb)<br>&#8226; no headache, vision symptoms, or jaw claudication<br><strong>Past Medical History:</strong><br>&#8226; hypertension<br><strong>Medications:</strong><br>&#8226; lisinopril<br><strong>Allergies:</strong><br>&#8226; no known drug allergies<br><strong>Family History:</strong><br>&#8226; noncontributory<br><strong>Psychosocial History:</strong><br>&#8226; retired<br>&#8226; does not use tobacco, alcohol, or recreational substances</p><p><u><strong>Physical Examination</strong></u></p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"Text-align:center;\"><tbody><tr><td><strong>Temp</strong></td><td><strong>Pulse</strong></td><td><strong>Resp</strong></td><td><strong>BP</strong></td><td><strong>O<font size=\"2\"><sub>2</sub></font> Sat</strong></td><td><strong>Ht</strong></td><td><strong>Wt</strong></td><td><strong>BMI</strong></td></tr><tr><td>37.1 C<br>(98.8 F)</td><td style=\"vertical-align:top;\">81/min</td><td style=\"vertical-align:top;\">14/min</td><td>122/71<br>mm Hg</td><td>98%<br>on RA</td><td>175 cm<br>(5 ft 9 in)</td><td>71 kg<br>(157 lb)</td><td style=\"vertical-align:top;\">23.2 kg/m<font size=\"2\"><sup>2</sup></font></td></tr></tbody></table>&nbsp;<p>&#8226; Appearance: awake and alert<br>&#8226; Pulmonary: clear lung fields<br>&#8226; Cardiac: regular rhythm; S<font size=\"2\"><sub>1</sub></font> and S<font size=\"2\"><sub>2</sub></font>; no tenderness on palpation of the arteries of the scalp, neck, and extremities<br>&#8226; Musculoskeletal: no overt synovitis at the joints; normal passive range of motion<br>&#8226; Neurologic: no abnormalities; fully oriented</p><p><u><strong>Diagnostic Studies</strong></u></p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Leukocytes</td><td style=\"vertical-align:middle;\">7,500/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Hematocrit</td><td style=\"vertical-align:middle;\">38%</td></tr><tr><td style=\"vertical-align:middle;\">Platelets</td><td style=\"vertical-align:middle;\">350,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Erythrocyte sedimentation rate</td><td style=\"vertical-align:middle;\">85 mm/hr</td></tr><tr><td style=\"vertical-align:middle;\">TSH</td><td style=\"vertical-align:middle;\">1.8 &micro;U/mL</td></tr><tr><td style=\"vertical-align:middle;\">Creatine kinase</td><td style=\"vertical-align:middle;\">33 U/L</td></tr></tbody></table><p><u><strong>Question:</strong></u> Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T81824\" style=\"overflow-x:auto;\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Polymyalgia rheumatica</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><p align=\"center\"><strong>Findings</strong></p></td></tr><tr><td><p align=\"center\"><strong>Symptoms</strong></p></td><td><ul><li>Age &gt;50</li><li>Bilateral pain &amp; morning stiffness &gt;1 month</li><li>Involvement of 2 of the following:<ul style=\"list-style-type:circle;\"><li>Neck or torso</li><li>Shoulders or proximal arms</li><li>Proximal thigh or hip</li><li>Constitutional (fever, malaise, weight loss)</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Physical examination</strong></p></td><td><ul><li>Decreased active ROM in shoulders, neck &amp; hips</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory studies</strong></p></td><td><ul><li>Elevated ESR</li><li>Elevated CRP</li><li>Normocytic anemia</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Oral glucocorticoids</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>CRP</strong>= C-reactive protein; <strong>ESR</strong> = erythrocyte sedimentation rate; <strong>ROM</strong> = range of motion.</p></td></tr></tbody></table></div><p>This patient has the following characteristic features of <strong>polymyalgia rheumatica</strong> (PMR):</p><ul><li><strong>Age &gt;50</strong></li><li>Subacute to chronic pain in the shoulder and hip girdles</li><li>Morning stiffness lasting &gt;1 hour</li><li>Absence of point tenderness and muscle weakness</li><li>Constitutional symptoms (eg, malaise, weight loss)</li><li><strong>Elevated erythrocyte sedimentation rate</strong> (ESR) or C-reactive protein</li></ul><p>Physical examination findings in PMR are nonspecific and frequently normal, although reduced range of motion (eg, limited shoulder abduction) may be present.&nbsp; When asked to identify the location of their pain, patients typically indicate the soft tissues and not the joints.&nbsp; Overt synovitis (eg, erythema, swelling) is not common.</p><p><strong>Low-dose glucocorticoid</strong> therapy (eg, prednisone 10-20 mg daily) is first-line treatment for PMR.&nbsp; Rapid and thorough relief of symptoms is expected, and lack of rapid improvement should call the diagnosis into question.&nbsp; PMR is occasionally associated with giant cell (temporal) arteritis (GCA); symptoms include headache, jaw claudication, vision loss, and tenderness over the temporal artery, none of which is present in this patient.&nbsp; Patients with suspected GCA should receive immediate treatment with a high-dose glucocorticoid (eg, prednisone 60-80 mg daily) and are generally referred for expedited temporal artery biopsy <strong>(Choice C)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; There are no specific serologic tests for PMR.&nbsp; Antinuclear antibody (ANA) assay is a screening test for systemic lupus erythematosus (SLE) and is frequently positive in other autoimmune conditions (eg, rheumatoid arthritis).&nbsp; ANA levels have poor specificity in the absence of characteristic SLE features (eg, malar rash, peripheral joint synovitis) and may be misleading.</p><p><strong>(Choice B)</strong>&nbsp; Regular low-impact aerobic exercise and good sleep hygiene are recommended for fibromyalgia, which is a common cause of pain and subjective stiffness in the muscles and joints.&nbsp; However, ESR would be normal in patients with fibromyalgia, and initial onset typically occurs at age &lt;50.</p><p><strong>(Choice D)</strong>&nbsp; Nonsteroidal anti-inflammatory drugs (NSAIDs) are much less effective than glucocorticoids for initial management of PMR and are not recommended.&nbsp; NSAIDs are commonly used in osteoarthritis, which can affect the hips and occasionally the shoulders.&nbsp; However, ESR is typically normal in osteoarthritis; symmetric onset of pain in both hips is rare, and involvement of both shoulders is uncommon.&nbsp; NSAIDs may also be used for ankylosing spondylitis, which can cause neck stiffness with elevated ESR; however, ankylosing spondylitis typically occurs in younger (age &lt;40) patients, and low back pain is usually present.</p><p><strong>Educational objective:</strong><br>Polymyalgia rheumatica (PMR) affects patients age &gt;50 and is characterized by pain and stiffness in the neck, shoulders, and hips, along with an elevated erythrocyte sedimentation rate.&nbsp; The treatment for uncomplicated PMR is low-dose prednisone, which results in rapid relief of symptoms.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 8281,
            "topic": "Polymyalgia rheumatica",
            "titleId": 8281,
            "title": "Polymyalgia rheumatica",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Assay for antinuclear antibodies",
                    "choiceNumber": 1,
                    "correctTaken": 3614,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Counsel on low-impact aerobic exercise",
                    "choiceNumber": 2,
                    "correctTaken": 950,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform temporal artery biopsy",
                    "choiceNumber": 3,
                    "correctTaken": 602,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe a nonsteroidal anti-inflammatory drug",
                    "choiceNumber": 4,
                    "correctTaken": 2593,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe low-dose prednisone",
                    "choiceNumber": 5,
                    "correctTaken": 7150,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "32868305",
                    "mediaDataId": 0,
                    "title": "Polymyalgia rheumatica: an updated review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/32868305",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 68,
            "othersAvgTimeSpent": 77,
            "notes": null,
            "peopleTaken": 14909,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 23,
            "questionId": 14065,
            "questionIndex": 15468,
            "questionText": "<p>An 11-month-old boy is brought to the emergency department due to irritability and poor fluid intake.&nbsp; Seven days ago, the patient developed a fever with poor appetite, and he has continued to have daily fevers.&nbsp; Over the past 2 days, the patient has only consumed half of the daily volume of formula he normally drinks.&nbsp; The patient has also been sweating while feeding.&nbsp; He is often irritable when awake and has been napping longer than usual.&nbsp; Temperature is 38.6 C (101.5 F), blood pressure is 74/38 mm Hg, pulse is 194/min, and respirations are 60/min.&nbsp; The patient appears irritable and is grunting.&nbsp; Examination shows an injected pharynx and bilateral conjunctivae.&nbsp; There is perianal peeling and periungual desquamation of his hands, fingers, and toes.&nbsp; Cardiopulmonary examination reveals an S3 gallop and diffuse, fine lung crackles bilaterally.&nbsp; The liver is 3 cm below the costal margin.&nbsp; There is edema of the bilateral lower extremities.&nbsp; Chest-x ray reveals pulmonary edema.&nbsp; Which of the following is the most likely etiology of this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33230\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Kawasaki disease</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology &amp; epidemiology</strong></p></td><td><ul><li>Medium-vessel vasculitis</li><li>Usually affects children age &lt;5</li><li>&uarr; Incidence in East Asian ethnicity</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnostic criteria</strong></p></td><td><ul><li>Fever &ge;5 days plus &ge;4 of the following:<ul style=\"list-style-type:circle;\"><li>Conjunctivitis: bilateral, nonexudative</li><li>Mucositis: injected/fissured lips or pharynx, strawberry tongue</li><li>Cervical lymphadenopathy: &ge;1 nodes &gt;1.5 cm</li><li>Rash: perineal erythema &amp; desquamation; polymorphous, generalized</li><li>Erythema &amp; edema of the hands/feet, periungual desquamation</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>&uarr; Platelets &amp; white blood cells; &darr; hemoglobin</li><li>&uarr; Acute-phase reactants (eg, C-reactive protein)</li><li>&uarr; AST &amp; ALT</li><li>Sterile pyuria</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Intravenous immunoglobulin &amp; aspirin</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>Coronary artery aneurysm</li><li>Ventricular dysfunction</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>ALT</strong> = alanine aminotransferase; <strong>AST</strong> = aspartate aminotransferase.</p></td></tr></tbody></table></div><p>This infant has prolonged fever and characteristic signs of <a href=\"723\">Kawasaki disease</a>, an acute vasculitis with potentially <strong>life-threatening cardiac sequelae</strong>.&nbsp; Pathophysiology of cardiac involvement relates to systemic inflammation leading to <strong>infiltration</strong> of lymphocytes and macrophages <strong>into cardiac tissues</strong> and vasculature.&nbsp; Complications include:</p><ul><li>Coronary artery aneurysm:&nbsp; severe dilatation can lead to stenosis/thrombosis and myocardial infarction</li><li><strong>Ventricular dysfunction</strong>:&nbsp; systemic inflammation or <strong>lymphocytic myocarditis</strong> can cause poor contractility and <strong>heart failure</strong></li><li>Pericardial effusion:&nbsp; cardiac tamponade may result</li></ul><p>This infant has symptoms of heart failure, including irritability, poor feeding, and <strong>diaphoresis during feeds</strong>.&nbsp; As seen here, <strong>pulmonary edema</strong>, lower extremity swelling, and <strong>hepatomegaly</strong>, along with tachypnea and tachycardia, occur with progressive left ventricular overload.&nbsp; An <strong>S3 gallop</strong> due to rapid ventricular filling is characteristic.</p><p>Prolonged fevers (&gt;14 days), delayed treatment with intravenous immunoglobulin (IVIG), and <strong>age &lt;1</strong> increase the risk for cardiac complications.&nbsp; Most aneurysms regress over time, and ventricular dysfunction typically improves with IVIG therapy.</p><p><strong>(Choice A)</strong>&nbsp; Arteriovenous malformation causes extracardiac left-to-right shunting, potentially leading to high-output cardiac failure from increased venous return.&nbsp; However, a wide pulse pressure caused by increased stroke volume is typical, and fever would not be seen.</p><p><strong>(Choice B)</strong>&nbsp; Bacterial endocarditis can cause acute fever and heart failure.&nbsp; However, a new murmur would be expected, and this patient&#39;s mucocutaneous inflammation (eg, conjunctivitis, mucositis) makes this diagnosis less likely.</p><p><strong>(Choice C)</strong>&nbsp; Eosinophilic myocarditis can present with fever, rash, and symptoms of heart failure.&nbsp; However, the rash is eczematous or urticarial, not desquamative.&nbsp; Moreover, pathophysiology typically involves hypersensitivity to an inciting medication, not present here.</p><p><strong>(Choice E)</strong>&nbsp; Acute rheumatic fever, a rare diagnosis before age &lt;3, can present with fever and carditis.&nbsp; However, this patient has no other associated findings (eg, arthritis, subcutaneous nodules, erythema marginatum, chorea), and a blowing, systolic mitral regurgitation murmur due to valvulitis would be expected.&nbsp; Moreover, conjunctivitis and desquamation would not be seen.</p><p><strong>Educational objective:</strong><br>In addition to an increased risk of coronary artery aneurysms, Kawasaki disease increases risk of ventricular dysfunction due to lymphocytic myocarditis, particularly in infants.&nbsp; Patients can have heart failure symptoms (eg, diaphoresis with feeds) and signs (eg, hepatomegaly, pulmonary edema, S3 gallop).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 15668,
            "topic": "Kawasaki disease",
            "titleId": 15668,
            "title": "Kawasaki disease",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "4",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Arteriovenous malformation",
                    "choiceNumber": 1,
                    "correctTaken": 630,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bacterial valvular vegetation",
                    "choiceNumber": 2,
                    "correctTaken": 2530,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Eosinophilic myocarditis",
                    "choiceNumber": 3,
                    "correctTaken": 1542,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lymphocytic myocarditis",
                    "choiceNumber": 4,
                    "correctTaken": 7415,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rheumatic mitral valvulitis",
                    "choiceNumber": 5,
                    "correctTaken": 4245,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31843876",
                    "mediaDataId": 0,
                    "title": "Lifetime cardiovascular management of patients with previous Kawasaki disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31843876",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28587647",
                    "mediaDataId": 0,
                    "title": "Risk factors and implications of progressive coronary dilatation in children with Kawasaki disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28587647",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 202,
            "othersAvgTimeSpent": 93,
            "notes": null,
            "peopleTaken": 16362,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 45,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 24,
            "questionId": 3312,
            "questionIndex": 3312,
            "questionText": "<p>A 30-year-old man comes to the office due to low back pain and stiffness for 2 months.&nbsp; The pain is worse in the morning and improves with activity.&nbsp; The patient has also had intermittent diarrhea and lower abdominal pain for the past 3 months.&nbsp; He has taken ibuprofen, which helped the back pain but made the diarrhea worse.&nbsp; He has not traveled outside the United States.&nbsp; The patient has been sexually active with the same female partner for 2 years and uses condoms regularly.&nbsp; He has no other medical conditions and does not use tobacco, alcohol, or recreational drugs.&nbsp; Vital signs are normal.&nbsp; Physical examination shows limited spine flexion and tenderness in the lower back.&nbsp; Laboratory studies demonstrate elevated C-reactive protein.&nbsp; Plain radiographs reveal sacroiliac joint inflammation.&nbsp; Which of the following best explains this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T87247\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Extraintestinal manifestations of inflammatory bowel disease</strong></p></td></tr><tr><td><p align=\"center\"><strong>Dermatologic</strong></p></td><td><ul><li>Erythema nodosum*</li><li>Pyoderma gangrenosum**</li><li>Hidradenitis suppurativa</li><li>Oral aphthous ulcerations*</li></ul></td></tr><tr><td><p align=\"center\"><strong>Hepatobiliary</strong></p></td><td><ul><li>Primary sclerosing cholangitis**</li></ul></td></tr><tr><td><p align=\"center\"><strong>Musculoskeletal</strong></p></td><td><ul><li>Inflammatory axial &amp;/or peripheral arthritis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Ophthalmic</strong></p></td><td><ul><li>Episcleritis</li><li>Anterior uveitis*</li></ul></td></tr><tr><td><p align=\"center\"><strong>Vascular</strong></p></td><td><ul><li>Venous thromboembolism (increased risk)</li></ul></td></tr><tr><td colspan=\"2\"><p>*More commonly seen with Crohn disease.</p><p>**More commonly seen with ulcerative colitis.</p></td></tr></tbody></table></div><p>This patient likely has <strong>inflammatory bowel disease</strong> (IBD) with associated <strong>inflammatory arthritis</strong>.&nbsp; IBD, which includes Crohn disease and ulcerative colitis, can demonstrate multiple <strong>extraintestinal manifestations</strong>, including arthritic, ocular, dermatologic, and hepatobiliary.&nbsp; Arthritis associated with IBD can involve the axial (eg, spine) or peripheral (eg, knee) joints, and affected patients frequently have an HLA B27 genotype.&nbsp; Patients with axial involvement (ie, <strong>spondyloarthritis</strong>) frequently have <strong>sacroiliitis</strong> that manifests with lower back and buttock pain and prolonged stiffness that improves with activity.</p><p>There are no specific tests to confirm the diagnosis of IBD-associated arthritis, but typical laboratory abnormalities include <strong>elevated inflammatory markers</strong> (eg, C-reactive protein), anemia of chronic disease, and a positive fecal calprotectin.&nbsp; <strong>Nonsteroidal anti-inflammatory drugs</strong> (NSAIDs) can relieve arthritis symptoms but <strong>may exacerbate bowel inflammation</strong> (possibly due to disruption of COX-mediated immunomodulation or intestinal microcirculatory blood flow).&nbsp; Consequently, NSAIDs are often avoided, and the medications used to treat the gastrointestinal manifestations of IBD (eg, azathioprine, infliximab) are commonly used to treat associated joint disease as well.</p><p><strong>(Choice A)</strong>&nbsp; Gluten-sensitive enteropathy (ie, celiac disease) causes malabsorptive diarrhea, which is frequently greasy.&nbsp; It is not worsened by NSAID administration, and an elevated C-reactive protein is not seen.&nbsp; The characteristic cutaneous finding is dermatitis herpetiformis.</p><p><strong>(Choice C)</strong>&nbsp; Gastrointestinal paraneoplastic syndromes include secretory, watery diarrhea due to vasoactive intestinal peptide-secreting tumors, carcinoid syndrome (eg, cutaneous flushing, watery diarrhea, respiratory difficulties), and gastroparesis due to autoimmune destruction of parasympathetic neurons.&nbsp; None of these syndromes would explain this patient&#39;s arthritis or worsening diarrhea with ibuprofen use.</p><p><strong>(Choice D)</strong>&nbsp; Reactive arthritis is an inflammatory arthritis that may occur several weeks following infectious diarrhea (eg, Shigella<em>,</em> Salmonella<em>,</em> Yersinia<em>,</em> Campylobacter, <em>Clostridioides difficile</em>) or sexually transmitted genitourinary infection (eg, <em>Chlamydia trachomatis</em>).&nbsp; The axial skeleton can sometimes be affected, but arthritis affecting one or several peripheral joints is more typical.&nbsp; It is less likely in this patient as NSAIDs are not expected to worsen infectious diarrhea, and he has not had recent high-risk sexual behavior.</p><p><strong>(Choice E)</strong>&nbsp; Rheumatoid arthritis usually involves peripheral arthritis (eg, metacarpophalangeal joints) with the lumbar or sacral spine rarely involved.&nbsp; Moreover, although rheumatoid arthritis can involve multiple organ systems, gastrointestinal manifestations are rare.</p><p><strong>(Choice F)</strong>&nbsp; Spinal osteomyelitis can present with subacute worsening of back pain, but the pain is typically worse with activity and fever is commonly present.</p><p><strong>Educational objective:</strong><br>Inflammatory bowel disease is frequently associated with inflammatory arthritis, which can involve the axial or peripheral joints.&nbsp; Treatment with nonsteroidal anti-inflammatory drugs may exacerbate the underlying bowel inflammation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 20590,
            "topic": "Inflammatory bowel disease",
            "titleId": 20590,
            "title": "Inflammatory bowel disease",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Celiac disease",
                    "choiceNumber": 1,
                    "correctTaken": 397,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inflammatory bowel disease",
                    "choiceNumber": 2,
                    "correctTaken": 6377,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Paraneoplastic syndrome",
                    "choiceNumber": 3,
                    "correctTaken": 283,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reactive arthritis",
                    "choiceNumber": 4,
                    "correctTaken": 2514,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rheumatoid arthritis",
                    "choiceNumber": 5,
                    "correctTaken": 724,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Spinal osteomyelitis",
                    "choiceNumber": 6,
                    "correctTaken": 272,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "34358489",
                    "mediaDataId": 0,
                    "title": "Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/34358489",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21734777",
                    "mediaDataId": 0,
                    "title": "Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome?",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21734777",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21122514",
                    "mediaDataId": 0,
                    "title": "The joint-gut axis in inflammatory bowel diseases.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21122514",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 109,
            "othersAvgTimeSpent": 49,
            "notes": null,
            "peopleTaken": 10567,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 60,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 25,
            "questionId": 18134,
            "questionIndex": 19599,
            "questionText": "<p>A 38-year-old man comes to the office for evaluation of bilateral progressive hand pain with intermittent swelling over the past 6 months.&nbsp; The patient has no other symptoms or history of trauma or family history of arthropathy.&nbsp; Medical history is significant for type 2 diabetes mellitus, for which he takes metformin.&nbsp; Vital signs are normal.&nbsp; BMI is 24 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Examination reveals mild swelling and tenderness over the second and third metacarpophalangeal (MCP) joints bilaterally.&nbsp; There is no muscle weakness.&nbsp; X-ray reveals joint space narrowing and chondrocalcinosis involving the second MCP joints with osteophyte formation at the second and third metacarpal heads.&nbsp; Serum alanine and aspartate aminotransferases are elevated.&nbsp; Which of the following therapies would be of most benefit to this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T61063\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Arthropathy of hereditary hemochromatosis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Onset at age &lt;40</li><li>Chronic pain &amp; bony swelling</li><li>Most common at 2nd &amp; 3rd MCP joints</li><li>Occasional acute flare</li></ul></td></tr><tr><td><p align=\"center\"><strong>X-ray signs</strong></p></td><td><ul><li>Joint space narrowing</li><li>Chondrocalcinosis</li><li>Hook-shaped osteophytes at metacarpal heads</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Oral analgesics (eg, acetaminophen, NSAIDs)</li><li>Therapeutic phlebotomy (to prevent other complications)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>MCP</strong> = metacarpophalangeal; <strong>NSAIDs</strong> = nonsteroidal anti-inflammatory drugs.</p></td></tr></tbody></table></div><p>This patient has chronic arthritis with joint space narrowing similar to osteoarthritis (OA), but several features suggest <strong>hereditary hemochromatosis (HH) arthropathy</strong>, including:</p><ul><li><p>Onset at <strong>age &lt;40</strong> versus &gt;40 with OA</p></li><li><p>Predilection for the <strong>second and third metacarpophalangeal (MCP) joints</strong> and wrists versus distal interphalangeal joints and thumb bases with OA</p></li><li><p>Presence of <strong>chondrocalcinosis</strong> (ie, cartilage calcification)</p></li></ul><p>HH is also suggested by comorbid <strong>diabetes</strong>, which is due to pancreatic iron deposition and is otherwise unusual in nonobese patients at this age.&nbsp; <strong>Elevated liver transaminases</strong> also suggest HH and make primary joint disorders less likely.</p><p>In addition to the hand and wrist, other joints (eg, hips, knees) can be affected by HH arthropathy; characteristic x-ray findings include periarticular bony enlargement and subchondral lucency.&nbsp; Joint examination typically shows <strong>no signs of synovitis</strong> (eg, erythema, warmth), but acute inflammatory flares may occasionally occur.&nbsp; Arthropathy typically becomes apparent early in the course of HH and may be the presenting feature, although later presentations are possible.</p><p>Management of HH arthropathy is primarily focused on symptom relief.&nbsp; Simple oral analgesics (eg, acetaminophen, nonsteroidal anti-inflammatory drugs [NSAIDs]) are usually used first.&nbsp; However, patients benefit most from <strong>therapeutic phlebotomy</strong>, which is necessary to prevent further joint injury (with limited effect on the established arthropathy) and minimize the systemic complications of HH (eg, liver disease).</p><p><strong>(Choices A, B, and D)</strong>&nbsp; Rheumatoid arthritis (RA) is typically treated initially with NSAIDs or systemic glucocorticoids (eg, prednisone) to provide acute symptom relief.&nbsp; Thereafter, disease-modifying antirheumatic drugs are initiated for long-term management; methotrexate is commonly recommended, with tumor necrosis factor inhibitors (eg, etanercept) and other biologic agents used for patients with refractory symptoms.&nbsp; Although RA commonly causes joint space narrowing in the MCP joints, x-ray typically shows periarticular osteopenia and bony erosions rather than the chondrocalcinosis and osteophytes seen with HH.</p><p><strong>Educational objective:</strong><br>Hereditary hemochromatosis (HH) arthropathy often resembles osteoarthritis but differs in age at onset (&lt;40); predilection for the second and third metacarpophalangeal joints and wrists; and presence of chondrocalcinosis.&nbsp; Management is primarily symptomatic (eg, acetaminophen, nonsteroidal anti-inflammatory drugs), but therapeutic phlebotomy is necessary to minimize other systemic complications of HH (eg, liver disease).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 16509,
            "topic": "Hemochromatosis",
            "titleId": 16509,
            "title": "Hemochromatosis",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Etanercept",
                    "choiceNumber": 1,
                    "correctTaken": 2202,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Methotrexate",
                    "choiceNumber": 2,
                    "correctTaken": 4547,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Phlebotomy",
                    "choiceNumber": 3,
                    "correctTaken": 6424,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prednisone",
                    "choiceNumber": 4,
                    "correctTaken": 4964,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 79,
            "othersAvgTimeSpent": 60,
            "notes": null,
            "peopleTaken": 18137,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 35,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 26,
            "questionId": 4572,
            "questionIndex": 4572,
            "questionText": "<p>A 40-year-old woman comes to the office due to joint pains.&nbsp; The patient has had achy pain in her hands and feet for the past several months, which is worse in the morning.&nbsp; She says her fingers feel stiff when she wakes up and she has difficulty opening doors or holding spoons.&nbsp; The pain gradually improves over 2-3 hours, but the patient feels fatigued throughout the day.&nbsp; Taking ibuprofen provides some symptom relief.&nbsp; Medical history is otherwise unremarkable, and she takes no other medications.&nbsp; Vital signs are within normal limits.&nbsp; Physical examination shows no rashes or oral ulcers.&nbsp; The wrists and fingers are swollen bilaterally and are tender to palpation.&nbsp; Laboratory testing reveals that hematocrit is 33% and serum creatinine is normal.&nbsp; This patient&#39;s current condition is most likely to directly increase her risk for which of the following?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t49921\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Extraarticular manifestations of rheumatoid arthritis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Systemic</strong></p></td><td><ul><li>Fever</li><li>Weight loss</li><li>Fatigue</li></ul></td></tr><tr><td><p align=\"center\"><strong>Pulmonary</strong></p></td><td><ul><li>Fibrotic lung disease</li><li>Pleural effusions</li><li>Lung nodules</li><li>Pulmonary hypertension</li></ul></td></tr><tr><td><p align=\"center\"><strong>Cardiovascular</strong></p></td><td><ul><li>Atherosclerosis</li><li>Vasculitis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Musculoskeletal</strong></p></td><td><ul><li>Osteopenia/osteoporosis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Dermatologic</strong></p></td><td><ul><li>Rheumatoid nodules</li></ul></td></tr><tr><td><p align=\"center\"><strong>Hematologic</strong></p></td><td><ul><li>Anemia</li></ul></td></tr><tr><td><p align=\"center\"><strong>Neuropsychiatric</strong></p></td><td><ul><li>Depression</li><li>Neuropathy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Other</strong></p></td><td><ul><li>Sj&ouml;gren syndrome</li><li>Raynaud phenomenon</li><li>Scleritis, episcleritis</li></ul></td></tr></tbody></table></div><p>This patient has a chronic symmetric polyarthritis consistent with <strong>rheumatoid arthritis (RA)</strong>.&nbsp; RA is a progressive inflammatory disorder that is more common in women; it can occur at any age, although peak incidence is at age 30-60.&nbsp; RA is characteristically associated with prolonged morning stiffness, and symptoms may be more noticeable in the dominant hand.&nbsp; The most commonly affected joints include the metacarpophalangeal joints, metatarsophalangeal joints, proximal interphalangeal joints, wrists, and knees.</p><p><strong>Extraarticular manifestations</strong> are common in RA, especially in patients with <strong>positive serologies</strong> (eg, rheumatoid factor, cyclic citrullinated peptide antibodies).&nbsp; Systemic features (eg, weight loss, fatigue, <strong>anemia</strong>) are frequently present.&nbsp; Rheumatoid nodules (firm, nontender, subcutaneous nodules) may be seen at pressure points such as the elbows or forearms.&nbsp; Other complications include pleural effusions, fibrotic/restrictive lung disease, coronary atherosclerosis, and autoimmune exocrine dysfunction (ie, Sj&ouml;gren syndrome).</p><p>In addition, inflammatory cytokines (eg, tumor necrosis factor, interleukin-1) in RA can promote focal, periarticular, or diffuse (ie, <strong>osteopenia/osteoporosis</strong>) bone loss.&nbsp; Relative immobility and treatment with systemic glucocorticoids can also contribute.&nbsp; The risk of osteoporosis is approximately twice as high in patients with RA compared to the general population and carries an associated risk for fractures.&nbsp; Management should include regular exercise, optimization of vitamin D and calcium intake, minimization of glucocorticoid doses, and bisphosphonate therapy.</p><p><strong>(Choice A)</strong>&nbsp; Dermatomyositis can be seen as a paraneoplastic manifestation of multiple malignancies, especially adenocarcinoma of the breast, lung, and ovaries.&nbsp; There is a small increased risk of lymphoma in RA, but RA does not appear to have a major association with breast cancer, and some studies have found a slight decrease in risk.</p><p><strong>(Choice B)</strong>&nbsp; Esophageal dysmotility is a major manifestation of systemic sclerosis (scleroderma) but is not prominently associated with RA.</p><p><strong>(Choice D)</strong>&nbsp; Inflammatory bowel disease is associated with both axial spondyloarthritis and peripheral arthritis.&nbsp; The peripheral arthritis can manifest as a self-limited pauciarticular arthritis (typically affecting the knee) or a chronic polyarthritis that primarily affects the metacarpophalangeal joints.&nbsp; Although this second type may resemble RA, it is uncommon and almost always follows onset of gastrointestinal symptoms.</p><p><strong>(Choice E)</strong>&nbsp; The lumbar facet joints are commonly involved by osteoarthritis, and the lumbar spine is also a common site for disc herniation and spinal stenosis.&nbsp; However, RA does not typically involve the thoracic, lumbar, or sacral spine.</p><p><strong>Educational objective:</strong><br>Patients with rheumatoid arthritis are at increased risk of developing osteopenia, osteoporosis, and bone fractures.&nbsp; Management includes adequate physical activity, optimization of calcium and vitamin D intake, minimization of glucocorticoid therapy, and bisphosphonate treatment.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 3769,
            "topic": "Rheumatoid arthritis",
            "titleId": 3769,
            "title": "Rheumatoid arthritis",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Breast cancer",
                    "choiceNumber": 1,
                    "correctTaken": 148,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Esophageal dysmotility",
                    "choiceNumber": 2,
                    "correctTaken": 2069,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Generalized bone loss",
                    "choiceNumber": 3,
                    "correctTaken": 6101,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inflammatory bowel disease",
                    "choiceNumber": 4,
                    "correctTaken": 5291,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lumbar spinal stenosis",
                    "choiceNumber": 5,
                    "correctTaken": 1902,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25626121",
                    "mediaDataId": 0,
                    "title": "Management of osteoporosis in rheumatoid arthritis patients.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25626121",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 138,
            "othersAvgTimeSpent": 64,
            "notes": null,
            "peopleTaken": 15511,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 39,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 27,
            "questionId": 14758,
            "questionIndex": 16181,
            "questionText": "<p>A 56-year-old woman comes to the office with her daughter to discuss knee pain, which has been ongoing for several years.&nbsp; The patient has a high tolerance for pain and has previously refused to see a doctor for her condition.&nbsp; Lately, the pain has been affecting the patient&#39;s daily activities, and she spends most of the day sitting in a chair.&nbsp; The knee pain and stiffness are more pronounced on the right side and are worse in the morning but gradually improve by the afternoon.&nbsp; She takes no medications.&nbsp; Review of systems is positive for fatigue.&nbsp; Vital signs are within normal limits.&nbsp; BMI is 31 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Lower extremity examination shows that both knees are swollen and tender but more so on the right side.&nbsp; The patient is unable to fully flex or extend the right knee.&nbsp; There is mild, bilateral atrophy of the quadriceps.&nbsp; Radiographs of the knees reveal osteopenia of the distal femur, multiple periarticular erosions, and soft tissue swelling.&nbsp; Which of the following is the best long-term management for the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t48956\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Osteoarthritis vs rheumatoid arthritis</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Osteoarthritis</strong></p></td><td><p align=\"center\"><strong>Rheumatoid arthritis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Age of onset</strong></p></td><td><p align=\"center\">&gt;40; increases with age</p></td><td><p align=\"center\">40-60; often younger</p></td></tr><tr><td><p align=\"center\"><strong>Joint involvement</strong></p></td><td><ul><li>Knees &amp; hips</li><li>DIP joint</li><li>First CMC joint</li></ul></td><td><ul><li>MCP joint</li><li>PIP joint</li><li>Wrists</li></ul></td></tr><tr><td><p align=\"center\"><strong>Morning stiffness</strong></p></td><td><p align=\"center\">None/brief</p></td><td><p align=\"center\">Prolonged</p></td></tr><tr><td><p align=\"center\"><strong>Systemic symptoms</strong></p></td><td><p align=\"center\">Absent</p></td><td><ul><li>Fever</li><li>Fatigue</li><li>Weight loss</li></ul></td></tr><tr><td><p align=\"center\"><strong>Examination</strong></p></td><td><ul><li>Hard, bony enlargement of joints</li></ul></td><td><ul><li>Soft/spongy, warm joints</li></ul></td></tr><tr><td><p align=\"center\"><strong>X-ray</strong></p></td><td><ul><li>Narrowed joint space</li><li>Osteophytes</li></ul></td><td><ul><li>Periarticular erosions</li></ul></td></tr><tr><td colspan=\"3\"><p><strong>CMC</strong> = carpometacarpal; <strong>DIP</strong> = distal interphalangeal; <strong>MCP</strong> = metacarpophalangeal; <strong>PIP</strong> = proximal interphalangeal.</p></td></tr></tbody></table></div><p>The 2 most prevalent forms of arthritis are osteoarthritis (OA) and <strong>rheumatoid arthritis</strong> (RA), and individuals may have both conditions concurrently.&nbsp; OA is much more common and characteristically involves the knees, hips, and distal finger joints.&nbsp; RA, an inflammatory arthritis, typically involves the metacarpophalangeal, proximal interphalangeal, and wrist joints.&nbsp; However, any joint may be affected.&nbsp; This patient&nbsp;has multiple clinical and radiographic features suggestive of RA:&nbsp; Her prolonged <strong>morning stiffness, systemic symptoms</strong> (ie, fatigue), and <strong>soft tissue swelling</strong> involving multiple joints are more consistent with RA than OA; she also has X-ray findings that favor a diagnosis of RA over OA, including <a href=\"22537\">periarticular erosions</a> (seen here on hand x-rays), distal osteopenia, and soft tissue swelling.</p><p>Additional evaluation of patients with suspected RA should include inflammatory markers (eg, erythrocyte sedimentation rate, <strong>C-reactive protein</strong>), which are typically elevated in RA but normal in OA.&nbsp; <strong>Cyclic citrullinated peptide antibodies</strong> are present in most patients with RA and can help confirm the diagnosis; rheumatoid factor should also be tested but has lower specificity.</p><p>Initial management of RA includes nonsteroidal anti-inflammatory drugs and systemic glucocorticoids (eg, prednisone) to acutely reduce pain; however, these interventions do not alter the long-term prognosis and are inadequate for definitive therapy <strong>(Choice C)</strong>.&nbsp; As soon as possible after the diagnosis is made, <strong>disease-modifying antirheumatic drugs</strong> (DMARDs) should be initiated to slow disease progression; first-line options include methotrexate, a folate antimetabolite that is cost-effective and well tolerated by most patients.&nbsp; Alternate options include sulfasalazine, leflunomide, and hydroxychloroquine.</p><p><strong>(Choice B)</strong>&nbsp; Nonpharmacologic interventions for OA include regular exercise and weight loss; knee braces may reduce pain in some patients but are unlikely to alter the long-term course of the condition.&nbsp; However, none of these interventions are adequate treatment for RA.</p><p><strong>(Choice D)</strong>&nbsp; Total knee arthroplasty is most commonly performed for patients with advanced OA.&nbsp; It is occasionally needed for patients with severe deformity due to RA, but early initiation of DMARD therapy may eliminate the need for later joint replacement.</p><p><strong>(Choice E)</strong>&nbsp; Urate-lowering therapy is indicated for long-term treatment of gout.&nbsp; Gout commonly affects the knee but typically causes episodic symptoms with brief but severe inflammatory changes (eg, redness, warmth, swelling).&nbsp; X-rays in early gout are generally normal, although chronic findings include <a href=\"21970\">punched-out erosions</a> with an overhanging rim of cortical bone (&#x22;rat bite&#x22; lesion).</p><p><strong>Educational objective:</strong><br>Clinical findings that favor the diagnosis of rheumatoid arthritis (RA) over osteoarthritis include prolonged morning stiffness, systemic symptoms, and soft tissue swelling.&nbsp; Other characteristic findings in RA include periarticular erosions on x-ray, elevated inflammatory markers, and positive cyclic citrullinated peptide antibodies or rheumatoid factor.&nbsp; Disease-modifying antirheumatic drugs (eg, methotrexate) slow disease progression and should be initiated on diagnosis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 3769,
            "topic": "Rheumatoid arthritis",
            "titleId": 3769,
            "title": "Rheumatoid arthritis",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antifolate immunosuppressant",
                    "choiceNumber": 1,
                    "correctTaken": 2325,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Knee braces and weight loss",
                    "choiceNumber": 2,
                    "correctTaken": 1098,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Systemic glucocorticoid",
                    "choiceNumber": 3,
                    "correctTaken": 540,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Total knee replacement",
                    "choiceNumber": 4,
                    "correctTaken": 962,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Urate-lowering therapy",
                    "choiceNumber": 5,
                    "correctTaken": 66,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29759122",
                    "mediaDataId": 0,
                    "title": "Early diagnosis and treatment of rheumatoid arthritis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29759122",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28774455",
                    "mediaDataId": 0,
                    "title": "Conventional radiology in rheumatoid arthritis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28774455",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 93,
            "othersAvgTimeSpent": 86,
            "notes": null,
            "peopleTaken": 5069,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 46,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 28,
            "questionId": 2880,
            "questionIndex": 2880,
            "questionText": "<p>A 43-year-old man comes to the physician reporting acute-onset right knee pain.&nbsp; He was diagnosed with diabetes mellitus a year ago and takes metformin.&nbsp; He does not use tobacco, alcohol, or illicit drugs.&nbsp; The patient is in a monogamous relationship.&nbsp; His father also has diabetes.&nbsp; His temperature is 37 C (98.6 F), blood pressure is 134/86 mm Hg, pulse is 86/min, and respirations are 16/min.&nbsp; BMI is 26 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination shows a slightly swollen and tender right knee and mild hepatomegaly.&nbsp; Right knee x-ray reveals chondrocalcinosis and a moderate effusion.&nbsp; Appropriate analgesic is administered for joint pain.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t33313\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Clinical manifestations of hereditary hemochromatosis </strong></p></td></tr><tr><td><p align=\"center\"><strong>Skin </strong></p></td><td><p>Hyperpigmentation (bronze diabetes)</p></td></tr><tr><td><p align=\"center\"><strong>Musculoskeletal </strong></p></td><td><p>Arthralgia, arthropathy &amp; chondrocalcinosis</p></td></tr><tr><td><p align=\"center\"><strong>Gastrointestinal </strong></p></td><td><p>Elevated hepatic enzymes with hepatomegaly (early), cirrhosis (later) &amp; increased risk of hepatocellular carcinoma</p></td></tr><tr><td><p align=\"center\"><strong>Endocrine </strong></p></td><td><p>Diabetes mellitus, secondary hypogonadism &amp; hypothyroidism</p></td></tr><tr><td><p align=\"center\"><strong>Cardiac </strong></p></td><td><p>Restrictive or dilated cardiomyopathy &amp; conduction abnormalities</p></td></tr><tr><td><p align=\"center\"><strong>Infections </strong></p></td><td><p>Increased susceptibility to <em>Listeria</em>, <em>Vibrio vulnificus</em> &amp; <em>Yersinia enterocolitica </em></p></td></tr></tbody></table></div></p><p>This patient has acute monoarticular <strong>arthritis</strong> with <a href=\"118\">chondrocalcinosis</a> (calcified articular cartilage on radiographs), diagnostic of calcium pyrophosphate dihydrate crystal deposition (<strong>CPPD</strong>) disease (pseudogout).&nbsp; Patients with pseudogout should be evaluated for secondary causes such as hyperparathyroidism, hypothyroidism, and hemochromatosis.&nbsp; Given this patient&#39;s recently diagnosed <strong>diabetes</strong> mellitus and <strong>hepatomegaly</strong>, <strong>hereditary hemochromatosis</strong> (HH) is highly likely.&nbsp; HH-induced iron deposition in the synovial fluid appears to promote CPPD.&nbsp; Diabetes in HH appears to be due primarily to loss of insulin secretion and often requires injectable insulin; however, mild or early disease is frequently managed with oral agents.</p><p>The initial evaluation of HH includes serum <strong>iron studies</strong>, which will show increased levels of serum iron, ferritin, and transferrin saturation.&nbsp; The diagnosis can be confirmed with genetic testing for hemochromatosis-associated mutations (eg, <em>HFE</em>).&nbsp; Liver biopsy is not required but may be useful to stage the extent of liver involvement (eg, in patients with significant liver function test abnormalities) or to confirm the diagnosis in patients who have iron studies indicating iron overload but negative results on the classic <em>HFE</em> gene markers <strong>(Choice C)</strong>.&nbsp; Long-term management of hemochromatosis involves serial phlebotomy to deplete excess iron stores.</p><p><strong>(Choices A and E)</strong>&nbsp; Chondrocalcinosis is not a typical feature of gout or rheumatoid arthritis (which is associated with anticitrullinated peptide antibodies).</p><p><strong>(Choice B)</strong>&nbsp; Antismooth muscle antibodies are seen in autoimmune hepatitis, which can be associated with other autoimmune disorders including type 1 diabetes mellitus, thyroid disease, and rheumatoid arthritis.&nbsp; Patients may develop a subacute, symmetric polyarthritis involving the small joints, but acute monoarthritis with chondrocalcinosis would not be seen.</p><p><strong>(Choice F)</strong>&nbsp; Slit-lamp eye examination is helpful in identifying the Kayser-Fleischer rings of Wilson disease.&nbsp; Wilson disease can cause hepatomegaly; however, it typically presents with neuropsychiatric manifestations, and almost all patients are diagnosed before age 35.</p><p><strong>Educational objective:</strong><br>Hereditary hemochromatosis is commonly associated with calcium pyrophosphate dihydrate crystal deposition in joints, leading to chondrocalcinosis, pseudogout, and chronic arthropathy.&nbsp; Patients commonly also have diabetes and liver disease.&nbsp; Diagnosis is suggested by iron overload on serum iron studies and can be confirmed by genetic tests.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 16509,
            "topic": "Hemochromatosis",
            "titleId": 16509,
            "title": "Hemochromatosis",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Anticitrullinated peptide antibodies",
                    "choiceNumber": 1,
                    "correctTaken": 3766,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Antismooth muscle antibodies",
                    "choiceNumber": 2,
                    "correctTaken": 2482,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Liver biopsy",
                    "choiceNumber": 3,
                    "correctTaken": 2034,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum iron studies",
                    "choiceNumber": 4,
                    "correctTaken": 17861,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum uric acid level",
                    "choiceNumber": 5,
                    "correctTaken": 9230,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Slit-lamp eye examination",
                    "choiceNumber": 6,
                    "correctTaken": 4204,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23418762",
                    "mediaDataId": 0,
                    "title": "Hereditary hemochromatosis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23418762",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21584944",
                    "mediaDataId": 0,
                    "title": "Characteristics of the arthropathy described in hereditary hemochromatosis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21584944",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 91,
            "othersAvgTimeSpent": 77,
            "notes": null,
            "peopleTaken": 39577,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 45,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 29,
            "questionId": 2317,
            "questionIndex": 2317,
            "questionText": "<p>A 33-year-old woman comes to the office due to skin lesions and pain in her ankles for a week.&nbsp; She has had no cough, sore throat, shortness of breath, abdominal pain, or bowel symptoms.&nbsp; She reports no recent travel or illness.&nbsp; The patient has no other significant medical history and takes no medications.&nbsp; She does not use tobacco, alcohol, or illicit drugs.&nbsp; She has no history of sexually transmitted diseases and has been married to a monogamous partner for the past 8 years.&nbsp; Her mother was diagnosed with ovarian cancer at age 65.&nbsp; Temperature is 37.2 C (98.9 F) and blood pressure is 126/76 mm Hg.&nbsp; On examination, the patient has multiple tender pink to reddish nodules below the knee, as shown in the <a href=\"13002\">exhibit</a>.&nbsp; Which of the following is the most appropriate next step in management?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t35180\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Common features of sarcoidosis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Epidemiology</strong></p></td><td><ul><li>Young adults</li><li>African Americans</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical</strong></p></td><td><ul><li>Constitutional symptoms</li><li>Cough, dyspnea &amp; chest pain</li><li>Extrapulmonary findings<ul style=\"list-style-type:circle;\"><li>Skin lesions</li><li>Anterior/posterior uveitis</li><li>L&ouml;fgren syndrome</li></ul></li><li>Parotid gland swelling</li></ul></td></tr><tr><td><p align=\"center\"><strong>Imaging</strong></p></td><td><ul><li>Bilateral hilar adenopathy</li><li>Pulmonary reticular infiltrates</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory</strong></p></td><td><ul><li>Hypercalcemia/hypercalciuria</li><li>Elevated serum ACE level</li></ul></td></tr><tr><td><p align=\"center\"><strong>Pathology</strong></p></td><td><ul style=\"margin-left: 120px;\"><li>Biopsy showing noncaseating granulomas<br />that stain negative&nbsp;for fungi &amp; acid-fast bacilli</li></ul></td></tr></tbody></table></div><p>This image depicts <strong>erythema nodosum</strong> (EN), which is characterized by painful, subcutaneous <strong>nodules</strong> that are most common on the anterior lower legs.&nbsp; Arthralgias and malaise can develop alongside the nodules.&nbsp; EN is thought to represent a delayed hypersensitivity reaction to antigens associated with various conditions and is often relatively benign with self-resolution in several weeks.&nbsp; However, EN can be an early sign of more serious disease, and identification of the cause may prevent morbidity.&nbsp; Diseases associated with EN include streptococcal infection, sarcoidosis, tuberculosis (TB), endemic fungal disease (eg, histoplasmosis), inflammatory bowel disease (IBD), and Beh&ccedil;et disease.</p><p>The initial workup includes basic laboratory tests (complete blood count, liver function, renal function), antistreptolysin-O antibodies, and TB skin testing.&nbsp; In addition, a <strong>chest x-ray</strong> should be obtained to assess for findings consistent with sarcoidosis (eg, bilateral hilar lymphadenopathy, reticular opacities) or with TB (unlikely in the absence of symptoms).&nbsp; The prevalence of <strong>sarcoidosis</strong> in patients with EN is as high as 28% in some populations.&nbsp; The absence of pulmonary symptoms (eg, dyspnea, cough) in this patient does not rule out sarcoidosis as up to 50% of cases are diagnosed by incidental chest x-ray findings prior to symptom development.</p><p><strong>(Choice A)</strong>&nbsp; Antinuclear antibodies have high sensitivity for systemic lupus erythematosus (SLE) and can be useful in ruling it out.&nbsp; However, SLE is not a common cause of EN.</p><p><strong>(Choice B)</strong>&nbsp; Skin biopsy is not indicated in diagnosing the etiology of EN except in cases with atypical appearance or in areas where TB is endemic.&nbsp; In addition, in patients with sarcoidoisis, biopsy of EN lesions typically shows nonspecific panniculitis rather than the classic noncaseating granulomas associated with the disease.</p><p><strong>(Choices D and E)</strong>&nbsp; EN can occur due to inflammatory bowel disease (IBD) (more commonly Crohn disease than ulcerative colitis), typically during periods of active intestinal disease.&nbsp; This patient has no symptoms to suggest IBD (eg, abdominal pain, diarrhea, fever), and therefore colonoscopy is not indicated.&nbsp; CT scan of the abdomen is generally not helpful in diagnosing the etiology of EN.</p><p><strong>(Choice F)</strong>&nbsp; An association between HIV and EN is not well established, and HIV testing is not part of the initial workup.</p><p><strong>(Choice G)</strong>&nbsp; <em>Neisseria gonorrhoeae</em> has no known association with EN, and <em>Chlamydia trachomatis</em> has only a rare association with EN.&nbsp; Testing for these organisms is not indicated in the initial workup.</p><p><strong>Educational objective:</strong><br>Erythema nodosum (EN) is a condition of painful, red or violaceous, subcutaneous nodules.&nbsp; It can be a sign of a more serious disease process.&nbsp; Even in the absence of respiratory symptoms, chest x-ray should be performed in patients with EN to assess for findings consistent with sarcoidosis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 13195,
            "topic": "Sarcoidosis",
            "titleId": 13195,
            "title": "Sarcoidosis",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antinuclear antibodies",
                    "choiceNumber": 1,
                    "correctTaken": 5536,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Biopsy of skin lesions",
                    "choiceNumber": 2,
                    "correctTaken": 1722,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Chest x-ray",
                    "choiceNumber": 3,
                    "correctTaken": 4742,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Colonoscopy and random biopsies",
                    "choiceNumber": 4,
                    "correctTaken": 1208,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "CT scan of the abdomen",
                    "choiceNumber": 5,
                    "correctTaken": 706,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "HIV testing",
                    "choiceNumber": 6,
                    "correctTaken": 631,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Urethral and rectal swabs",
                    "choiceNumber": 7,
                    "correctTaken": 915,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23461074",
                    "mediaDataId": 0,
                    "title": "The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23461074",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 124,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 15460,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 31,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 30,
            "questionId": 3059,
            "questionIndex": 3059,
            "questionText": "<p>A 45-year-old woman comes to the office due to progressive weakness for the past several months.&nbsp; The patient has had difficulty lifting her foster children and getting in and out of her car.&nbsp; She also reports difficulty swallowing and has had several episodes of choking while drinking water.&nbsp; She has no medical problems, but there is a history of breast cancer in her mother.&nbsp; The patient does not use tobacco, alcohol, or illicit drugs.&nbsp; Vital signs are within normal limits, and she has normal sensation and deep tendon reflexes.&nbsp; Strength is 4/5 in the deltoid and quadriceps muscle groups, and there is no limitation in range of motion.&nbsp; Physical examination is otherwise unremarkable.&nbsp; Erythrocyte sedimentation rate is 50 mm/hr, and serum creatine kinase is elevated.&nbsp; TSH is normal.&nbsp; Which of the following is the best initial treatment for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t31233\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\" style=\"width:38.0%;\"><p align=\"center\"><strong>Distinguishing features of fibromyalgia, polymyositis &amp; polymyalgia rheumatica</strong></p></td></tr><tr><td style=\"width:20.0%;\"></td><td style=\"width:42.0%;\"><p align=\"center\"><strong>Clinical features</strong></p></td><td style=\"width:38.0%;\"><p align=\"center\"><strong>Diagnosis</strong></p></td></tr><tr><td style=\"width:20.0%;\"><p align=\"center\"><strong>Fibromyalgia</strong></p></td><td style=\"width:42.0%;\"><ul><li>Young to middle-aged women</li><li>Chronic widespread pain</li><li>Fatigue, impaired concentration</li><li>Tenderness at trigger points (eg, midtrapezius, costochondral junction)</li></ul></td><td style=\"width:38.0%;\"><ul><li>&ge;3 months of symptoms with widespread pain index or symptom severity score</li><li>Normal laboratory studies</li></ul></td></tr><tr><td style=\"width:20.0%;\"><p align=\"center\"><strong>Polymyositis</strong></p></td><td style=\"width:42.0%;\"><ul><li>Proximal muscle weakness (eg, increasing difficulty climbing stairs)</li><li>Pain mild/absent</li></ul></td><td style=\"width:38.0%;\"><ul><li>Elevated muscle enzymes (eg, creatine kinase, aldolase, AST)</li><li>Autoantibodies (anti&ndash;Jo-1, ANA)</li><li>Biopsy: endomysial infiltrate, patchy necrosis</li></ul></td></tr><tr><td style=\"width:20.0%;\"><p align=\"center\"><strong>Polymyalgia rheumatica</strong></p></td><td style=\"width:42.0%;\"><ul><li>Age &gt;50</li><li>Systemic signs &amp; symptoms</li><li>Stiffness &gt; pain in shoulders, hip girdle, neck</li><li>Association with giant cell (temporal) arteritis</li></ul></td><td style=\"width:38.0%;\"><ul><li>Elevated ESR, C-reactive protein</li><li>Rapid improvement with glucocorticoid therapy</li></ul></td></tr><tr><td colspan=\"3\" style=\"width:38.0%;\"><p style=\"margin-left:7.65pt;\"><strong>ANA</strong> = antinuclear antibody; <strong>AST</strong> = aspartate aminotransferase; <strong>ESR</strong> = erythrocyte sedimentation rate.</p></td></tr></tbody></table></div></p><p>This patient has features of <strong>polymyositis</strong>, including chronic <strong>proximal muscle weakness</strong>, otherwise normal neurologic findings, and an <strong>elevated creatine kinase</strong>.&nbsp; Peak incidence occurs at age 40-50, and women are more commonly affected than men.&nbsp; Proximal muscle weakness typically manifests as difficulty climbing stairs, getting into or out of a low chair or car, or working with the arms overhead (eg, combing hair).&nbsp; Involvement of upper esophageal musculature can cause <strong>dysphagia</strong> with regurgitation and aspiration.&nbsp; Inflammatory markers (eg, erythrocyte sedimentation rate) may be elevated, and most patients have detectable autoantibodies (eg, antinuclear antibody, anti-Jo-1).&nbsp; Definitive diagnosis is established on <strong>muscle biopsy</strong>.&nbsp; Polymyositis resembles dermatomyositis but without associated skin manifestations.</p><p>Initial remission can be induced with <strong>glucocorticoids</strong> (eg, prednisone), and most patients also receive a <strong>glucocorticoid-sparing agent</strong> (eg, methotrexate, azathioprine) to minimize the long-term adverse effects of treatment.&nbsp; Because polymyositis frequently occurs as a <strong>paraneoplastic syndrome</strong>, patients should also receive age-appropriate cancer screening.</p><p><strong>(Choices A)</strong>&nbsp; Amitriptyline is a tricyclic antidepressant used in a number of chronic pain disorders (eg, fibromyalgia).&nbsp; Fibromyalgia can cause fatigue and reluctance to exercise, but true muscle weakness is absent.</p><p><strong>(Choices B, E, and G)</strong>&nbsp; Beta interferon is sometimes used in the treatment of multiple sclerosis, which initially presents at age 15-50 with episodic neurologic deficits in different distributions (episodes are disseminated in space and time).&nbsp; Pyridostigmine is a cholinesterase inhibitor used to treat myasthenia gravis, which is characterized by weakness that worsens with activity and involves facial and distal limb muscles in addition to proximal muscles.&nbsp; Riluzole is used for amyotrophic lateral sclerosis, a progressive neurodegenerative disorder that causes asymmetric upper (spastic weakness, hyperreflexia) and lower (muscle atrophy, fasciculations) motor neuron features.&nbsp; Muscle enzymes (eg, creatine kinase) are generally normal in these conditions.</p><p><strong>(Choice C)</strong>&nbsp; Cyclobenzaprine is indicated for short-term treatment of muscle spasm associated with acute musculoskeletal conditions (eg, lumbar strain).&nbsp; It is not helpful for muscle weakness.</p><p><strong>(Choice F)</strong>&nbsp; Expedited radiation therapy is necessary for metastatic spinal cord compression.&nbsp; Early signs of cord compression include progressive back pain, symmetric lower extremity weakness, and diminished deep tendon reflexes.</p><p><strong>Educational objective:</strong><br>Polymyositis is characterized by proximal muscle weakness and elevated creatine kinase.&nbsp; Initial treatment includes systemic glucocorticoids (eg, prednisone), and most patients also receive a glucocorticoid-sparing agent (eg, methotrexate, azathioprine) to minimize the adverse effects of treatment.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 15037,
            "topic": "Inflammatory myopathies",
            "titleId": 15037,
            "title": "Inflammatory myopathies",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amitriptyline",
                    "choiceNumber": 1,
                    "correctTaken": 258,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Beta interferon",
                    "choiceNumber": 2,
                    "correctTaken": 226,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cyclobenzaprine",
                    "choiceNumber": 3,
                    "correctTaken": 167,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prednisone",
                    "choiceNumber": 4,
                    "correctTaken": 11425,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pyridostigmine",
                    "choiceNumber": 5,
                    "correctTaken": 2739,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Radiation therapy",
                    "choiceNumber": 6,
                    "correctTaken": 62,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Riluzole",
                    "choiceNumber": 7,
                    "correctTaken": 651,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25641317",
                    "mediaDataId": 0,
                    "title": "An overview of polymyositis and dermatomyositis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25641317",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 141,
            "othersAvgTimeSpent": 55,
            "notes": null,
            "peopleTaken": 15528,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 74,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 31,
            "questionId": 4123,
            "questionIndex": 4123,
            "questionText": "<p>A 60-year-old man comes to the office due to fatigue and muscle weakness in the extremities.&nbsp; The weakness has progressively worsened over the past few months, and is associated with a 7-kg (15.4-lb) weight loss.&nbsp; He has no other medical conditions.&nbsp; The patient smokes 2 packs of cigarettes daily and consumes alcohol occasionally.&nbsp; On examination, he has difficulty rising from the chair to sit on the examining table.&nbsp; Muscle strength is 3/5 in the proximal muscle groups symmetrically and is not improved by repeated muscle contractions.&nbsp; Reflexes are intact and symmetric&nbsp;bilaterally.&nbsp; No sensory abnormality is present.&nbsp; There are erythematous patches and violaceous papules involving the dorsum of the fingers.&nbsp; Chest x-ray reveals an ill-defined mass in the right lower lobe.&nbsp; The patient&#39;s muscle weakness is most likely due to a pathologic process at which of the following?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t65200\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Neuromuscular paraneoplastic syndromes</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Involved site</strong></p></td><td><p align=\"center\"><strong>Clinical features</strong></p></td></tr><tr><td><p align=\"center\"><strong>Myasthenia gravis</strong></p></td><td><p align=\"center\">Acetylcholine receptor in postsynaptic membrane</p></td><td><ul><li>Fluctuating muscle weakness<ul style=\"list-style-type:circle;\"><li>Ocular (ptosis, diplopia)</li><li>Bulbar (dysphagia, dysarthria)</li><li>Facial, neck &amp; limb muscles</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Lambert-Eaton syndrome</strong></p></td><td><p align=\"center\">Presynaptic membrane voltage-gated calcium channels</p></td><td><ul><li>Proximal muscle weakness</li><li>Autonomic dysfunction (eg, dry mouth)</li><li>Cranial nerve involvement (eg, ptosis)</li><li>Diminished or absent deep tendon reflexes</li></ul></td></tr><tr><td><p align=\"center\"><strong>Dermatomyositis &amp; polymyositis</strong></p></td><td><p align=\"center\">Muscle fiber injury</p></td><td><ul><li>Symmetric &amp; more proximal muscle weakness</li><li>ILD, Raynaud phenomenon</li><li>Polyarthritis</li><li>Dysphagia</li><li>Skin findings (eg, Gottron papules, heliotrope rash) in dermatomyositis</li></ul></td></tr><tr><td colspan=\"3\"><p><strong>ILD</strong> = interstitial lung disease.</p></td></tr></tbody></table></div><p>This patient with progressive&nbsp;muscle weakness and a rash also has features concerning for lung cancer (weight loss, smoking history, right lower lobe mass). &nbsp;Malignancies can cause&nbsp;<strong>paraneoplastic syndromes</strong>, which are not directly related to the cancer&#39;s invasion but rather&nbsp;are&nbsp;due to tumor-produced&nbsp;hormones, cytokines, or cross-reactive antibodies (eg, shared antigens between proteins expressed on tumor cells and human cells).&nbsp; They are most commonly seen in <strong>cancers</strong> of the <strong>lung</strong>, breast, and ovaries and in lymphomas.&nbsp; Manifestations typically resemble those of primary endocrine, metabolic, hematologic, or neuromuscular disorders.</p><p>Paraneoplastic syndromes affecting the peripheral nerve and/or muscle (eg, myasthenia gravis, Lambert-Eaton syndrome, dermatomyositis) most commonly present with <strong>muscle weakness</strong>, as seen in this patient.&nbsp; This patient likely has <strong>dermatomyositis</strong>, an idiopathic inflammatory myopathy with immune-mediated <strong>muscle fiber</strong> injury.&nbsp; It typically presents with <strong>symmetrical, proximal</strong> muscle weakness and an <strong>erythematous rash</strong> on the dorsum of the fingers <a href=\"674\">(Gottron sign)</a> and/or <a href=\"673\">upper eyelids (heliotrope eruption)</a>. &nbsp;The weakness is often painless, although mild tenderness can occur in 25%-50% of cases. &nbsp;Reflexes and sensation are preserved. &nbsp;Myositis-specific antibodies (eg, anti&ndash;Jo-1) can be helpful in clarifying the condition, and muscle biopsy is often diagnostic, although not always necessary.</p><p>Other paraneoplastic syndromes include the following:</p><ul><li><p>Myasthenia gravis, which is due to autoantibodies against acetylcholine receptors in the postsynaptic membrane.&nbsp; It is characterized by fluctuating ocular (ptosis, diplopia), facial, and/or bulbar muscle weakness that becomes worse with repetitive tasks.&nbsp; This patient&#39;s skin findings and absence of eye findings make myasthenia gravis less likely <strong>(Choice C)</strong>.</p></li><li><p>Lambert-Eaton myasthenic syndrome, which is a paraneoplastic disorder (commonly occurring in lung malignancy) characterized by antibody-mediated inflammation of the voltage-gated calcium channels on the presynaptic membrane.&nbsp; It can cause proximal muscle weakness, but patients usually have autonomic dysfunction (eg, dry mouth, erectile dysfunction) and absent or diminished&nbsp;reflexes, and symptoms usually improve with repeated isometric contractions&nbsp;<strong>(Choice D)</strong>.</p></li><li><p>Paraneoplastic myelopathy of the spinal cord, which typically presents with flaccid or spastic paraplegia or quadriplegia, sensory deficits, and/or urinary or fecal retention/incontinence <strong>(Choice E)</strong>.</p></li></ul><p><strong>(Choice B)</strong>&nbsp; Peripheral nerve injury can cause motor weakness but typically manifests with sensory (eg, numbness, paresthesia) abnormalities and abnormal reflexes on physical examination.&nbsp; This patient&#39;s normal reflexes and sensory examination make this unlikely.</p><p><strong>Educational objective:</strong><br>Dermatomyositis is an inflammatory myopathy characterized by immune-mediated injury to muscle fibers that often occurs as a paraneoplastic syndrome in malignancy.&nbsp; Patients typically have symmetrical, proximal muscle weakness and an erythematous rash over the dorsum of the fingers (Gottron sign) and/or upper eyelids (heliotrope rash).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 15037,
            "topic": "Inflammatory myopathies",
            "titleId": 15037,
            "title": "Inflammatory myopathies",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Muscle fibers",
                    "choiceNumber": 1,
                    "correctTaken": 7090,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Peripheral nerves",
                    "choiceNumber": 2,
                    "correctTaken": 500,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Postsynaptic membrane",
                    "choiceNumber": 3,
                    "correctTaken": 1874,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Presynaptic membrane",
                    "choiceNumber": 4,
                    "correctTaken": 3678,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Spinal cord",
                    "choiceNumber": 5,
                    "correctTaken": 276,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31279808",
                    "mediaDataId": 0,
                    "title": "Dermatomyositis: clinical features and pathogenesis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31279808",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 76,
            "othersAvgTimeSpent": 50,
            "notes": null,
            "peopleTaken": 13418,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 53,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 32,
            "questionId": 4585,
            "questionIndex": 4585,
            "questionText": "<p>A 54-year-old man comes to the office due to morning facial puffiness and bilateral leg swelling.&nbsp; Medical history includes psoriasis and recurrent pulmonary infections due to bronchiectasis.&nbsp; Blood pressure is 143/92 mm Hg and pulse is 92/min.&nbsp; BMI is 22 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination shows hepatosplenomegaly, bilateral ballottable enlarged kidneys, and 2+ pitting edema of the bilateral lower extremities to the knees.&nbsp; Urinalysis shows 4+ proteinuria and normal urinary sediment.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t70953\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"5\"><p align=\"center\"><strong>Major types of systemic amyloidosis</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Primary</strong></p></td><td><p align=\"center\"><strong>Secondary</strong></p></td><td><p align=\"center\"><strong>Age related</strong></p></td><td><p align=\"center\"><strong>Dialysis related</strong></p></td></tr><tr><td><p align=\"center\"><strong>Disease<br />association</strong></p></td><td><p align=\"center\">Plasma cell dyscrasia</p></td><td><p align=\"center\">Chronic infection/<br />inflammation</p></td><td><p align=\"center\">Elderly men</p></td><td><p align=\"center\">ESRD on dialysis</p></td></tr><tr><td><p align=\"center\"><strong>Precursor<br />protein</strong></p><p align=\"center\"><strong>&darr;</strong></p><p align=\"center\"><strong>Misfolding<br />mechanism</strong></p><p align=\"center\"><strong>&darr;</strong></p><p align=\"center\"><strong>Amyloid<br />fibril type</strong></p></td><td><p align=\"center\">Immunoglobulin<br />light chains</p><p align=\"center\">&darr;</p><p align=\"center\">Increased<br />production</p><p align=\"center\">&darr;</p><p align=\"center\">AL</p></td><td><p align=\"center\">Serum<br />amyloid A</p><p align=\"center\">&darr;</p><p align=\"center\">Increased<br />production</p><p align=\"center\">&darr;</p><p align=\"center\">AA</p></td><td><p align=\"center\">Transthyretin<br />(prealbumin)</p><p align=\"center\">&darr;</p><p align=\"center\">Accumulation<br />over time</p><p align=\"center\">&darr;</p><p align=\"center\">ATTR*</p></td><td><p align=\"center\">&beta;<sub>2</sub>-Microglobulin<span style=\"display:none\">&nbsp;</span><br />&darr;</p><p align=\"center\">Decreased<br />clearance</p><p align=\"center\">&darr;</p><p align=\"center\">A&beta;<sub>2</sub>M</p></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />manifestations</strong></p></td><td colspan=\"2\"><p align=\"center\">Nephropathy, hepatosplenomegaly, cardiomyopathy (AL &gt; AA), peripheral neuropathy, macroglossia, skin bruising</p></td><td><p align=\"center\">Cardiomyopathy, CTS, other peripheral neuropathy</p></td><td><p align=\"center\">Scapulohumeral arthritis, CTS</p></td></tr><tr><td colspan=\"5\"><p>Amyloid names begin with &quot;A&quot; followed by the precursor protein abbreviation.</p><p>*ATTR also occurs in a hereditary form that affects younger patients.</p><p><strong>CTS</strong> = carpal tunnel syndrome; <strong>ESRD</strong> = end-stage renal disease.</p></td></tr></tbody></table></div><p>This patient&#39;s clinical presentation of facial swelling, bilateral lower extremity edema, and massive proteinuria is consistent with <strong>nephrotic syndrome</strong>. &nbsp;A common unifying diagnosis is&nbsp;<strong>amyloidosis&nbsp;</strong>given the multisystemic findings suggestive of infiltrative disease, including&nbsp;palpable and <strong>enlarged kidneys</strong>, <strong>hepatomegaly</strong>, and <strong>splenomegaly</strong>.&nbsp; Specifically, this patient likely has secondary (AA) amyloidosis, which can be seen with <strong>chronic inflammatory </strong>disease (eg, rheumatoid arthritis, <strong>psoriatic</strong> arthritis, inflammatory bowel disease) or chronic<strong> infection</strong> (eg, <strong>bronchiectasis</strong>, tuberculosis, osteomyelitis), as serum amyloid A protein is an acute-phase reactant.</p><p>Similar to amyloidosis light-chain (AL amyloidosis), deposition of the abnormally folded protein fibrils can affect <strong>many organ systems</strong>; cardiac involvement is much less common with AA amyloidosis than AL amyloidosis.&nbsp; The diagnosis is confirmed by the presence of amyloid on abdominal fat pad biopsy; renal biopsy can be considered if fat pad biopsy is nondiagnostic.&nbsp; Histology demonstrates amorphous hyaline material that stains with Congo red.&nbsp; Treatment is usually directed at the underlying inflammatory disease.</p><p><strong>(Choice B)</strong>&nbsp; Hepatorenal syndrome refers to acute renal failure in patients with severe acute or chronic liver disease and portal hypertension.&nbsp; The renal failure results from reduced renal blood flow and does not cause significant proteinuria.</p><p><strong>(Choice C)</strong>&nbsp; Hypertensive nephrosclerosis is seen in patients with chronic hypertension and is associated with retinopathy, progressive renal failure, and mild proteinuria (generally &lt;1 g/day).&nbsp; The kidneys are usually small and hepatomegaly is not present.</p><p><strong>(Choice D)</strong>&nbsp; IgA nephropathy is a type of glomerulonephritis that usually presents with hematuria on urinalysis.&nbsp; It is not typically associated with other organ involvement and would not explain this patient&#39;s hepatomegaly and splenomegaly.</p><p><strong>(Choice E)</strong>&nbsp; Patients with polycystic kidney disease typically have flank pain, hematuria, progressive renal failure, hypertension, and large, palpable kidneys.&nbsp; Hepatomegaly can also be present due to cystic liver involvement.&nbsp; However, splenomegaly is not typical, and overt nephrotic syndrome, as seen in this patient, is unusual.</p><p><strong>Educational objective:</strong><br>Secondary amyloidosis is a complication of a chronic inflammatory condition (eg, chronic infection, inflammatory bowel disease, rheumatoid arthritis) resulting in extracellular tissue deposition of protein fibrils into tissues and organs.&nbsp; Patients can develop multiorgan dysfunction (eg, kidneys, liver).&nbsp; Management usually involves treating the underlying inflammatory disease.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 5441,
            "topic": "Amyloidosis",
            "titleId": 5441,
            "title": "Amyloidosis",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amyloidosis",
                    "choiceNumber": 1,
                    "correctTaken": 5881,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hepatorenal syndrome",
                    "choiceNumber": 2,
                    "correctTaken": 2233,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypertensive nephrosclerosis",
                    "choiceNumber": 3,
                    "correctTaken": 473,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "IgA nephropathy",
                    "choiceNumber": 4,
                    "correctTaken": 1712,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Polycystic kidney disease",
                    "choiceNumber": 5,
                    "correctTaken": 3073,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22653707",
                    "mediaDataId": 0,
                    "title": "AA amyloidosis: basic knowledge, unmet needs and future treatments.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22653707",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 66,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 13372,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 44,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 33,
            "questionId": 3321,
            "questionIndex": 3321,
            "questionText": "<p>A 49-year-old woman comes to the office due to difficulty swallowing solid food.&nbsp; The patient&#39;s symptoms are worse with breads and crackers, but she has no difficulty with liquids, and she uses sips of water to help with swallowing.&nbsp; She thinks that she may have lost weight.&nbsp; The patient&#39;s medical history is significant for hypertension and hypothyroidism treated with amlodipine and levothyroxine, respectively.&nbsp; She also uses over-the-counter saline eye drops for eye dryness.&nbsp; The patient has never used tobacco or alcohol.&nbsp; Family history is negative for cancer.&nbsp; She has been monogamous with her husband for 15 years.&nbsp; Blood pressure is 140/90 mm Hg and pulse is 60/min.&nbsp; BMI is 19 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination shows oral thrush, prominent dental caries, and bilateral, firm submandibular nodules.&nbsp; There is no lymphadenopathy.&nbsp; Cardiopulmonary examination shows no abnormalities.&nbsp; Abdomen is soft and nontender with no organomegaly.&nbsp; There is no peripheral edema.&nbsp; Which of the following is the best next step to confirm this patient&#39;s diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t35939\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Sj&ouml;gren syndrome</strong></p></td></tr><tr><td><p align=\"center\"><strong>Exocrine<br />features</strong></p></td><td><ul><li><strong>Keratoconjunctivitis sicca</strong></li><li>Dry mouth, salivary hypertrophy</li><li>Xerosis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Extraglandular<br />features</strong></p></td><td><ul><li><strong>Raynaud phenomenon</strong></li><li>Cutaneous vasculitis</li><li>Arthralgia/arthritis</li><li>Interstitial lung disease</li><li>Non-Hodgkin lymphoma</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnostic<br />findings</strong></p></td><td><ul><li>Objective signs of <strong>decreased lacrimation</strong> (eg, Schirmer test)</li><li>Positive <strong>anti-Ro</strong> (SSA) &amp;/or <strong>anti-La</strong> (SSB)</li><li>Salivary gland biopsy with focal lymphocytic sialoadenitis</li><li>Classification: primary if no associated CTD, secondary if comorbid CTD&nbsp;(eg, SLE, RA, scleroderma)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>CTD</strong> = connective tissue disease; <strong>RA</strong> = rheumatoid arthritis; <strong>SLE</strong> = systemic lupus erythematosus; <strong>SSA/SSB</strong> = Sj&ouml;gren syndrome (antibody) A/B.</p></td></tr></tbody></table></div></p><p><strong>Sj&ouml;gren syndrome (SS)</strong> is an autoimmune disorder characterized by inflammation of exocrine glands, with a greatest incidence in middle-aged women.&nbsp; Patients can have severe <strong>dry mouth</strong> (xerostomia) with <strong>dysphagia</strong> (difficulty swallowing), thrush, and dental <strong>caries</strong>.&nbsp; Involvement of lacrimal glands causes <strong>keratoconjunctivitis sicca</strong> (eg, dry eyes).&nbsp; Extraglandular features include arthritis, Raynaud phenomenon, cutaneous vasculitis, interstitial lung disease, and increased risk for non-Hodgkin lymphoma.</p><p>The diagnosis of SS is made in patients with ocular or oral dryness when there is:</p><ul><li>Evidence of dry mouth and eyes.&nbsp; In the <strong>Schirmer test</strong>, a sterile strip of filter paper is placed under the lower eyelid, and the area moistened by the absorbed fluid is measured after 5 minutes.</li><li>Either histologic evidence of lymphocytic infiltration of the salivary glands or presence of serum <strong>autoantibodies</strong> directed against <strong>SSA (Ro) and/or SSB (La)</strong>.</li></ul><p>Antinuclear antibodies and rheumatoid factor are less specific but helpful when positive.</p><p><strong>(Choice B)</strong>&nbsp; Autoimmune sialoadenitis in SS causes enlargement of the salivary glands visible on MRI or ultrasound.&nbsp; CT scan of the neck can be used to evaluate for malignancy, which is less likely to explain this patient&#39;s dry eyes, bilateral submandibular nodules, thrush, or prominent caries.</p><p><strong>(Choice C)</strong>&nbsp; Bulimia can cause dental caries and transient salivary gland hypertrophy but is less likely to cause dysphagia or dry eyes.</p><p><strong>(Choice D)</strong>&nbsp; The evaluation of patients with suspected esophageal dysphagia can include CT scan (extrinsic compression) and esophageal endoscopy (intrinsic obstruction).&nbsp; However, these patients typically have a sensation of food sticking in the chest following large unchewed food boluses (eg, meat) and frequently have a history of smoking.&nbsp; Endoscopy with biopsy can also diagnose Barrett esophagus in patients with chronic gastroesophageal reflux.</p><p><strong>(Choice E)</strong>&nbsp; Biopsy of salivary glands can confirm the diagnosis of SS if other evaluations are nondiagnostic.&nbsp; However, samples are usually taken from the minor glands of the lip rather than submandibular glands.</p><p><strong>(Choice F)</strong>&nbsp; A videofluoroscopic swallowing study is used to evaluate oropharyngeal and esophageal function in patients with suspected neuromuscular dysphagia.&nbsp; In SS, patients may have a delayed swallow and decreased upper esophageal contractility, but the results are nonspecific and not needed for diagnosis or management.</p><p><strong>Educational objective:</strong><br>The diagnosis of Sj&ouml;gren syndrome requires evidence of dry mouth and eyes (eg, positive Schirmer test result for decreased lacrimation) with either histologic evidence of lymphocytic infiltration of the salivary glands or serum autoantibodies against SSA (Ro) and/or SSB (La).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 8551,
            "topic": "Sjogren syndrome",
            "titleId": 8551,
            "title": "Sjogren syndrome",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antibodies to Ro/SSA and La/SSB",
                    "choiceNumber": 1,
                    "correctTaken": 11559,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "CT scan of the neck",
                    "choiceNumber": 2,
                    "correctTaken": 299,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Eating disorder assessment",
                    "choiceNumber": 3,
                    "correctTaken": 505,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Esophageal endoscopy with biopsy",
                    "choiceNumber": 4,
                    "correctTaken": 1187,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Submandibular gland biopsy",
                    "choiceNumber": 5,
                    "correctTaken": 1467,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Videofluoroscopic swallowing study",
                    "choiceNumber": 6,
                    "correctTaken": 576,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19323359",
                    "mediaDataId": 0,
                    "title": "Diagnosis and management of Sj&#246;gren syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19323359",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 164,
            "othersAvgTimeSpent": 52,
            "notes": null,
            "peopleTaken": 15593,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 74,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 34,
            "questionId": 14814,
            "questionIndex": 16237,
            "questionText": "<p>A 55-year-old business executive comes to the office due to worsening joint pains for the past several months.&nbsp; He says, &#x22;My hands and fingers feel tight on waking up in the morning, and they are painful to move.&nbsp; I can&#39;t hold my toothbrush or button up my shirts.&nbsp; It slowly gets better by the time I get to the office in the morning.&#x22;&nbsp; The patient has also felt excessively tired and has lost 4.5 kg (10 lb) over the past 6 months, which he attributes to extra work for a new business venture.&nbsp; He has no prior medical problems and takes no medications.&nbsp; The patient occasionally drinks alcohol and does not use tobacco or illicit drugs.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 132/86 mm Hg, and pulse is 72/min.&nbsp; Physical examination shows no scleral icterus or oral lesions.&nbsp; The lungs are clear to auscultation.&nbsp; Heart sounds are normal.&nbsp; The abdomen is soft and nontender with no organomegaly.&nbsp; Metacarpophalangeal and proximal interphalangeal joints of both hands show mild boggy swelling with tenderness on gentle squeezing.&nbsp; There is no increased joint warmth or erythema.&nbsp; No skin rashes are present.&nbsp; Laboratory results are as follows.</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Erythrocyte sedimentation rate</td><td style=\"vertical-align:middle;\">80 mm/hr</td></tr><tr><td style=\"vertical-align:middle;\">Rheumatoid factor</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">Antinuclear antibody</td><td style=\"vertical-align:middle;\">negative</td></tr></tbody></table><p>Which of the following is the most appropriate next step in evaluation of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32126\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Clinical features of rheumatoid arthritis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical&nbsp;presentation</strong></p></td><td><ul><li>Pain, swelling &amp; morning stiffness in multiple joints</li><li>Small joints (PIP, MCP, MTP); spares DIP joints</li><li>Systemic symptoms (fever, weight loss, anemia)</li><li>Cervical spine involvement: subluxation, cord compression</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory/<br />imaging&nbsp;studies</strong></p></td><td><ul><li>Positive rheumatoid factor &amp; anti&ndash;CCP antibodies</li><li>C-reactive protein &amp; ESR correlate with disease activity</li><li>X-ray: soft tissue swelling, joint space narrowing, bony erosions</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>anti&ndash;CCP</strong>&nbsp;=&nbsp;anti&ndash;cyclic citrullinated peptide; <strong>DIP</strong>&nbsp;=&nbsp;distal interphalangeal; <strong>ESR</strong>&nbsp;=&nbsp;erythrocyte sedimentation rate; <strong>MCP</strong>&nbsp;=&nbsp;metacarpophalangeal; <strong>MTP</strong>&nbsp;=&nbsp;metatarsophalangeal; <strong>PIP</strong>&nbsp;=&nbsp;proximal interphalangeal.</p></td></tr></tbody></table></div><p>This patient has a prolonged morning stiffness and a chronic <strong>symmetric polyarthritis</strong> with synovitis (bogginess on examination) predominantly involving the proximal interphalangeal and metacarpophalangeal joints.&nbsp; In association with the elevated erythrocyte sedimentation rate and systemic symptoms (ie, fatigue, weight loss), this presentation suggests <strong>rheumatoid arthritis (RA)</strong>.</p><p>RA is diagnosed primarily based on clinical findings; however, serologies can help clarify the diagnosis.</p><ul><li><strong>Rheumatoid factor</strong> (RF; antibodies directed at the Fc portion of IgG) has moderate sensitivity (~70%), but the specificity is poor.&nbsp; It may be positive in a variety of disorders (eg, Sjogren syndrome, mixed cryoglobulinemia, viral hepatitis) and in healthy individuals.</li><li><strong>Cyclic citrullinated peptide</strong> antibodies (anti-CCP) have similar sensitivity to RF but <strong>higher specificity</strong> (&gt;90%) for RA.</li></ul><p>In patients in whom RA is suspected but who have a negative RF test result, anti-CCP testing should be obtained.&nbsp; <strong>Seronegative RA</strong> (ie, negative assays for RF and anti-CCP) often carries a better prognosis; however, many patients with initially seronegative disease will develop positive markers later in their course.</p><p><strong>(Choice B)</strong>&nbsp; Anti&ndash;double-stranded DNA antibodies are primarily used to evaluate systemic lupus erythematosus (SLE).&nbsp; They have higher specificity for SLE than antinuclear antibodies (ANA) but lower sensitivity.&nbsp; SLE can cause arthritis and constitutional findings (eg, weight loss), but the patient has no other manifestations of SLE.&nbsp; In addition, if ANA is negative, as in this patient, further serologic testing for SLE is not needed.</p><p><strong>(Choice C)</strong>&nbsp; Hypertrophic osteoarthropathy is a paraneoplastic syndrome associated with intrathoracic malignancy and other pulmonary diseases (eg, cystic fibrosis) that could be apparent on CT scan.&nbsp; However, although it can cause a polyarthropathy, it is also associated with digital clubbing and periostosis (excessive bone formation).</p><p><strong>(Choices D and E)</strong>&nbsp; Spondyloarthropathies (eg, ankylosing spondylitis, reactive arthritis) are associated with HLA-B27 and are characterized by asymmetric oligoarthritis involving the large joints (eg, knees), enthesitis (inflammation at the insertion of ligaments and tendons), and back pain.&nbsp; Hand involvement is rare.&nbsp; Reactive arthritis typically occurs acutely following a gastrointestinal or genitourinary infection (eg, <em>Chlamydia trachomatis</em>) and resolves within a few months.</p><p><strong>(Choice F)</strong>&nbsp; Parvovirus B19 causes a symmetric arthritis that affects the hands, knees, and feet.&nbsp; It may resemble RA, but the symptoms usually resolve spontaneously within a few weeks.</p><p><strong>(Choice G)</strong>&nbsp; Gout is caused by deposition of uric acid crystals in the synovial space; the incidence correlates roughly with serum uric acid levels.&nbsp; However, gout most commonly presents with episodic acute monoarthritis, with dramatic redness and warmth involving the toes, ankles, or knees.</p><p><strong>Educational objective:</strong><br>Rheumatoid arthritis (RA) causes a chronic, symmetric polyarthritis predominantly affecting the small joints of the hands.&nbsp; Rheumatoid factor (low specificity) and cyclic citrullinated peptide antibodies (high specificity) are the primary serologic markers for RA.&nbsp; Patients who have negative assays for both markers (seronegative RA) may have a more favorable prognosis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 3769,
            "topic": "Rheumatoid arthritis",
            "titleId": 3769,
            "title": "Rheumatoid arthritis",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "1",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Anti&ndash;cyclic citrullinated peptide antibody assay",
                    "choiceNumber": 1,
                    "correctTaken": 10969,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Anti&ndash;double-stranded DNA antibody assay",
                    "choiceNumber": 2,
                    "correctTaken": 822,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Contrast-enhanced CT scan of the chest",
                    "choiceNumber": 3,
                    "correctTaken": 1488,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Human leukocyte antigen (HLA)&ndash;B27 testing",
                    "choiceNumber": 4,
                    "correctTaken": 1624,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nucleic acid amplification testing for <em>Chlamydia</em>",
                    "choiceNumber": 5,
                    "correctTaken": 100,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Parvovirus B19 IgG antibody assay",
                    "choiceNumber": 6,
                    "correctTaken": 211,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum uric acid assay",
                    "choiceNumber": 7,
                    "correctTaken": 318,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25481556",
                    "mediaDataId": 0,
                    "title": "Seronegative rheumatoid arthritis: pathogenetic and therapeutic aspects.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25481556",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 164,
            "othersAvgTimeSpent": 80,
            "notes": null,
            "peopleTaken": 15532,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 71,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 35,
            "questionId": 3815,
            "questionIndex": 3815,
            "questionText": "<p>A 35-year-old woman comes to the office due to oral ulcers.&nbsp; She has multiple painful sores on her oral mucosa that began a few days ago.&nbsp; The patient had similar lesions 3 months ago that healed without scarring.&nbsp; In addition, she recently was evaluated by an ophthalmologist for blurred vision and was diagnosed with anterior uveitis.&nbsp; She has also had recurrent genital lesions requiring frequent gynecology appointments over the last year.&nbsp; On examination, there are visible oral ulcerations as well as scattered hyperpigmented skin lesions and tender, indurated areas on her legs.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t82152\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Beh&ccedil;et disease</strong></p></td></tr><tr><td><p align=\"center\"><strong>Epidemiology</strong></p></td><td><ul><li>Young adults</li><li>Turkish, Middle Eastern, or Asian descent</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />findings</strong></p></td><td><ul><li>Recurrent, painful oral aphthous ulcers</li><li>Genital ulcers</li><li>Eye lesions (eg, uveitis)</li><li>Skin lesions (eg, erythema nodosum, acneiform lesions)</li><li>Thrombosis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Evaluation</strong></p></td><td><ul><li>Pathergy: Exaggerated skin ulceration with minor trauma (eg, needlestick)</li><li>Biopsy: Nonspecific vasculitis of different sized vessels</li></ul></td></tr></tbody></table></div></p><p>This patient has characteristic features of <strong>Beh&ccedil;et syndrome</strong>, including recurrent painful <strong>oral</strong> and <strong>genital aphthous ulcers</strong>, uveitis, and erythema nodosum (tender red nodules usually in the pretibial area).&nbsp; These patients are also at high risk of vascular disease (vasculitis) with venous and arterial thrombosis.&nbsp; Patients may also demonstrate <a href=\"4124\">pathergy</a>, an exaggerated ulcerating skin response following minor injuries (eg, needlestick).</p><p>Beh&ccedil;et syndrome is more common in patients of Turkish, Middle Eastern, and Asian descent.&nbsp; The diagnosis is made based on <strong>clinical features</strong>, and laboratory evaluation is primarily directed to ruling out other disorders.&nbsp; Biopsy of affected tissues is not usually needed but may show a nonspecific vasculitis, often involving small or medium-sized vessels.</p><p><strong>(Choice B)</strong>&nbsp; Herpes simplex can cause oral and genital ulcers and uveitis.&nbsp; However, it typically presents as vesicles (which coalesce to form lobe-shaped ulcers) that usually recur at the same location.&nbsp; The combination of erythema nodosum, recurrent ulcers, and uveitis makes Beh&ccedil;et syndrome more likely.</p><p><strong>(Choice C)</strong>&nbsp; Reactive arthritis can share a number of features with Beh&ccedil;et syndrome, including arthritis, uveitis, and oral ulcerations.&nbsp; However, it usually follows an acute gastrointestinal (eg, <em>Salmonella</em>, <em>Yersinia</em>) or genitourinary (eg, <em>Chlamydia</em>) infection and causes subacute to chronic, rather than episodic, symptoms.</p><p><strong>(Choice D)</strong>&nbsp; Sarcoidosis is a systemic disease characterized by noncaseating granulomas, most commonly in the lung.&nbsp; It can also be associated with arthritis, uveitis, and erythema nodosum.&nbsp; However, it usually causes significant respiratory symptoms, and recurrent orogenital aphthous ulceration is not a typical feature.</p><p><strong>(Choice E)</strong>&nbsp; Systemic lupus erythematosus is a multisystem disease typically presenting with a malar rash, arthritis, and constitutional symptoms (eg, fever).&nbsp; Oral ulcers are a common feature, but are typically painless.</p><p><strong>Educational objective:</strong><br>Beh&ccedil;et syndrome is a multisystem inflammatory condition characterized by recurrent oral and genital ulcers.&nbsp; Skin and ocular involvement is common.&nbsp; Thrombosis is a major cause of morbidity.&nbsp; It is most common in patients of Turkish, Middle Eastern, and Asian descent.&nbsp; The diagnosis is made based on clinical features.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 17548,
            "topic": "Behçet's disease",
            "titleId": 17548,
            "title": "Behçet's disease",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Beh&ccedil;et syndrome",
                    "choiceNumber": 1,
                    "correctTaken": 30363,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Herpes simplex infection",
                    "choiceNumber": 2,
                    "correctTaken": 3687,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reactive arthritis",
                    "choiceNumber": 3,
                    "correctTaken": 2801,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sarcoidosis",
                    "choiceNumber": 4,
                    "correctTaken": 3090,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Systemic lupus erythematosus",
                    "choiceNumber": 5,
                    "correctTaken": 2949,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26868128",
                    "mediaDataId": 0,
                    "title": "Beh&#231;et&#39;s disease physiopathology: a contemporary review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26868128",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 68,
            "othersAvgTimeSpent": 46,
            "notes": null,
            "peopleTaken": 42890,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 71,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 36,
            "questionId": 4573,
            "questionIndex": 4573,
            "questionText": "<p>A 44-year-old woman comes to the office due to painful oral ulcers.&nbsp; She was initially evaluated 2 months ago for worsening pain, stiffness, and swelling in her hands; x-rays revealed periarticular osteopenia and bony erosions, and laboratory results at that time showed mild anemia with normal liver and renal function studies.&nbsp; Therapy with a disease-modifying drug was begun, and the patient&#39;s joint symptoms have gradually improved.&nbsp; However, she has developed painful ulcerations in her mouth, which make eating difficult.&nbsp; She has had no fever, chills, nausea, vomiting, or abdominal pain.&nbsp; Vital signs are within normal limits.&nbsp; Physical examination shows tender ulcerations of buccal mucosa and gingiva.&nbsp; There is no cervical lymphadenopathy.&nbsp; Laboratory studies reveal the following:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Hematocrit</td><td style=\"vertical-align:middle;\">34%</td></tr><tr><td style=\"vertical-align:middle;\">Platelets</td><td style=\"vertical-align:middle;\">190,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Leukocytes</td><td style=\"vertical-align:middle;\">4,400/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Creatinine</td><td style=\"vertical-align:middle;\">0.8 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Total bilirubin</td><td style=\"vertical-align:middle;\">1.3 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Alkaline phosphatase</td><td style=\"vertical-align:middle;\">90 U/L</td></tr><tr><td style=\"vertical-align:middle;\">Aspartate aminotransferase (SGOT)</td><td style=\"vertical-align:middle;\">120 U/L</td></tr><tr><td style=\"vertical-align:middle;\">Alanine aminotransferase (SGPT)</td><td style=\"vertical-align:middle;\">90 U/L</td></tr><tr><td style=\"vertical-align:middle;\">Erythrocyte sedimentation rate</td><td style=\"vertical-align:middle;\">20 mm/h</td></tr></tbody></table><p>Which of the following is the most likely cause of this patient&#39;s current symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t38387\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Disease-modifying antirheumatic drugs</strong></p></td></tr><tr><td><p align=\"center\"><strong>Agent</strong></p></td><td><p align=\"center\"><strong>Mechanism</strong></p></td><td><p align=\"center\"><strong>Adverse effects</strong></p></td></tr><tr><td><p align=\"center\"><strong>Methotrexate</strong></p></td><td><ul><li>Folate antimetabolite</li></ul></td><td><ul><li>Hepatotoxicity</li><li>Stomatitis</li><li>Cytopenias</li></ul></td></tr><tr><td><p align=\"center\"><strong>Leflunomide</strong></p></td><td><ul><li>Pyrimidine synthesis inhibitor</li></ul></td><td><ul><li>Hepatotoxicity</li></ul><ul><li>Cytopenias</li></ul></td></tr><tr><td><p align=\"center\"><strong>Hydroxychloroquine</strong></p></td><td><ul><li>TNF &amp; IL-1 suppressor</li></ul></td><td><ul><li>Retinopathy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Sulfasalazine</strong></p></td><td><ul><li>TNF &amp; IL-1 suppressor</li></ul></td><td><ul><li>Hepatotoxicity</li><li>Stomatitis</li><li>Hemolytic anemia</li></ul></td></tr><tr><td><p align=\"center\"><strong>TNF inhibitors</strong><br />(eg, adalimumab, certolizumab,<br />etanercept, golimumab, infliximab)</p></td><td></td><td><ul><li>Infection</li><li>Demyelination</li><li>Congestive heart failure</li><li>Malignancy</li></ul></td></tr><tr><td colspan=\"3\"><p><strong>IL-1</strong> = interleukin&nbsp;1;<strong>TNF </strong>= tumor necrosis factor.</p></td></tr></tbody></table></div><p>This patient has bilateral hand arthritis with inflammatory changes on x-ray&nbsp;(eg, bony erosions, osteopenia) and mild anemia (likely due to chronic inflammation).&nbsp; This presentation is&nbsp;consistent with <strong>rheumatoid arthritis (RA)</strong>.&nbsp; <strong>Disease-modifying antirheumatic drugs</strong> (DMARDs) can improve long-term joint function and are initiated as soon as possible after diagnosis.&nbsp; The patient&#39;s oral ulcers and liver function test abnormalities are likely side effects of <strong>methotrexate</strong>, the preferred first-line DMARD for most patients with RA.</p><p>The anti-inflammatory properties of methotrexate are mediated largely by inhibition of dihydrofolate reductase, which causes cellular folate depletion.&nbsp; This leads to <strong>impaired DNA synthesis</strong>, an effect that is most pronounced in rapidly dividing cells.&nbsp; Therefore, side effects include <strong>oral ulcers/stomatitis</strong> and bone marrow suppression (eg, <strong>macrocytic anemia</strong>).&nbsp; Methotrexate is also associated with <strong>hepatotoxicity</strong>, which can range from mild elevations in hepatic transaminases to chronic liver disease and cirrhosis.&nbsp; Much of the toxicity, including hepatotoxicity and stomatitis, can be mitigated by concurrent administration of <strong>folic (or folinic) acid</strong>, which does not reduce the effectiveness of the drug.</p><p><strong>(Choice A)</strong>&nbsp; Oral ulcers are a common manifestation of systemic lupus erythematosus (SLE) and are a direct effect of the underlying autoimmune process.&nbsp; SLE can also cause bilateral arthritis, but this is often transient and not associated with erosive changes on x-ray.</p><p><strong>(Choice B)</strong>&nbsp; Disseminated cytomegalovirus infection can occur in patients on immune suppressive therapy.&nbsp; The infection can cause cytopenias, hepatitis, and esophagitis (with ulcerations); however, other frequent manifestations include colitis (eg, diarrhea), and oral ulcers are uncommon.</p><p><strong>(Choice C)</strong>&nbsp; RA is associated with an increased risk of lymphoproliferative diseases and malignancy, but squamous cell malignancy is uncommon and typically presents with a singular ulceration or mass, not with multifocal oral ulcers.&nbsp; Methotrexate does not carry a significant risk of malignancy.</p><p><strong>(Choice E)</strong>&nbsp; Riboflavin (vitamin B<font size=\"2\"><sub>2</sub></font>) deficiency can cause angular stomatitis and cheilosis in addition to other systemic effects, including liver injury.&nbsp; However, oral ulcers are not typical.&nbsp; Regardless, methotrexate causes a functional folate, not riboflavin, deficiency.</p><p><strong>Educational objective:</strong><br>Methotrexate is a disease-modifying antirheumatic drug used in treatment of rheumatoid arthritis.&nbsp; Its effects are mediated largely by inhibition of dihydrofolate reductase, which causes folate depletion and leads to impaired DNA synthesis.&nbsp; Side effects include oral ulcers, macrocytic anemia, and hepatotoxicity.&nbsp; Much of the toxicity of methotrexate can be mitigated by the administration of folic acid, which does not reduce the effectiveness of the drug.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 3769,
            "topic": "Rheumatoid arthritis",
            "titleId": 3769,
            "title": "Rheumatoid arthritis",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Autoantibody formation against cellular components",
                    "choiceNumber": 1,
                    "correctTaken": 1902,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Disseminated cytomegalovirus infection",
                    "choiceNumber": 2,
                    "correctTaken": 357,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Malignant transformation of squamous epithelium",
                    "choiceNumber": 3,
                    "correctTaken": 65,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medication-induced inhibition of DNA synthesis",
                    "choiceNumber": 4,
                    "correctTaken": 12280,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Metabolic pathway impairment from riboflavin deficiency",
                    "choiceNumber": 5,
                    "correctTaken": 967,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23728635",
                    "mediaDataId": 0,
                    "title": "Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23728635",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 64,
            "othersAvgTimeSpent": 72,
            "notes": null,
            "peopleTaken": 15571,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 79,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 37,
            "questionId": 4460,
            "questionIndex": 4460,
            "questionText": "<p>A 72-year-old woman comes to the office due to frequent headaches, fatigue, and recent weight loss.&nbsp; Her shoulder muscles feel stiff in the morning.&nbsp; A tender cord&nbsp;is palpated in the right temporal area.&nbsp; The erythrocyte sedimentation rate is 85 mm/hr.&nbsp; Which of the following&nbsp;is the most likely complication of this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<p>The patient has typical features of <strong>giant cell arteritis (GCA)</strong>, also known as temporal arteritis.&nbsp; Manifestations include headache, jaw claudication, muscle fatigue, weight loss, and visual disturbance.&nbsp; On examination, patients have scalp tenderness and a decreased pulse over the <strong>temporal artery</strong>, which may have a cord-like feel.&nbsp; Many patients with GCA have associated polymyalgia rheumatica, with morning stiffness affecting the shoulders and hips.&nbsp;The erythrocyte sedimentation rate&nbsp;is generally markedly elevated (eg, <strong>&gt;50 mm/hr</strong>).</p><p>A feared complication of GCA is permanent vision loss, which&nbsp;can develop in up to 20% of patients and is often sudden, painless, and irreversible.&nbsp; It is often due to anterior ischemic optic neuropathy from the arteritis.&nbsp; Another recognized complication, which has also been noted in 10%-20% of patients,&nbsp;is&nbsp;<strong>aortic aneurysm</strong>&nbsp;due to large-vessel involvement.&nbsp; Patients with aortic aneurysm are typically followed with serial imaging studies.</p><p><b>(Choice A)&nbsp;&nbsp;</b>Chronic lymphocytic leukemia is the most common form of leukemia in older individuals.&nbsp; The presentation is very insidious.&nbsp; Although the exact etiology is unclear, certain chromosomal abnormalities can predispose individuals to this condition.</p><p><b>(Choice B)&nbsp;&nbsp;</b>The most common cause of hypothyroidism is chronic lymphocytic thyroiditis (Hashimoto disease).&nbsp; Radiation to the thyroid region predisposes to the development of hypothyroidism.</p><p><b>(Choice D)&nbsp;&nbsp;</b>Ulcerative colitis is an inflammatory bowel disease involving the large intestine.&nbsp; It is more common among Ashkenazi&nbsp;Jews, and those with a positive family history.</p><p><b>(Choice E)&nbsp;&nbsp;</b>Important causes of membranous glomerulonephritis include hepatitis B and C, syphilis, gold, penicillamine, systemic lupus erythematosus, and rheumatoid arthritis.&nbsp; Many patients have no predisposing factors.</p><p><b>Educational objective:</b><br>Aortic aneurysms can occur in patients with giant cell (temporal) arteritis due to the involvement of the branches of the aorta.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 18251,
            "topic": "Giant cell arteritis",
            "titleId": 18251,
            "title": "Giant cell arteritis",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "3",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Chronic lymphocytic leukemia",
                    "choiceNumber": 1,
                    "correctTaken": 31853,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypothyroidism",
                    "choiceNumber": 2,
                    "correctTaken": 27987,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Aortic aneurysm",
                    "choiceNumber": 3,
                    "correctTaken": 146270,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ulcerative colitis",
                    "choiceNumber": 4,
                    "correctTaken": 24698,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Membranous glomerulonephritis",
                    "choiceNumber": 5,
                    "correctTaken": 74513,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 39,
            "othersAvgTimeSpent": 51,
            "notes": null,
            "peopleTaken": 305321,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 38,
            "questionId": 13469,
            "questionIndex": 14852,
            "questionText": "<p>A 6-year-old boy is brought to the office due to fever and a lump on his neck.&nbsp; The patient has had fever for the past 6 days, and the mother felt the lump when she was bathing him yesterday.&nbsp; This morning she noticed that he has a rash on his trunk and redness in his eyes.&nbsp; The patient has had no cough, rhinorrhea, diarrhea, or emesis.&nbsp; He has a history of intermittent asthma and takes albuterol as needed.&nbsp; Vaccinations are up to date.&nbsp; Temperature is 39.4 C (102.9 F), blood pressure is 90/60 mm Hg, and pulse is 125/min.&nbsp; On physical examination, the child is irritable but intermittently consolable by his mother.&nbsp; Bilateral conjunctivae are injected.&nbsp; A 2-cm, tender, mobile anterior cervical lymph node is palpated.&nbsp; Heart rate is regular with mild tachycardia and no murmurs, rubs, or gallops.&nbsp; A blanching erythematous rash is present across the trunk.&nbsp; The tongue and lips appear erythematous, and the posterior pharynx has no exudates or tonsillar hypertrophy.&nbsp; Which of the following additional examination findings would be consistent with this patient&#39;s presumed diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"723\" src=\"https://www.uworld.com/media/highresdefault/L12671.jpg\"  ></p><p>This patient with prolonged fever has clinical findings consistent with <strong>Kawasaki disease</strong> (KD), a systemic vasculitis of primarily medium-sized arteries.&nbsp; In addition to <strong>fever for &#8805;5 days</strong>, patients have at least <strong>4 of the following 5</strong> mucocutaneous findings:</p><ul><li><strong>Conjunctivitis:</strong>&nbsp; bilateral, nonexudative, limbus sparing</li><li><strong>Oral mucosal changes:</strong>&nbsp; erythematous, fissured lips; strawberry tongue</li><li><strong>Polymorphous rash:</strong>&nbsp; often beginning in the perineal area</li><li><strong>Distal extremity changes:</strong>&nbsp; erythema, <strong>edema</strong>, desquamation of the hands/feet</li><li><strong>Cervical lymphadenopathy:</strong>&nbsp; &gt;1.5-cm node</li></ul><p>Of these clinical criteria, this patient has conjunctivitis, mucositis, rash, and a 2-cm cervical lymph node.&nbsp; The additional finding most consistent with KD is <strong>distal extremity changes</strong>, which are often the last to develop.&nbsp; Similar to other KD manifestations, edema and erythema of the hands/feet are related to vascular inflammation and fragility; skin desquamation often occurs several weeks after fever onset.</p><p>A high index of suspicion must be maintained in any child with &#8805;5 days of fever because the diagnostic findings of KD may not present in a particular order, and some symptoms may resolve before the onset of others.</p><p><strong>(Choices B and E)</strong>&nbsp; Fever can be prolonged with Epstein-Barr virus (EBV) (eg, infectious mononucleosis) and some cancers (eg, leukemia), which often present with diffuse lymphadenopathy (eg, inguinal, axillary) and splenomegaly.&nbsp; However, patients with EBV typically have an exudative pharyngitis as well as posterior cervical lymphadenopathy (not seen here), and leukemia does not explain this patient&#39;s blanching rash or conjunctivitis.&nbsp; Moreover, lymphadenopathy in malignancy is often nontender and matted, unlike this patient&#39;s tender and mobile cervical node.&nbsp; Splenomegaly and noncervical lymphadenopathy are not features of KD.</p><p><strong>(Choice C)</strong>&nbsp; Petechiae represent bleeding from extremely small vessel capillaries, often due to thrombocytopenia, and are an expected finding in Rocky Mountain spotted fever.&nbsp; Unlike this case, the associated rash typically spreads from the extremities toward the trunk, and patients often have severe abdominal pain.&nbsp; In addition, an isolated, enlarged cervical lymph node is atypical.&nbsp; Petechiae are not characteristic of KD, a primarily medium-vessel vasculitis associated with thrombocytosis.</p><p><strong>(Choice D)</strong>&nbsp; Scarlet fever may present with fever, exudative pharyngitis, and a sandpaper-like rash most prominent along skinfolds (eg, axillae, groin).&nbsp; This patient has no posterior pharyngeal findings, and the rash is present only on the trunk.&nbsp; Moreover, this patient&#39;s conjunctivitis makes scarlet fever less likely.</p><p><strong>Educational objective:</strong><br>Kawasaki disease presents with &#8805;5 days of fever in addition to 4 of 5 mucocutaneous findings: conjunctivitis, mucositis, rash, distal extremity changes, and cervical lymphadenopathy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 15668,
            "topic": "Kawasaki disease",
            "titleId": 15668,
            "title": "Kawasaki disease",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Extremity edema",
                    "choiceNumber": 1,
                    "correctTaken": 2935,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inguinal lymphadenopathy",
                    "choiceNumber": 2,
                    "correctTaken": 309,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Petechiae",
                    "choiceNumber": 3,
                    "correctTaken": 387,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sandpaper-like skin texture",
                    "choiceNumber": 4,
                    "correctTaken": 1055,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Splenomegaly",
                    "choiceNumber": 5,
                    "correctTaken": 351,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29131549",
                    "mediaDataId": 0,
                    "title": "Diagnosis of Kawasaki disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29131549",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 189,
            "othersAvgTimeSpent": 89,
            "notes": null,
            "peopleTaken": 5037,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 58,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 39,
            "questionId": 10921,
            "questionIndex": 12057,
            "questionText": "<p>A 29-year-old woman comes to the office due to a 6-month history of numbness and pain in her arms.&nbsp; The pain is worse on the left and is exacerbated by lifting or other activities.&nbsp; Associated symptoms include fatigue, fleeting joint pains, and a 5-kg (11-lb) weight loss.&nbsp; Medical history is unremarkable, and the patient does not use tobacco or illicit drugs.&nbsp; She emigrated from Vietnam 5 years ago and works in a furniture repair shop.&nbsp; Blood pressure is 140/90 mm Hg in the right arm and 90/55 mm Hg in the left; pulse is 78/min and regular.&nbsp; Conjunctival and oral mucosae are moist and without lesions.&nbsp; Cardiopulmonary examination shows clear lung fields and no heart murmurs; however, a bruit is heard in the left supraclavicular fossa, and the left radial and brachial pulses are decreased.&nbsp; Abdominal examination is unremarkable.&nbsp; No skin lesions are present.&nbsp; Complete blood count, electrolytes, urinalysis, and renal function are normal.&nbsp; Erythrocyte sedimentation rate is 80 mm/hr.&nbsp; Which of the following is the most likely diagnosis for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T78961\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Takayasu arteritis</strong></p></td></tr><tr><td style=\"width: 30%;\"><p align=\"center\"><strong>Risk factors</strong></p></td><td style=\"width: 70%;\"><ul><li>Female</li><li>Asian</li><li>Age 10-40</li></ul></td></tr><tr><td style=\"width:25.0%;\"><p align=\"center\"><strong>Symptoms</strong></p></td><td style=\"width:75.0%;\"><ul><li>Constitutional (eg, fever, weight loss, fatigue)</li><li>Arterioocclusive (eg, claudication, ulcers) in upper extremities</li><li>Arthralgias/myalgias</li></ul></td></tr><tr><td style=\"width:25.0%;\"><p align=\"center\"><strong>Examination findings</strong></p></td><td style=\"width:75.0%;\"><ul><li>Blood pressure discrepancies</li><li>Pulse deficits</li><li>Arterial bruits</li></ul></td></tr><tr><td style=\"width:25.0%;\"><p align=\"center\"><strong>Diagnosis</strong></p></td><td style=\"width:75.0%;\"><ul><li>Elevated inflammatory markers (eg, ESR, CRP)</li><li>Chest x-ray: aortic dilation, widened mediastinum</li><li>CT/MR angiography: wall thickening, narrowing of lumen</li></ul></td></tr><tr><td style=\"width:25.0%;\"><p align=\"center\"><strong>Treatment</strong></p></td><td style=\"width:75.0%;\"><ul><li>Systemic glucocorticoids</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>CRP</strong> = C-reactive protein; <strong>ESR</strong> = erythrocyte sedimentation rate.</p></td></tr></tbody></table></div><p>This patient with exertional arm pain (likely claudication), systemic symptoms, and left arm pulse deficits (likely left subclavian stenosis) has typical features of <strong>Takayasu arteritis</strong>, a chronic <strong>large-artery vasculitis</strong> that predominantly affects <strong>Asian women age &lt;40</strong>.&nbsp; It primarily involves the aorta and its branches and is characterized by mononuclear infiltrates and granulomatous inflammation of the vascular media, leading to arterial wall thickening with stenosis, occlusion, or aneurysmal dilation.</p><p>Initial symptoms are nonspecific (eg, fever, arthralgias, weight loss).&nbsp; As the disease progresses, vascular involvement with <strong>arterioocclusive manifestations</strong> (eg, claudication) may develop, particularly in the upper extremities.&nbsp; Examination findings include <strong>blood pressure discrepancies</strong>, <strong>pulse deficits</strong>, and bruits due to localized arterial stenosis.&nbsp; Patients commonly have elevated inflammatory markers (eg, erythrocyte sedimentation rate [ESR], C-reactive protein).&nbsp; <strong>CT or MR angiography</strong>, the preferred diagnostic modality, may reveal <a href=\"4951\">thickening</a> of large-artery walls and narrowing of the arterial lumen.</p><p><strong>(Choice A)</strong>&nbsp; Coarctation of the aorta proximal to the left subclavian artery can cause pulse deficits and decreased blood pressure in the left upper extremity.&nbsp; However, systemic symptoms (eg, fatigue, arthralgias, weight loss) and elevated inflammatory markers (eg, ESR) would not be expected.</p><p><strong>(Choice B)</strong>&nbsp; Polyarteritis nodosa is a necrotizing vasculitis of medium-sized (eg, renal) arteries that can present with systemic symptoms (eg, fatigue, arthralgias).&nbsp; However, because the kidneys are the most commonly involved organ, renal function and urinalysis are usually abnormal.&nbsp; Large-vessel stenosis (eg, subclavian artery) does not typically occur.</p><p><strong>(Choice C)</strong>&nbsp; Systemic lupus erythematosus (SLE) can cause systemic symptoms, joint pains, and elevated ESR.&nbsp; It classically involves <a href=\"1256\">multiple systems</a>, including the skin (eg, rash), mucosa (eg, ulcers), kidneys (eg, nephritis), and/or blood (eg, anemia, leukopenia); it is less likely in this patient who has no skin or mucosal lesions and normal complete blood count, urinalysis, and renal function.&nbsp; In addition, SLE rarely causes large-vessel stenoses.</p><p><strong>(Choice E)</strong>&nbsp; Thromboangiitis obliterans (Buerger disease) causes inflammation of the small and medium-sized vessels in the extremities.&nbsp; As the disease progresses proximally, this can manifest as claudication; however, distal involvement (eg, digital ischemia/gangrene) typically occurs first.&nbsp; Thromboangiitis obliterans occurs primarily in heavy smokers.</p><p><strong>Educational objective:</strong><br>Takayasu arteritis is a large-artery vasculitis most common in women age &lt;40 of Asian descent.&nbsp; It often begins with systemic symptoms (eg, fever, arthralgias, weight loss) and progresses to arterioocclusive symptoms (eg, claudication, blood pressure discrepancies, pulse deficits).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 8657,
            "topic": "Takayasu arteritis",
            "titleId": 8657,
            "title": "Takayasu arteritis",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "4",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Coarctation of the aorta",
                    "choiceNumber": 1,
                    "correctTaken": 2503,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Polyarteritis nodosa",
                    "choiceNumber": 2,
                    "correctTaken": 854,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Systemic lupus erythematosus",
                    "choiceNumber": 3,
                    "correctTaken": 277,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Takayasu arteritis",
                    "choiceNumber": 4,
                    "correctTaken": 11642,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thromboangiitis obliterans",
                    "choiceNumber": 5,
                    "correctTaken": 304,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26033561",
                    "mediaDataId": 0,
                    "title": "Update on Takayasu arteritis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26033561",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24461381",
                    "mediaDataId": 0,
                    "title": "Diagnostic and classification criteria of Takayasu arteritis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24461381",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 150,
            "othersAvgTimeSpent": 58,
            "notes": null,
            "peopleTaken": 15580,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 75,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 40,
            "questionId": 3322,
            "questionIndex": 3322,
            "questionText": "<p>A 49-year-old woman comes to the office due to swelling and stiffness of the hands for the past several months.&nbsp; For the last year, she has also had intermittent episodes of pain and bluish discoloration of the fingers, especially when exposed to cold.&nbsp; The patient is unable to play tennis on weekends like she did before due to fatigue and breathlessness.&nbsp; She takes pantoprazole for heartburn and lisinopril for hypertension.&nbsp; The patient drinks alcohol on social occasions but does not smoke cigarettes.&nbsp; Temperature is 37.1 C (98.8 F), blood pressure is 140/90 mm Hg, and pulse is 78/min.&nbsp; Physical examination shows puffiness of the hands and skin thickening in the fingers, as shown in the image below.</p><p><img id=\"7102\" src=\"https://www.uworld.com/media/U28986.jpg\"  draggable=\"false\" ></p><p>Lung auscultation reveals bibasilar fine inspiratory crackles.&nbsp; Which of the following tests is most likely to be positive in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31109\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Systemic sclerosis</strong></p></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Pathogenesis</strong></p></td><td><ul><li>Progressive tissue fibrosis</li></ul><ul><li>Vascular dysfunction</li></ul></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Clinical features</strong></p></td><td><ul><li>Skin: telangiectasia, sclerodactyly, digital ulcer, calcinosis cutis</li><li>Extremities: arthralgia, myalgia, contracture</li><li>Gastrointestinal tract: esophageal dysmotility, dysphagia, acid reflux</li><li>Lungs: dyspnea, dry cough</li><li>Vascular system: Raynaud phenomenon</li></ul></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Autoantibodies</strong></p></td><td><ul><li>Antinuclear</li><li>Anti&ndash;topoisomerase type I (anti&ndash;Scl-70) (diffuse SSc)</li><li>Anticentromere (limited SSc)</li></ul></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Complications</strong></p></td><td><ul><li>Lungs: interstitial lung disease, pulmonary arterial HTN</li><li>Kidneys: HTN, scleroderma renal crisis (severe HTN, AKI, MAHA)</li><li>Heart: myocardial fibrosis, pericarditis, pericardial effusion</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>AKI</strong> = acute kidney injury; <strong>HTN</strong> = hypertension; <strong>MAHA</strong> = microangiopathic hemolytic anemia; <strong>SSc</strong> = systemic sclerosis.</p></td></tr></tbody></table></div><p><strong>Systemic sclerosis</strong> (SSc, often termed scleroderma) is characterized by connective tissue thickening due to fibroblast dysfunction and increased collagen and ground substance production.&nbsp; Cutaneous features include thickening of the skin that begins in acral sites (hands and feet) with edema that transitions to dermal sclerosis (<strong>sclerodactyly</strong>) and obliteration of skin appendages (eg, hair follicles, sweat glands).&nbsp; Vascular dysfunction (eg, <strong>Raynaud phenomenon</strong>) is present in most patients.&nbsp; Extradermal manifestations are common, especially in patients with more extensive skin involvement.&nbsp; Frequent complications include esophageal dysmotility, <strong>interstitial lung disease</strong> (eg, fatigue, breathlessness, fine crackles), and hypertension (due to renal involvement).</p><p>The diagnosis of SSc is based primarily on clinical manifestations and serologic markers.&nbsp; <strong>Antinuclear antibodies</strong> are present in almost all patients but are nonspecific.&nbsp; <strong>Anti-topoisomerase I</strong> (anti-Scl-70) and <strong>anti-RNA polymerase III</strong> are less sensitive but more specific and are associated with extensive disease.&nbsp; <strong>Anticentromere antibodies</strong> may also be seen, primarily in patients with limited disease.</p><p><strong>(Choice A)</strong>&nbsp; Cardiolipin is the most common phospholipid substrate used in antiphospholipid assays.&nbsp; Anticardiolipin antibodies are present in patients with antiphospholipid syndrome, characterized by arterial or venous thrombosis and intrauterine fetal demise.</p><p><strong>(Choice B)</strong>&nbsp; Rheumatoid factor is positive in a number of autoimmune disorders, most prominently rheumatoid arthritis.&nbsp; Anti-cyclic citrullinated peptide antibodies are a more specific marker of rheumatoid arthritis.&nbsp; These markers may be positive in patients who have an overlap syndrome with features of SSc, but most patients would have more prominent joint involvement (eg, symmetric morning stiffness).</p><p><strong>(Choice C)</strong>&nbsp; Antimitochondrial antibodies are associated with primary biliary cholangitis (primary biliary cirrhosis), which can present with fatigue, pruritus, and right upper quadrant discomfort along with an elevated serum alkaline phosphatase level.</p><p><strong>(Choice D)</strong>&nbsp; Anti-neutrophil cytoplasmic antibodies are present in granulomatosis with polyangiitis (Wegener granulomatosis), microscopic polyangiitis, and other forms of autoimmune vasculitis.</p><p><strong>(Choice E)</strong>&nbsp; Anti-smooth muscle antibodies are associated primarily with autoimmune hepatitis, which can present with a range of manifestations, from an asymptomatic elevation of aminotransferases to hepatosplenomegaly, cirrhosis, or liver failure.</p><p><strong>Educational objective:</strong><br>Systemic sclerosis is characterized by connective tissue thickening due to fibroblast dysfunction.&nbsp; Cutaneous features include thickening of the skin with dermal sclerosis and vascular dysfunction (eg, Raynaud phenomenon).&nbsp; Extradermal manifestations include esophageal dysmotility, interstitial lung disease, and hypertension.&nbsp; Anti-topoisomerase I (anti-Scl-70) is a specific serologic marker and is associated with extensive disease.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 209,
            "system": "Rheumatology/Orthopedics & Sports",
            "topicId": 3789,
            "topic": "Systemic sclerosis",
            "titleId": 3789,
            "title": "Systemic sclerosis",
            "topicAttributeId": 330558,
            "topicAttribute": "Autoimmune disorders and vasculitides",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Anticardiolipin antibodies",
                    "choiceNumber": 1,
                    "correctTaken": 544,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Anti-cyclic citrullinated peptide antibodies",
                    "choiceNumber": 2,
                    "correctTaken": 1278,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Antimitochondrial antibodies",
                    "choiceNumber": 3,
                    "correctTaken": 669,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Anti-neutrophil cytoplasmic antibodies",
                    "choiceNumber": 4,
                    "correctTaken": 970,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Anti-smooth muscle antibodies",
                    "choiceNumber": 5,
                    "correctTaken": 1403,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Anti-topoisomerase I antibodies",
                    "choiceNumber": 6,
                    "correctTaken": 10518,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26802722",
                    "mediaDataId": 0,
                    "title": "Systemic sclerosis: an update in 2016.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26802722",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 46,
            "othersAvgTimeSpent": 46,
            "notes": null,
            "peopleTaken": 15382,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 68,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "abstractList": null,
    "deckList": [
        {
            "deckId": 9788456,
            "deckName": "Notes",
            "deckColor": "#36c8a3",
            "isDefault": true,
            "dateCreated": "01/01/0001 12:00:00 AM",
            "noOfFlashCards": 4,
            "groupId": null,
            "studySettingsId": null,
            "lastStudyDate": null,
            "isCustomStudyDeck": false,
            "parentDeckId": null,
            "customStudySettings": null,
            "subscriptionId": 0
        }
    ],
    "newExamYearQuestionList": null,
    "flashCardList": null,
    "questionModes": [
        {
            "id": 1,
            "name": "UNUSED"
        }
    ],
    "subscriptionElapsedTime": 0.0,
    "isFacultyControlled": null,
    "endCATTest": null,
    "questionSourceIds": null
}